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Clinical*observation suggests that there is a timo-lag
between administration of corticosteroids to asthmatic patients and
the appearance of improvement. This study was designed to fol¬
low changes during the period forty-eight hours before to thirty-
six hours after the administration of a single oral dose of 40 rr
of Prednisolone to chronic asthmatic patients. The investiga¬
tion was divided into two stages. Besides the effect of pred¬
nisolone, the effect of a single intravenous dose of 200 mg hydro¬
cortisone was also studied in the second stage. A number of
pulmonary function tests was us d to monitor the effects of the
drugs given. ,,,
.A statistically significant improvement in F.E.V. (P< 0.025)
could be detected onp hour after prednisolone administration, a
statistically significant increase in P.E.F.R. (p< 0.001) occurred
two hours after the drug had been given. In the group as a whole,
the maximum change in various tests occurred nine hours after pred¬
nisolone had been given. The change in P.E.P.R. and F.E.V.^
xvas still statistically significant (P<0.05; P<0.05) thirty-three
hours after administration of prednisolone but had fallen to non¬
significant levels by thirty-si:: hours. However specific con¬
ductance when last measured, thirty-six hours after treatment, was
still significantly increased in the second group of patients
Use other side if necessary.
studied (p< 0.05).
In contrast, the mean change in P.E.F.R, was significantly-
increased, one hour after the intravenous injection of hydro¬
cortisone, the peak effect being attained in five hours. Tie
mean change in P.E.F.R. was no longer statistically significai
*
twelve hours after the injection.
Pulmonary gas exchange was studied before and nine hours
after the dose of prednisolone, in the second stage of the study.
Arterial PO^ rose in all patients and the alveolar-arterial PO,,
difference decreased. Dead space:tidal volume ratio showed
little change.
The changes in pulmonary function found in the chronic
asthmatic patients investigated duringihis study appear to follow
the time course of other biologioal effects of corticosteroids,
such as those on carbohydrate metabolism and circulating eosino¬
phils.
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SUMMARY:
Clinical observation suggests that tbere is a time-lag between
the administration of corticosteroids to patients suffering from
bronchial asthma and the appearance of improvement in their condi¬
tion. Although various time intervals hav been suggested, no
systematic physiological studies have previously b en carried out.
This study was designed to follow the course of events during
the period forty-eight hours before to thirty-si}: hours after the
administration of a single oral dose of 40 rag of prednisolone to
patients with chronic asthma. The investigation was divided in
to two stages. Besides the effect of prednisolone, the effect
of a single intravenous dose of 200 mg hydrocortisone was also in
studied in the second stage. Great care iras taken in selecting
patients to ensure that they were in a stable state. Patients
were given placebo tablets on two days prior to the adrninistration
of prednisolone and on the following day. dleven patients were
studied during the first stage of the investigation and twelve pati¬
ents during the second stage. Various pulmonary function tests
including dynamic and static lung volumes, body plcthysmographic
measurements and flow-volume curves were used to monitor the effect
of prednisolone. The tests were performed at fixed times during
the day. Peak expiratory flow rate was measured hourly for
twelve hours after the administration of hydrocortisone.
A statistically significant improvement in P»E.V«. (P4. 0.025)
could be detected one hour after prednisolone administration, a
statistically significant increase in P.E.F.R. (P 0.001) occured
two hours after the drug had h en giv n. In the group as a whole,
the peal: effect inP.J.Y.^, F.V.C., P.J.F.R. and SGaw occurred nine
hours aft or prednisolone had been given. Flow-volume curves
a :cured at the mouth and static lung olunes showed parallel changes.
The change in P.J.F.R. and was still statistically significant
(P O.Opj P O.Op) thirty-three hours after administration of pred¬
nisolone but had fall n to non-signifioant levels by thirty-si hours.
Howover, specific conductance when last measured, thirty-six hours
after treatment, was still significantly increased in the second
group of patients 3tudied (? 0.05).
In contrast, the a an change in P.J.F.R. was significantly in¬
creased at the time of its first measurement, one hour after the
intravenous injection of hyirocortison , the p ak ff ct being at¬
tained in five hours. Eh® mean change in P.J.P.R, was no longer
statistically significant at the time of the led measurement,
twelve hours aft r the injection.
Pulmonary gas xchange was studied before and nin hours aft r
the dose of prednisolone, in the s cond stag of the study.
Arterial P0o rose in all patients and the alveolar-arterial PO^ dif¬
ference deer as. d. Pead spacestidal volume ratio show d little
change.
The changes in pulmonary function found in the chronic asthma¬
tic patients investigated during this study appear to follow the time
cours of other biological eff cts of corticost roids, such as those
on carbohydrate metabolism and circulating eosinophils.
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ii?racr<JCTiog«
The word asthma is derived from the Creek, which means
"panting". The first clinical d scription is attributed to
Aretaeus (ca. 300) who, emphasising the br athlessn so of asthmatic
patients wrote, "they agerly go into th' op n air, since no house
sufficeth for their r spiration". Van Helmont (1662) has provided
us with a vivid description of a. monk who had attacks "as oft as any
place is Sw pt, or the Wind doth otherwise stir up the the
same monk also had attacks when "he eateth Fishes fried with Oyl".
This is probably the first refer nc to all rgy being involv d in
th aetiology of pjatiuaa. He is also thought to be the first to
suggest that asthma is du to a "drawing tog th r of th small st
terminal bronchi" (Speiss, 1843)• Perhaps th most i tailed
description of asthma is that of Thomas Willis (1S84) who idntifi d
two forms, "pneumonic" and "convulsive". H associat 4 "pneumonic
asthma" with "obstruction of th- bronc i by thick humors, sv? lling
of their walls and obstruction from without". He b li ved "con-
vulsiv " asthma to be due to "compression of th' Bronchia, fro 1 the
n re Cramps of the .moving fibres". In 169Q, Sir John Floyer,
hiras If an asthnatie, published his classical book on asthma.
He adopted " illis's classification of two forms of asthma which h
called "periodic" (convulsiv ) and "continued" (pneumonic) and
assign-d as a caus for th paroxysms "a contracture of th macular
fibres of the bronchi".
Long t, in 1842, first demonstrated that stimulation of the
distal end of a cut vagus nerve induced contraction of the bronchi.
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He gave mom ntum to th th ories of "nervous asthma", first hinted at
by Cullen (1784) and which w re laborated by Hyd Salter (1368) who
believed that th lesion of spasmodic asthma resiled in the vagus.
3alter*s book is notable in its icoount of the clinical aspects of
th" disease; he d-scrib d eosinophils in the sputum before they came
to be called as such by ihrlich (1279) •
For a long tine asthma v;as consider d to be a disease of moderate
morbidity and negligibl mortality. Inde 4, Oliver Wendell Holmes
is quoted in Osl r*s book as calling asthma "the slight ailment that
promotes longevity" and Trousseau call d it "1 br vet do longue vie".
Until Hubor and Ko ssler*8 paper in 1922, it had, be n claimed that
death did not occur in th asthmatic paroxysm. AltTrough the
dangers of asthma are now fully appreciated, it i3 disturbing to
com across statements in th literature such as "Bronchial asthma
alone rarely cans s dath. When it does prove fatal it is due
eith r to th concurrent bronchitis and bronchiolitis or to h art
failure (cor pulmonale)", (Sp nc r, 1958).
Between 1959 «ad 1956 a at ady rise in mortality from asthma
was observed in Sngland and Wales, th increase being more pronounced
at ages 5 - 34 y are. Speiser t al (1953, a) showed that th
rise was r al and not due to a change in diagnostic dhols or regis¬
tration of cause of death. A similar but less marked increase in
d aths from aathaa, largely confined to the 5-34 age group has
also been reported in Scotland (? nireigh, I9S8). Speizer et al,
3.
(1963, b) subsoquently examined tho possible r aeons and concluded
thai th incr asa in mortality was most lik ly due to changes in
treatment. Sympathomimetic aerosols and corticosteroids w re
th only drugs to have been us i by a larg proportion of th pat-
i nts who di d. The use of corticosteroids, which had b en
introduced in 1951, did not s em to b relat 4 to th cause of
d ath and sympatho aim tic .-aerosols, introduc 4 in 19>j1, ver in-
criminat d. Following the publicity giv n to the possible
dangers of xc ssive inhalation, ther was a drop in sales which
has been parallel d by a downward tr n-d in the r ported number of
deaths due to asthma (inr.man and Adelstein, 19695 Fras r et al 1971)•
Sev ral aechanis .is wher by sympathomimetic aerosols light be
responsible for the incr as in asthma death rate hav be n sugg s-
ted. The induDtiawa of fatal oardiao arrythmias by sympatho-
aim tie drugs, esp dally in th hypoxic stat , is on of the xplamo¬
tions giv n (Lockett, 1965; Gr enberg and Fines, 1967; and Collins
et al, 1969)• Fluorooarboms, used as prop 11 nt agents in the
a rosols, have also be n blam d for producing arrythmias (Bass,
1970). Mor recently, Conolly and his co-work' rs (1971) hav
claim d that prolonged administration of th se bronchodilators
might r suit in resistance b ing developed not only to the sympatho¬
mimetic drugs thorns lv s but also to endogenous sympathetic stimula¬
tion. They suggest that this could hav led to the let rioration,
and finally to death, in asthmatic patients using syapathomim tic
aerosols.
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JUrthiaa, which may boat b regards! as a coople functional state
which can be trigger d off by a wide variety of agents, still presents
a gr**at number of difficult problems and th ro are far nor qu-.stions
to be asked than nnsv rs to be given. Although there have been
several attempts at defining the condition (Ciba Gu st Symposium,
1959? American Thoracic Society 1962; Scad-ding, 19^9)t there is still
no agr e 1 nt betv?een clinicians, respiratory physiologist8, Immunolo-
gists and pharmacologists on a final d finition. (Working Group on the
definition of Asthma, 1971).
Haturally, this lack of agre :aent on a final definition, aak*rs
the s lection of patients for a study of soma of the aspects of
asthma rather difficult. In contrast to the great amount of work
carried out on the effect of sy; pathoni tic drugs ii asthma there is
scanty information available r garding th time course of action of
corticosteroids in this condition and comparatively little data on
how thes drugs alt r pulmonary function in asthma, A syat -matte
study of th effects of corticosteroids in chronic bronchial asthma
has therefor be n carried out in an attempt to try to find out wh n
and in what raann- r pulmonary function alters with this fori of treat¬
ment .
For the purpose of this present work, chronic asthma is defined
as a oondition in which diffuse rev rsibl airway obstruction is
pres nt continuously, with, an! son ti cs *ithout, brief spontaneous
remissions. It was consider d impractical to carry out this study
on acutely ill pati nts. The r asons for this were two-fold.
Acutely asthmatic patients frequently require otter for is of therapy,
such as intravenous aainophyllin, which i Quid interfere with the inv
tigation? it would have been un thioal to withhold such drugs from
these patinta. Furtheraor , pati nts with acut asthma, b cause
of the v ry nature of their illness, would have found it extremely
difficult if not istpoeslbl , to co-op rate fully in carrying out r -
p at dly th number of tests employed in this study.
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to-: aetiology of bronchial astk:a*
The aetiology and precis*- pathogen sis of bronchial asthma are
3ti 1 uncertain although a great deal of evidence is now forthcoming
about the various factors that are capabl of triggering off an
attack. The relative importane of gen tie pr disposition, enviro¬
nmental allergens, immunological techanisns, infection .and emotional
factors, in det rntinlns the diff rent patt ms of the Us as is far
from ol MP* It apparo likely that thee- various factors contri¬
bute to a diff rent d gr e and in a diff rent aann r in various
pati nts and act upon some final common path resulting in tho clini¬
cal picture that is so w 11 known.
(i) Her lit .ry factors.
As early as 1916 Cooke and Van d- r V or etr ss d the hereditary
nature of allergic die is e. Hawev r, as pointed out by Ratnr
and Silb rnann (I953)f although tho clinical evid nc of inh ritance
of atopic diseases is often very sugg stive, th evidence is not as
conclusive as it is sonetia- s made out to b .
Williams and Williams (1949) found that about rff of patients
gav a history of allorgy in c os relatives • Schwartz (195?)
proluc i evid no suggesting that asthma is an inherited disease
and pointed out that both vasomotor rhinitis and Desni r*s prurigo
were gen tically r latei to asthma. His evidence for a her di-
tary factor in the aetiology of aethm has been claim d to be the
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b» Bt available in the literature (Frankland 1968). fl jiwilj
r lation betwen asthnja, atopic dermatitis and atopic rhinitis has
also be a found by Sohnyd r (19'50)* Leigh and Karley (19-7)
found that about 43, of first d.gr e rlativ s of patients with
asthma develop d the disease by th age of sixty-five years.
Hajka (1960) pointed out that what nay be inherit & is not
th allergic manifestation but the .allergic disposition. Al¬
though it has been suggested that atopy is d t©rained by a single,
autosomal, dominant gene with reduced penetrance (Schnyd r, 19^0),
the xaet g netic factor and the nod inh ri co are still far
from certain.
(ii) fccainologioa.1 gap etc.
Bronchial astbaa is often very broadly classified into two
major sub-divisions, * ••xtrtnaic* and •intrinsic* asthma. In
xtrinsio asthma an e ternal allergen can be 4< nonetrated, the age
,
of onset is usually early and a Type I ((toll and Coombs,
i':aediate allergic reaction is generally the caus . The t ra
intrinsic asthma was applied by Rackeiaaan (1947) to desorlb a
group of patients in whoa no external all rg n could be shown
(prick tests being negative to a wide range of antigens) and whose
synpto .es began in adult life. Although the division is a con¬
venient on , it oust b realise! that it is only provisional, as
allergic factors .say in lu cours bo iiscov red (Crofton and
Douglas, 1969).
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The type of hypersensitivity most commonly encountered in
-xtrinsic asthma is that due to a Type I immediate r action.
In Type I allergy th antibody responsible for m dieting the release
of pharmacological factors responsible for this kind of asthma was
originally termed "reagin" (Coca and Grove, 19?5)• It is a heat
labile, *non-aggluti.oating*, 'non-precipitating* and *non-co nple v nt*
d pendent* antibody. Reagin has been shown to b long to a s par-
ate class of immunoglobulin (Ishizaka et al, 19^6, Johansson, 19^7)
now termed Ig3 (WHO, 19*>8). Igd is pr sent in very small quanti¬
ties in normal individuals, but 1 vels of ov r 700 ng/nl, repr seat¬
ing a si -fold increas , wer found in "S3 of a s ri s of patients
with extrinsic allergic asthma (Johansson, 19'7) • IgS appears to
b produced in the lymphoid tissu of the respiratory tract, especi¬
ally in the tonsils and in plasma cells in bronchial walls; as well
as in the gastrointestinal tract (Ishizaka and Ishazaka, 1970).
It has recently been shown that leuoocyt s capable of r leasing
histamine when challenged by an allergen ar mainly coated with Ig'i
iamunoglobulin (Assea and cAll n, 1970). Stenius and his associ¬
ates (1972) found no correlation between total Ig£, amounts of
specific Ig3 and the age of onset of asthma or with its sev rity and
duration. Total Id may also b within the "normal" range in
atopic subjects in whom specific Igi3 is pr sent.
There are innunerabl allergens that have been implicated in
reagin mediated asthma. Th r include such commonly ncounter i
substances in the environment as pollens, animal land r and fur,
and the rec ntly i scrib d hous dust mite (Voorhorst et al, 19^4).
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Besides the well established vidence for the role of in netLate
Type I allergy" in bronchial asthma, it now se ns probable that asth.oa
.my also be initiated by hypersensitivity mechanisms whioh do not in-
volv* reagin. P pya (197?) thus subdivides xtri sic asthma into
atopic and nan-atopic types. P pys and his co-workers (19">°, 1969)
have sho n that precipitating, h at stable antibodies, which ar comp¬
lement dependent and known to b important in Type III reactions, may
play a part in asthma developing slowly over sev ral hours, becoming
maximal about s ven to ight hours after all rgn e posur . In
thiB type of e trinsic, non-atopic asthma it is the particular nviron-
nental --yposore which is of primary import one , wher as in the Type I
group it is th subjects constitution which is so (? pys, 197^).
Late asthma of this typ has be n associated with Aspergillus fUniga-
tus infection and has also been shown in bird fanciers using avian
protein extracts and in work rs rposed to nzjrrsss extracted from
Bacillus subtilis. In certain circu ist anc a, .g. bronchopulmonary
asp rgillosis th re may be a combination of Type I and III reaction.
Th patients when challenged with attracts of Asp rgillus fuaigatus
d velop iam diate airway obstruction which rapidly r solves, only to
r cur after four to fiv hours, wh n it is .ior sever and persistent
(Pepys et al, 1958)*
Intrinsic asthma remains a very obscure form of the disease.
'Th re is no evidence in this fori of asthma of any history of e trin¬
sic all rgy or of a Typ I allergic reaction to skin or inhalation
tests. IgE lev Is in this group have been reported to b either
normal or low (Johansson, 19;67) in contrast to the raised lev Is i
10.
extrinsic asthraa in which a direct relationship has "been shown between
the amount of IgS and the number of allergens to which the subject re¬
acts (Wide et al, 1967). In the intrinsic asthma the blood eosino-
philia tends to be higher than in the extrinsic form. Assem et al
(1971) have reported that the white cells of some intrinsic asthmatics
t^hose total IgE levels are within the "normal" range, seem to have
more IgS attached, of a comparable degree to the IgS content of the
white cells of extrinsic asthmatics. This appears to constitute
some evidence of an IgB reaction in the intrinsic asthmatic. Hall
et al (1966) first reported that women with intrinsic asthma appear to
have increased amounts of autoantibodies especially to gastric parie¬
tal cells, thyroid and nuclear materials, compared with women with
extrinsic asthma. Smooth muscle antibody has also been found in a
small but significantly greater proportion of patients with intrinsic
asthma (Turner Warwick and Haslam, 1970)* I"t is unlikely that
these antibodies are responsible for intrinsic asthma and probably
only indicate an increased immunological responsiveness present in
patients with this form of asthiA (Turner Warwick 1971)• Of
course the possibility that non-immunological mechanisms may have a
role to play cannot be discounted; .
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(iii) Possible role of ph;rmaco1 ogica1 :e li-vtors in bronchial asthma.
Most of the Imowledge at pres at available about the various
chemical a diators and their possible role in bronchial asth a, has
be n obtained fro, esp riments in th guinea pig, in which the res¬
piratory tract is th first target organ to react, and react in¬
tensely, to anaphyla. is. Herrh in r ( 19 '7) wrot "gain a pig
bronchi react in % similar -my as hwuian asthmatic bronchi".
These rperiaents have served as a basis for a much narrower range
of clinical investigations in nan. Although Pharmacolagists
point out that the chemical mediators released following an anaphyl¬
actic re notion are similar and their effects on trachea branchial
ousele comparable in the two species, i nmiolagists hnv found out
that th' sensitizing -echnnisa of guin a pig anaphyla- is differs
from that of atopy in mn (B no rraf, 1963). Interpretatian of
results obtained in animal p ri ients oust therefore be applied
•ith groat caution to the human situation. Thus although 5-
Hydroxytryptn.iin is iopOMB to be an important che deal mediator in
some species th re is no direct evidence connecting it with ha san
bronchial asthma.
..'hen isolated lungs of sensitiz d guin a pigo are perfus d
with antigen in saline, various bronohoaotive subctmcos or their
precursors appar in the p rfusatc. Those substances includ
histamine (Bartosch, P ldberg and Bagel, 1932) slo* reacting sub-
stano of anaphylaxis (SRS—A) (Kellcray and 'Prethe* io, 1940),
"...alli-'xein (Brook1 hurst and Lahiri, 1962? Jonasson and B cm r
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1956) and the prostaglartdins E2 and F? (Piper and Vane, 1959)?
See ntly a factor abl' to attract eosinophils, called eosinophil
1 ucocyte ohenotactio factor of anaphylaxis (EOF-A) (Kay and Austen,
1971) has be n identified* In man, definite vidence is not/ avail¬
able that histaain- , SR5-A and 3CF-A are Pharmacologioal . ediators
associated with anaphylaxis. Ho reports on the release of kalli-
kr in or bradyklnin from antign-stiaulated sensitized human tissu
have b en published; thia is also true of the prostag andins E1, S2 and
F? .
Hiotadno^
Since the identification of hista- sine by Barg*r and "ale (1910)
and the let; ruination of its pharmacological actions by B&l - and
Lai Haw (1911) ther has be s 1 great 1 al of evil ne linking
histamine r lease with hypersensitivity. Kats and Cohen (1941)
first reported that histamine was released from the tissues of an
allergic individual wh a they skewed that whole blood of a pati nt
with ragwe-d hypersensitivity lib rated histamine when incubated with
antigen* Histamine was 1 ter shown to b released by the antigen-
antibody reaction from human isolated lung (Schild t al, 1951; Hawkins
and Mongar 1954; Parish, 1967; Asses and Sehili, 1968). Phe
available data regarding blood histamine 1 vsls in asthaa is oft a
conflicting. Some authors have r ported increased levels during
attacks and normal or only slightly si vated lv la in the asympto¬
matic period (Ji sen a-Piaz ©t al 1955; Konoehita, 1953); others have
found no increase in blood histamine levels in asthmatic patients
("®?' Is and Vfel mans, 1956) or in nine?"* histaniw lew is (Beall*
13.
1963) • Serafini (1948) measured blood histamine 1 vels during
aathmatie attacks over a p riod of 1 Ohours, samples of blood being with
drawn at fix! time int rvals. He report d an initial rise in
blood histamine at the onset of the attack, quickly follow d by a drop
to belo?-- normal values. Porter and 'itchall (1970) have rec ntly
r ported blood histamine lvels, in childr n with asthmatic symptoms
which were significantly higher than in a control group. Phesa
levels fell to near normal values in th asymptomatic period and
during long-ten st raid treatment. Phe significance of histidine
1 carbo ylase, th onssym - involved in the formation of histaain is
still not suffici ntly appr dated. It is known however, that its
activity can be very quickly incr as d as a r suit of stress (Broc1 le-
hurst, 1968); and it is conceivable that this might veil be one of the
mechanisms involved in the triggering off of asthma during periods of
particular stress.
(b) SRS—A
Ther is a great leal of indirect evid nc indicating that SRS—A
has a rol to play in asthma, although the importano of such a role
has not as y t b en definitely evaluated. SRS—A was detectable when
lung tissue from asthmatic subjects was brought into contact with the
sensitising antigen (Brooklehurst, 19^) and bronohooonstriotion was
induced in man when it was inhaled as an aerosol spray (Her A'dra r and
Stresenann, 1953). It is known that the contraction due to SRS—A
is very long lasting, much more than that produced by histamine.
>111 the videnoe at pr seat available s ems to indicate that SRS-A
is formed by nzyndo processes activated by th© union of antigen with
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reaginic antibody, vher as histamine is r leased from a pre-formed
store (Brocklehnrat, 197'D) • However, although it is fair to con-
clui» that SRS-A appears to have a rol in asthma, because it is as yet
very much an unidentified substanc on.- can ojily speculate about its
importance.
(c) .Brulykinin,
Ther- is very littl evidence available in the literature
about the formation and role of bradytdnin in bronchial asthma.
Austen (1971) shoved that it had no action in th normal subject
when administered by aerosol and that th response report d in
asthmatics by Herxh i.a r and Stresenann (19 >1) could have been non¬
specific. Ther has be a one r port however, that the blood
kinin lev 1 is raised in aev re bronchial asthma (Ab et al, 19^7)•
( d ) ?rQ3t ogl wilins
Prostogiandins ar naturally occurring fatty acids that are
widely distributed in a variety of tissues. Thir chemical
structure was first deter,du d by B rgstrom and his co-workers
in 1962. Small amounts of the prostaglandins 32 and P2 have
been shown to b released from th guinea pig lung during anaphy¬
laxis (?ip r and Vane, 1969) but such observations hive not y t
b en report d in man. Prostoglindins 32 and P2 have both be n
isolated from human lungs (Anggard, 1965? Karia et al, 1967)*
Sweatnan and Collier (1970) found that PG32 relax e isolated human
bronchial uscle vhilst contraction results when PQP2 is applied.
Heither atronine nor mepyramln® decreased the< response prcduo~d by
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PGP2 and ther fore it do s not appear to act by stimulating
cholinergic nerve3 or by releasing histamine. Cuthbert (19'9»
1971) reported that inhalation of PQS1 and BfiEg r~suited in an
iricr -is in the F3V1 in asthraatics. Hedquist (1971) has sha*m
a drop in SGaw in normal subjects after the inhalation of PGEF2 ;
this .1 cr aee in SOaw was ov r in ten ainut s, Phe function of
prostoglandins in the normal lung i3 unknown and their r Intionship
with bronchial asthnia re gains to be prov-n. Horton (19^9) sug¬
gested that overproduction of the bronchoconstrictor PQF2 at the x-
pense of th rola ants PG"^ and PO.d^ light e plain changes assooia-
ted vith bronchospas.;. ibis, hovev r, is still rare speculation
and th re is no evidence to support it. It has b en claimed that
and increase lcucocytic cyclic AMP levels by ati ulating
adenyl cyolaso (Lichtenstein et al, 1971).
(iv) ITon-i . unologioal echmi .s in asth > •..
In addition to the inrainologioal aspects of asthma it has been
suggested that this condition may also be due to a functional imbal¬
ance of th; autonomic nervous system. Phis hypothesis was first
put forward by dppinger and Hess in 1917 when they introduced th ir
concept of vagotonia nd suggested that asthma night be duo to an
rc ssive cholinergic activity.
More recently illiais (1950) claimed that "a consid ration of
all rgy as a result of a dysfunctional prcpond ranee of the cholinergic
portion of the autonomic nervous system seems to fit the availabl
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evidence best". How ver, a perin ntal support for these stat —
m nts has bc-n lac ing until conparativ ly rec ntly.
An important advance in the study of the autonomic nervous
system was mad© by Ahlquist (1943) who first sugg std that the
differ nt pharmacological ff cts of air nergic drugs on smooth
Muscle could b accounted for if one accepted th eiat nc of two
sets of rec ptors which h designed alpha and b ta, in or n or the
target organs affected by thes substanc s. Beta adren rgic
action, ;as proiuc d for e ample by isoprenallne,is associated with
bronchial smooth utuscI relaxation, ayooardial stimulation and
periph ral vasodilation. The b ta reo ptors wer further sub¬
divided into the Pi r-captors which were cone rn 1 with the ff eta
&
on the heart and the"? rec ptors "hich w re mainly associated with
bronchial smooth muscle r ia .ation (Lands t al, 19^7)• Id is
now generally b li vel that the b ta rec ptor is an naytae, ad nyl
cyclase, (Sutherland and Rail 1950; Belleau, 1957? Robison et al,
1957) 'hich is thought to be located in the cell membrane, and
indications are that it nay be a lipoprotein, (Sutherland et al,
195?). Adren rgically activated adenyl cyclas catalyses th
formation of cyclic 3»5 - A,!',?., an intracellular nucl otide, from
adenosine triphosphate, in the preS'-nc of magnesium ions.
Cyclic 3,5 - A. .?♦ then functions as an intracellular mediator of
adren rgic action (Sutherland et al, 1953). Stimulation of alpha
rec ptors is claiaed to caus bronchoconstriction but as will b
discussed further on, ther is still sons controversy as to th
existence of alpha receptors in the lung.
Weiss and his co workers (1929) reported that intravenously
administer d histamine produced a fall in vital capacity in asthmatic
subjects at dosage lev 1g which loft pulmonary ventilation unaffec¬
ted in normals. The hypersensitivity to histamine present in
asthmatic subj cts has no be n dnonstrated by a nunb r of workers
and shown to persist ev nil th aayiptonatic phase. (Curry 194^5
Bouhuyo t al, 1960; Powell et al, 19^6). Parfenjev and Gooiline
(1948) showed fiat mice which are usually resistant to th effect of
inj ct d histamine, lev loped hyp rs nsitivity to this drug after
th injection of a vaccine prepared from 3or! tella pertussis.
Investigation of this phenom non in aic and rats by Pishel, Ssenti-
vvnyi .and Taloag© (1962) showed that the administration of dichloro-
isoprot renol, a b ta-adren rgic blocking drug, increased their s n-
sitivity to histanin to the sanw e te t as the inj ction of the
Bord tella vaccin . Thes authors sugg at d that histamine hyp r-
sensitivity is th result of a functional imbalance b tv en the alpha
and b ta roc ptors. Sz ntivanyi (1958) v.-eat on to propose th'-
theory that partial b ta-udren rgic blocked is the major caus of
bronchial hyp rs asitivity in asthma.
Th so observations gained in importance when KoKelll (l9r<4)
r ported that propranolol, a beta adren rgie r oeptor blocking drug,
re.duc d the vital capacity in asthmatics -and that this was not r ver¬
sed by isoprenalinc. Similar effects on asthmatics given proprano¬
lol for cardiac conditions were r ported by Beaterman and Pri dlanler
(19^5)• Using the PUVj as an index, Zaid and B all (1$66) were
unable to show an increase in hypersensitivity to histamine in
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normals, following the administration of propranolol. Using a,
body plethys iograph, . oN- ill and Ingram (1955), however, showed a
50 to 100 per cent increase in airway r sistance in normal subjects
within the first thirty minutes of a&ninistration of th' beta
blocker. Richardson and Sterling (1969) reported a mean fall of
34,9. in specific conductanc in asthmatics folio ing intravenous
propranolol but showed no change in normals who wer given the drug.
iLacDonald et al (1967) had also reported a rise in airway resistance
following intravenous propranolol administration and showed that
this effect • is largely prev nt 1 by atropine. Linger (195?)
si alarly showed atropine antagonism of propranolol aerosol off ct
in asthnatic pati nts. icdanald and, his co-workers conclud d
that this bronchoconstriction could be explain d on th basis of
unoppos d vagal activity* Subsequent r ports confirmed that
atropine aerosol pr vented a 1 cr as in FEV. in asthmatic patients
vrho had b en giv n propranolol intravenously (Cfri eo 1970» Grieoo
and Pierson, 1971)*
The effect of beta adren rgic receptor block rs has also ben
attributed to their unmus-ing of alpha adrenergic roc ptor activity
in bronchial smooth usele (PI isch ot al, 1973). Th pr sonce
of alpha adren rgic r ceptors in bronchial smooth ruiocl is a natter
of son controversy. Pcrater (1965) found no vilence of alpha
rec ptors in the trachea of the guin a pig and the sat e conclusion
was roach ! by Cabeaas et al, (1971) who studi d the airways of dogs.
Giurgis and IcN ill (1969) studying isolated human bronchial muse le¬
also reported results sir*g sting that th adren rgic r ceptors in
tkA human bronchi are of the bete type. Bronchial aloha receptors
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have, ho- «v r, been shorn to e lot in ao « animal spcia (Castro ie
la !4ata et al, 19&»? >v ritt and Calmeroes, fethe ?t al
(1971) Have present 1 evil no , froa their studies on isolate! stripe
of hu ;an bronchi, that alpha receptors '©r' pr sent, although they
app xr 1. to bo sparse.
Oovendaraj and K rr (19$?) and Kerr et al, (1970) showed that
in asthmatics, bronohooonstrietion occurring after histamine admini¬
stration could be i hibitel by the alpha-bloc1 ing drugs phono ybcn-
zauine and phentalanine. Although the® workers claimed that this
effect vas due to the alpha rec ptcr blockad , their evidence for the
presence of these .rec ptoro is inconclusive as both drugs are known
to have additional effects which tight tnv contributed to or ©v n
oaus-d this eff ct. fas pheaoryberusamine is known to ter an
anti- istaaia© action which is as powerful as my of the anti-hist-v*
'dnes us d clinically, and ph ntolain hue a direct ction on th
adrenal a dull ', leading to an incr as- of cat cholaiin-s, (Sood.n&n
and ail-on, 1979). Tfcyr-o in© has been described as the tost
select! alpha adr nergic bloclcing drug availobl at present
(Brownie , 19^') and is -no n to be without effect cm beta receptors
(MrajllghSffl Sad Szolosanyi., 19*>5)« It also lacks the aired
actions s en vith other a&r nergic blocking drugs* Bianco t U
(1972) first demonstrated that thy o . .in© prevent© 1 :ost of the
led in in specific conduct-one cause I by th inhalation of 400 g
of histamine in four aonal subjects. Saddle t .1 (1977) using
thy.'iO arise show-1 tJy.it it had a protectiv effect against hietaiine-
induood broachaeonstriction in e trineic asthmatics. Phey sug¬
gested that this una evil no for th" pr-s-rass of alpha adrtm -r«ie
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receptors in human bronchial uscl®.
The evidence for the xistence of alpha receptors in hunan air¬
ways is based on the us of alpha adrenergic blocking drugs to pro¬
tect against hietanine-inducd bronchoconstriction. Ho-qv r,
the vicien.ee is not quite conclusiv as ven thyao amine, which ie
the most sel ctive of the alpha block rs is known to hav a weak
antihistamine ruction., (Birmingham and 37,01 sanyi, 19<S5)« Thus
unopposed cholinergic impulses might b responsible for the broncho-
constriction r suiting from beta adrenergic bloc? ad , the a ohanisns
and relative importance of which in the aetiology of asthma are still
to a gr at xt nt unknown.
Although the aetiology of bronchial hyp raotivity in asthma
and the .cchanisns by which it is pressed are uxic rtnin, (Cade and
Pain, 1971) hypersensitivity of th bronchial tr a s ems to be the
.cost basic functional def ct demonstrable in asthma, ("^e Vries et al
1962); Parker et al 19*>3)» Hypersensitivity Iocs a t sc n to be
related to the typ of asthma (id in and Salvaggio, 1966) nor to s x,
age, initial 1 vol of aimays obstruction or treatment with cortico¬
steroids (Cad© and Pain, 1971).
(v) Other factors associated in asthma.
(a) Respiratory infection.
Acute r spiratory infections are often known to trigger off
attacks in asthmatic patients. These infectio s are also known
to increase the reactivity of th bronchi to metacholine aerosol
both in asthmatic patients m w 11 as in nomal subjects, (Paoker
t al, 19^5). The caus of this alter d r activity is unknown.
Phere is soae evicl nc suggesting a rol for raiorobial products in
the d velop ant of bronchial liyp r-reactivity. Thus Cooke (1947)
reported attacks of asthma developing in asthmatic patients follow¬
ing injections of autog nous bact rial vaccine. Si rilarly Hajos
(1963) showed that attacks v re provok d when asthrntios inhaled
a roeols of influenza virus or bacterial vaccines, and Hampton et
al, (1953) showed the ©arse effects with an aerosol containing an
er tract of neisseria eatarrbalis. Ou 11 tt and Reed (1965)
noted that asthmatics rer • sore s nsitive to met -.choline foilaiming
an injection of kill d influenza virus vaccine; normal subjects did
not slim; this increase in s nsitivity.
Various microbial products are known to be able to r lease
son of the p-araccological mediators of bronchoconstrictio .
Th nature of such, a microbial activity is not known but is pre¬
sumed to be a ncm-imnunologioal direct effect on such c lis as the
mast cells (Sa ntivanyi, 1971). The o: oto in, to in, from
Staphylococcus pyogenes has been shown to lib©rat histaiin (Brown
et al, 1966) as have endotoxins from 3. ooli (~)uvi 3 et al, 1963).
(b) Psychological factors.
It has been a long standing clinical observation that emotional
factors and stress frequently precipitate attacks of wheeaing in so r
asthmatic patients. Hippocrates 'rota * th© asthmatic should
guard himself against his own anger*. Dkk r and Green (1956)
showed that attacks of astbm. could be regularly produced in ®os» of
th-ir aathmtio patients by inducing an iety by discussing with then
e.-iotianally charged situitions derived from th-ir cas histories.
Luparello and his co-work-.rs (19^9) carried cut son® v ry interesting
work showing that suggestion operated in asthinatic patients. -They
asurod changes in airway resistance and showd that alnoat %' of
the patients studied showed an i:acrease when gi -n a bulis d saline
to inhal , and w re told that it was th allergen which the patient
had previously associated with his attacks. In a number of those
an inhaled saline placebo rev- rs A the attacks of broor" • ooonstriction
which had developed. In a s cond study, Luparello et al (1970)
gave their asthaatic patients isoprenalins and carbaohol to inhale
under double-blind conditions, suggesting to then that on<-- was a
bronchodilator .and the other a branchoconstrictor. The sugg s-
tions r suited in significant changes in the r spans-- to the drugs
in th- way that had b en suggested. Re s (19^7) rr-ported major
psychological stress icnediat ly preceding the ons t of asthma in
35;* of 800 asthmatic patients. Zeal lay t al, (1970) investiga¬
ting psychopathoiogy in asthmtic patients conclud d that traits of
sensitivity, arai ty, obsession, d pendency .and low self-confidence
ver commoner in asthmatics than in nomal controls. They
point d out however, that psychopathology n sd not be i mplicated as
the causa of the asthmatic diathesis; it is as likely that concomi¬
tant psychopathology only det nines th clinical presentation.
hcFadden t al (1969) showed that the asthmatic response to
suggestion could b abolished by atropine and sugg at d that it was
thus raediat--d via efferent cholinergic pathways. Hyp rv ntilation
is a conmon accompaniment of intense e action and could possibly be
another n*ethod !*y which stress could pr oipitate asthma since hypocap-
nia is known to lead to inor as. 1 ir'.-ay resistance (JTevhouse t al,
19^4).
It is worthwhile considering that Francis Rack'osssum had to say
on aathna as far back as 1931; "The situation is somewhat amlagou3
to that of a loaded gun. A good deal of knowledge is b ing ob¬
tained about the great vari ty of triggers which fir th charg ,
but why is the gun loaded ? And what constitut s the load ?w
'
As alio 11 in the prcc ding s ctions, his questions are still far from
answered more than forty y ars later.
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HE PATHOLOGY OP BRONCHIAL ASTHMA.
Most of the knowledge at pres nt available about the pathology
of asthma has been obtained from lungs of patients dyixig in status
asthnsaticus. Little is known about the pathology of the Ess
sev re forms of asthma. However, important information has also
ben yielded from bronchial biopsy material and sputum studies.
At post-mortem the striking f ature is that the lungs often
appear ov rdist nd d and fail to collaps • They hav be n
likened to the lungs in fresh-wat r drowning (Sough, 1955).
S ail area of collapse involving a small number of s coniary lobules
I
are oft a n en and occur most frequently along the ant rior margins
of the lung. The cut surface of the lung shows the presence of
occluding iucub plugs and occasional areas of bronchiectasis and there
is a notable abs-nc of destructive emphysema, the archit otural
pattern of the lung b ing well 'maintained. Both the larg aad
the small airways may oontairt th mucus plugs but they occur typically
in the saga ntal bronchi and in the bronchi of three or four genera¬
tions distal to this. Any bronc.-.i otasis is probably s condary to
th absorption collaps - following bronchial occlusion by the mucus
plugs (Dunnill, 1970*
The outstanding finding in any section of asthmatic lung is
the presence of a d nse enidation in the bronchial lai n. The
rudat consists of both mucus produced from the glands in th
bronchial wall as well as a prat in-laden serous yuiat arising
from the increased permeability of dilated capillari s in th sub-
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laioosa. The presence of this serous component is thought to hav
en adverse effect on th ciliary action of th mucosal c lis (Hi1ding,
193^)• The o llular component of the icudat- is road up of eosino¬
phils tog ther with normal or d generate ooluraiar r spiratory epith-
elial cells* Shedding of ciliated imcosal cells has been descri-
b d as a constant feature in any asthmatic lung; and it is consider d
by sorie work rs to b du to the transudation of oedema fluid from
the submcosa through the mucosa (Dunnill, 1971)* San rkin and.
Evans (1965) have sction-d sputa from asthmatic subj cts and have
i monstrat-d that* the non-aiooid el meats of the © udate organise
into the strips and laainac which become the basis of the spirals
described by Curshrmann in 1883* Autolysis of th cellular
laments is thought to lead to th- formation of Charcot-L yd n
crystals. More recently Tteylor, (1962) drew attention to the
presence of compact clusters of columnar epithelium cells 1 known
as Crola bodies, in tho sputum of asthnetics.
A detailed description of th ohang 0 pros nt in the bronchial
mucosa of patients dying in status asthmatious has been given by
Tkmnill (196O). 'Mucosal o-deraa with separation and sh dding of
the superficial ciliated columnar o il lay r is a common finding.
Metaplastic or r generating epithelium is s en in all pati nts
dying of asthma. Eosinophils are often pr sent b tw en the
nucosal cells. Th- basem nt membrane is almost invariably
thicken i (Cardell, 1956, Rose and Raderraeeker, 1971; Eunaill, 1971)*
Electron-microscopic studies have shown that this thickening is due
essentially to an incr as of the collag n fibr s (MeCart r and
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Vazques, 1$66). Thr pr sonee of iamunoglobin d position just
below the bronchial pitheliua of biopsy specie ns from asthmatic
lungs has been demonstrated by irssunofluorescence and includ Ig3»
IgA and Igii (Callarane et alf 19^9)* Since IgC seems to be the
roajor irimnoglobin implicated in xtrinsic asthm it would be x-
pected that it should hav- be n found too# However, sinoe only
nirnit quantit i s of this highly active inaunoglobin are r quired
to induce symptoms, its deiionstration may be difficult.
The capillaries in the subiucosa are dilated and their endo¬
thelial c lis often oed natous. A cellular infiltrate is fre¬
quently pr sent in which osinophils are prominent but which also
contains lymphocytes and sen- mast c lis. ifocus gland hyp r-
trophy is g nerally thought to b pr sent. Marked tissue osino-
philia is frequent in asthmatic patients (Glynn and Michaels, 19&>»
Balvata, 19^8? Camel, 1971)* Eosinophils vmv- found mor fre¬
quently in bronchial tissues than in the blood or sputum, and in
general there was no relation between the numbers found in thes
three situations.
Salvato (1959» 19&8) biopsied the bronchial wall of asthmatic
patients before and during an asthmatic attack and found signifi¬
cantly lower mast cell counts in biopsy material removed from patients
during an pisod of asthra than in biopsy material obtained from the
same patients during the asymptomatic phase of the die as . His
findings were corroborate?! by th work of Cornell (1970» Id is
suggested that the paucity of the roast cells is almost certainly duo
to the fact that th y are i gramxlat I, and 'egramlated ast cells
cannot be identified in tissue s ctions. It is veil known that
legrviulation of ast c lis occur folio-ins .onaphyla is (I'ota 1953)
and treat—nt with the histain liberator 48/80 (Salvato 19<1,
1953)» It see s likely that ast oell ■ granulation in aethaa
has the sane functional significano . Although it is known that
nast cells are rich in biologically active substances such as hista-
uin , h parin, hyaluronic acid and oat probably si or- reacting sub-
stance of anaphylaris neither their precise physiological function
nor the possible role they .night play in conditions suoh as asthma
has as yet been deteruin 4 (Kahlson an ! osengren 1971) *
Connell (1971) also observ d an inverse relationship bet. ©en
th eosinophilic infiltrate and the aast cell content of th bron¬
chial wall; th gr at r th iiuab r of eosinophils, th fever the
number of roast cells. Archer (19^3) shoved that th behaviour
of roast cells light govern tissue eooiaophilia. V.'est (1959) poin¬
ted out that eosinophils app ar in mastocytomas only when th<re is
disruption of vast cells and W lsh and Or er (1959) describe phago¬
cytosis by eosinophils of granul s of nast c lis disrupted by 48/80.
Hence it is tempting to infer that in bronchial asthma the tissue
osinophilin is s -eondary to massive d granulation of mast cells
(Salveto 1968). Howav r, although it hits be n dmonstrated that
osinophils are capable of phagooytosing antigen-antibody conpl yes,
little is actually known of th ir action in asthma (ilansinger t al
1972), or of the inter-r latiorvships between eosinophils and mat
cells in this condition.
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On other stridng f ature in th pathology of usthaa is the
presence of mrked hypertrophy of th bronchial smooth .aaacle
(bpenoer 19=58) which was first described by Hub r .ud uoesslar in
1922. unnill t alf (19&9) found that 11.9 + 3*4. of the s g-
msntal bronchial wall was 'occupied by smooth nuscle in oases of
status asthoaticus compared with 4«6 +, 2.2; in normals* 2he
relative inportanc of bronchial smooth uscla hyp rtrophy ucosal
ood na mid plugs of tenacious .racus in the pathogenesis of airway
obstruction is discussed ere fully in the ne t s otion.
The role of snoot nuscl in noraal ai v p in bronchi.;! aarfchpn.
Since R iscei3on*s anatoaioal study of th bronchial nniscula-
tur-- and the demonstration of airway smooth ;iuecl in 188?, and
Varaier*s original observation in 1779 of its powers of contraction,
th re hav« appe red a m bsr of fundamental papers r vi wing its
structure, regulation of ton and. possible function (foldt, 1883?
ill 1921; : :',c.; 1 *.vt, 19?9? yss,195?» 'riddioonbe, 19&3? Olson et
al, 1957).
HeisBeisen point 4 out that the arohit ctural structur of
airway snooth muscle is such as to allow asily the adaption of
th rhythmic changes la length and width of airways, which h re¬
cognised to b an integral part of th psroc ss of breathing.
Toldt (1338) gives on of the arliest ;ore detail d 4 scriptions
of th mscl layer in th© bronchi? he described the muscle fibres
as b-'-ing arranged in a 1attic -like form (gitt rforaige).
Miller (1921) in hie classical paper on bronchial musculature con¬
firm d Poldt's description that the musculature surrounding the
bronchi and bronchioles is not in the form of distinct bands which
encircl th' airways but is in the fori of a network. He d es¬
cribed the muscle bands forcing th^ network as "geodesic", i.e.
lying along th short st rural path between any two points. H
stated that th s "g od sic" bands pr vented tangential notion,
and in this way provid d for the greatest amount of strength and
at the sane time permitting th gr at st amount of c tension and
contraction of th© airways. '. icklew ( '9-9) described the bron¬
chial usculature as a contractile n t embracing the .ucosa of th
entir bronchial tr e. The prevalent viet is that the smooth
usele rt nds from th trachea down to the alv olax ducts, (Widdi-
combo and Stirling, 1979). In the bronchioles and alvrolar ducts
th © .tooth mscl is thicker relative to the liars ter of the luu n
(Hue art,1913; MacV:lA*k, 19-9" '• "iddicoabe, 19 3) and it is to be a -
p ot d that changes in branchonotor ton would affrct the diameter
of these air:rays nor , both bccans of the greater bulk of smooth
mscl .and also b cause the centripetal fore du to mural t nsioti
varies inv rs ly with the radius - Laplace*s law ( Jiddiconb , 19^3).
The precise physiological function of airway smooth muscle is
still unknown ( ougl .s t al 1966} acxdea, 1971), and ther< is as
y t no general agre nent on th role that it sight play in airway
obstruction. Studi s p rfor.a d .0 detemin the effect of smooth
muscle tone on the .aschanical properti 0 of airways have resulted in
conflicting vidence. Radford and Lefco (1955) found that con-
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striction of isolated bronchi did not alter the length-tension
characteristics of the airways. Olsen and his co-workers (19^7)
however, found that this was only true of the trachea; constriction in¬
creased both the circumferential as well as the longitudinal t nsion
in bronchi. Bronchoconstriction led to a d crease in bronchial
compliance so that the airway became not only less distensible but
also less compressible. This would seem to indicate that in the
constricted state a greater compr ssing pressure is necessary to close
the airway than in th helaxed state. Olsen attributed this to
the pr sence of cartilaginous plaques in the aim-jay wall that are
pull d into an overlapping position when the bronchi are constrict d
extending the Collagen fibres between the plaques and increasing the
rigidity of the aim-jay.
Widdicombe and Nadel (1953) have put forward the suggestion that
smooth muscle tone helps to adjust the dead space and the airway
resistance to optimal values at which the -chanical work of breath¬
ing is minimal. Bouhuys et al, (1959) have suggested that in
small airways muscle tone may help to keep unequal gas distribution
to a minimum. Bouhuys and Van de Woestyne (197*1) measured lung
volumes, air ay conductance, iso-volume pressur flow curves and
static lung recoil curves in normal subjects before and after the
administration of a bronchodilator aerosol. Their results -
a marked increase in airways conductance with little change in the
flow rates of the maximum expiratory flow volume curv s - are in
keeping with 01sen*s suggestion that normal airway smooth muscle
tone in man may help large airways to withstand dynamic compression
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luring forced xpiration.
The relative importance of mucosal o dena and cong stion, ia-
cr as-- d mucus secretion, the obstruction of snail bronchioles by
tenacious mucus plugs, bronchial mscle hypertrophy and ;iuocl con¬
traction in the pathog nasis of bronchial asthma is still a matter
of some controversy. La*nn c in 1819 wrot "On concoit tres bi n
qu la contraction spasiodiqu- de ces fibres puisse tr' port©
assez loin pour etrangl^r 1 a conduits aeriens et empecher la p ne~
tration d- l*air dans un grand parti des poumons".
3ut although "bronchospasi" has long been regarded as an
important, if not the main, co apon nt of bronchial obstruction in
asthma, there has be n little direct proof of this. Franklaad
(1958) rightly nak~s a plea for th word •bronchospasm* not to bo
used in reference to asthma as its use would s en to indicat a
precise knowledge of the pathogenesis of asthma which e do not
have. Unlike aammalian striated muscle, which is activated
exclusiv ly by a cholin rgic effector system, mammalian smooth
muscle can b activated by a variety of endog nous and e og nous
agents (Somilyo and Soolyo, 1970). The causes of bronchoconstric-
tion are numerous and conpl 5: and not fully understood. Thus
various factors such as histamine, bradykinin, prostaglandins and
slow reacting substance of anapylamis are known to cause bronchocon-
striction (Collier, 1958); besides it se as lik ly that Chang s in
automatic balance play a part, for -a spl in the ff ct of emotions
on the bronchi. Schild ©t al (1951) xposed isolated bronchial
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uscl© frott th lung of IB asthmatic patient to a dilute solution of
the specific antig n to which th patient w&s known to b clinically
s nsitive and show d that it contracted. Rosa and '.cDowall (1951)
similarly starved contraction of a bronchial chain pr paration,
obtained from th lung of an asthaatio patient who underwent pn uuon-
ct o iy for a branchog nic c trcinom, when this wae brought ii contact
with a flour—lust © tract to which th patient was known to be aller¬
gic. Pottglas «t ill (19S5) d aonstrat-d hyperactivity of the
bronchi in asthmatics by a insuring the "squ ez " preasur e rt d by
th bronchi luring e piratio.i by j ans of a balloon in a s go ntal
bronchus.
Pharmacological r suits indicate that cholin rgic, presumably
vagal, nervous activity contributes to bronchoconatriction in aone
asthmatic patients, since ..tropin- has be n Motown for a long ti to
reliev airways obstruction in these pati ate (H r hei ®r, 1959?
Chamberlain et al, 1962; Altounyan, 1954). Hypocapaia, too .say
induce bronchooonstriotian in .»n, probably tediat d by the vagus,
(Sewhouse, 1954? Pirnay ©t al, 1954) and nay hav a larg r effect in
asthmatic than in healthy subj ots (Hafez and Cronptoa, 1958).
Hypooapnia is not unco; non in asthma of mil l to toderat severity,
is a result of hyp rv ntilation. Stirling (196-8) showed that
aeut hypo it causes -an increase in airways resistone in nor mal
subjects. He suggested that this is due to constriction of
bronchial smooth mod since it can largely be prev nt d by orci-
prsnalina. He showed that hypo- i \ sec as to act dir oily on th
bronchial tuscl a® atropine had no effect on the bronchoconstrio-
tion response.
fh© dominant role of smooth muscle contraction in th • patho¬
genesis of bronchial asthma ia now being questioned by various
workers (^hinnill, 19^9)» a® the importano of -oucosil oedema, in¬
creased :mcus s or tion and blocking of peripheral airways by tena¬
cious mucus plugs becomes increasingly more r cognised. PIoyer
(1593) pointed out the importance of mcus plugs in the pathology
of asthma, when he wrot "If the Pits continue long, vis. two, three
or four lays, the first two days non or little phi gn is spit up,
but on the third or fourth day it is cough*d up soriewhat dig sted
and 1 as viscid". As early as 1950*Pn 3oia de Kontreynaud r -
port d s sing on direct bronchoscopy, a rapidly forming bronchial
raxcosa oedema in all rgic subjects in whom asthmatic r actions v re
provok i by inhalation of op cific all rg no. Punnill (1960,
1969) spcculat d that the smooth muscle hyp rirophy found in
asthmatic lungs, where ciliary action is often defoctiv , was a
response to increased cl aranc of mdat«, possibly by a milking
action; as augg- st d in the cineradiographic study of Holden and
Ardraa (195?)» It is perhaps aor likely that it represents
work hyp rtrophy from bronohoco.nstriction (Takiaawa and Thurlbeck,
1971).
It thus s ens probable that in the arlier stages of an
attack active bronchoconstriction is the mjor factor, sine
dramatic relief is obtained with syipathoroinetic drugs, (Hiddioomb
and Stirling, 1970) hut when an acute attack b comes protracted or
the condition becomes more chronic, th situation is conplioat d
by oedema of the mucosa and by r tention of very viscid mucus.
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The at itua of the hypothala-ic-pituitary-adr nal a-is in asthma.
Since it was established that corticosteroid therapy is
frequently of great benefit in asthma, it has b en tempting to
postulat that fail-ore of th" adrenal cort >- -ray be an unci rlying
defect in aoa isthmtio patients. Recently there have been
reports of asthma occurring in patients with Addison*s dis as and
in one of thes asthma appeared to b th pr seating symptom of
adrenal insuffici noy (Oreen and Lin, 1971? Harris and Colitis, 1971).
The infrequency of asthma in Ad.dison#s die as , variously r ported
as 5.5 (Maranon t al, 1955) and 4 (Carry r et al, 1950), hos.-ev r,
ma>- the proposition most unlikely.
Several papers on adrenal function in asthaa hav bo a pub-
lished, some r porting inu-i quate basal function or inadequat re-
spons to str 33 and oth rs finding no videno© at all of sue., dys -
function. Thar has also b en one report by Siagal et al (1955)
in which increased levels of plasma 17-hydro /corticosteroids (17 OHCS)
ware found. Thes workers r ported that the plasma 1 vels of 17
OHCS were significantly higher in a group of patientB with moderate
(13.0 + 2.01 sog ) or a vere symptoms (18.8 + 7-51 meg ) than in
mild groups (3.3 + 0.51 icg) or in an asymptomatic group (3.3 +
0.61 meg ).
darly work rs using tests th a available, report i r duced
adr nal function in asthmatic pati nts (Rank• nann, 1945* driksson-
Lihr, 1951; Rose et al, 1955). Spaner t al, (19&>) found re-
duced levels of urinary 11-hydro-ycorticosteroids (11 —OHCS) during
an asthmatic attaok. Vaoareaza(l9<S1) reported normal plasm
Cortisol levels and normal values of urinary 17-hydro ycortico¬
st roids (17-OHGS) in 22 adult asthmatics hut a poor plasma Corti¬
sol response to corticotrophin stimulation. Robson and Kilbom
(1965) found that although plasma Cortisol 1 vels re normal at
rest, almost 10 of their asthmatic pati nts had a significantly
diminished response to an intravenous infusion of A,C»?.H.
Some evidence that the hypothalaaic-pituitary-adr nal ar-.is my be
impaired in asthma has r cently be n r ported by Collins et al
(1971). Three of th ir ight pati nts with acut asthma, who
had not previously rec iv d corticosteroids, had pretreatant
plasma 11-OCKS levels of less than 10 g p r 100 ml and all had
levels of 23 g or 1 ss. Th y coram nt that such 1 vels are w 11
below the rang e: pected in r spons to str ss. Low levels of 11-
OHCS could possibly r prrsent 4 or ss on of hypothalamic activity by
hypo: a- raia.
On th other hand, Kass and Appleby (19*50) found no diff rence
in the amounts of 17-OHCS >-;cret d in th uri e of asthmatic patients
and norraal controls, befor and after corticotrophin stimulation.
Sirailar results were publish d by Nelson et al (1966)• 31u men-
thai and his oo-workers (19-56) aeasur d plasma Cortisol levels,
urinary 17-OHCS and performed th oral m tyrapone test and measured
the response to intravenous A.C.P.H. in five patients with trinsic
asthma. Th y fail d to find any abnormality either during th
asymptomatic period or -when attacks wore induced with ragw el pollen.
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Dwyer t al (1967) too, r ported normal 11-OHCS r epons to intra¬
venous hydrocortisone in three asthmatic patients with acute epi¬
sodes who had n ver be n given corticosteroids.
A number of e planations can be put forward to account for soras
of thea iiscr panci s. The variety of methods us 4 for a asur-
ing corticost roids and their ra tabolites is an important factor
which aay have contributed to the differ nt results. The bio-
assay proc durea used in many of the arlier studi s are known to
yield rath r variabl results, sp cially wh a comparisons ar made
b tv? en differ nt laboratories. Th patient population studied
also appears to b widely differ® t. The type of asthma, its
sev rity and the pres nc or absnc of associated complications
or diseases are but a few of the many ways in which the subjects
of t. various studies have diff red. dach of thes variables
nay affect corticosteroid lev Is. Fh nutritional status of
tiie pati nt nay also affect corticosteroid etabolis ,; thus ven a
low prot in, high carbohydrate diet nay result in a decrease of
both plasma and urinary cortioost roid 1 vsls. Similarly, con¬
comitant endocrin , r nal or liv r disease and drugs, such as pheno-
barbitone, may influ nc corticosteroid lev Is. Insufficient
data is provided to ensure that son of these factors wer not
op< rativ in a nuaber of th pati nts studied.
It app ars that dysfunction of the hypothala dc-pituitary-
adrenal axis is not a necessary pr disposing factor for th develop¬
ment of -asthma. But on cannot e: elude th© possibility that it
could well be a conditioning factor in sou patients, although the
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the relatively infrequent occurrence of atopic diseases in patients
with Addison's disease lends little support to this conjecture.
ALPiRS? r'ULMQM.iY ."U'dCflO-? IT? BIOSCHIAL AS'TH&v.
(i) Airways r aistance in asth ,a.
Increase-! airway resistance aay be said to be the physiologi¬
cal hallmark of bronchial asthma. Phis incr *s« in resistone
to th flow of air is w-11 reflect©1 in the physiological indices
us 1 as tests in its d teotion and monitoring. In gen ral, the
fore d e pired volu me in one s oond (PaVj): and the aa im ■ raid-
c piratory flaw rate (-8IFR) and the p ok piratory flow rate (P«E»
F.R.) ar found to b consist ntly decreased froa th predict d and
are usually veil re1st < d to th severity of syrapto n. However,
it is now r cognised that subjective improvement is not always nec¬
essarily reflected in a similar ohang in the tests s atiaad abov .
Phe ratio of the forced pired volu v in one second to th fore d
vital capacity ie also found to be reduced. Airway r*sistance
(R ;v) as measured by body plethysaagraphy provid s a dir ot measur -
i nt of the r sistanco to the flow of air. Various studi s using
body plethysmography have now been carri 1 out in asthmatic patients
both during th symptomatic phase as well as following th rapy.
Phe Raw is always i.ncr as d, frequently very considerably, and the
specifio conduct one (SQnw), that is the conductn.no livid d by th
thoracic gas volume at which th airway resistance is measured, oor-
r spondlngly d or as 1 during the aeat phase? both indices return
towards acrn-il values as th® pati nt^a condition improves (Lapp Le
Roy and Hyatt, 19671 HoFaddea and Lyons, 1968, 1969? Hersog et al,
1958; ?• las r and Thomson, 1969l Fisher t al, 1970| Daly, 1971}
Vassftllo «t a!f 107'}). An incr as-d Raw has b rm found to be
39.
present even during the asymptomatic phase in some asthmatic patients
(Ruth and Andrews, 1959? B rnstein and Kreindlr, 1953).
Cade et al, (1971) provoked hronchoconstriction in asympto¬
matic asthmatic subjects with nebulise metacholine. They found
that pulmonary resistance increased within one breath of the m ta~
choline inhalation and was the measurement of lung function which
changed most in response to the drug.
(ii) Lung volumes
The vital capacity is generally decreased in asthma and is
usually more s verely diminish d the greater the degree of airway
obstruction, A decrease in vital capacity not infr qu ntly p r-
sists during the asymptomatic phase of bronchial asthma. Levin
et al, (1970) have r ported values of vital oapacity as low as 4A
and 61'/' of the predicted in two asthmatic subjects who were clini¬
cally asymptomatic. Lowell et al, (1955) have used the vital
capacity to follow changes in asthmatic patients, but, on the whole,
it has proved a far 1 ss sensitive ind oc for this purpos • than .dyna¬
mic ventilatory tests.
A number of reports have appeared in which measurements of
Total lung capacity (T.L.C.) Functional Residual capacity (F.R.C.)
or Residual Volume (R.V.) in asthmatics w re found to be elevated,
thus reflecting the presence of a certain degr e of hyperinflation.
In fact, a rev rsible increase in T.L.C. has b en documented in
asthma as early as 1934, when fftrrtado and KaltreMer ob'Served a
40.
deor- as-- in T.L.C. following the administration of epinephrine to
patients with ncut asth:aa«
Turing an exacerbation of asthma the F.R.C. is frequently
levat 4 wher s the T.L.C. aay remain unohangei, . ;ay increase or
even decrease ( .'ooloock and Read, 1968). Before Sngatro^s
study of asthmatic children in 1964, no systematic study of the
s rial changes in the various subdivisions of the lung volumes
occurring during th<- various stages of this condition had b en re¬
ported. kigstroa found that the T.L.C. was above the predict d
1 vols in nearly all his subjects ven whon the children vers clini¬
cally asymptomatic. suggested that ther was an increased
rat of growth of the lungs in these children; his sugg stion is
however, unlik ly becaus when such childr n are maintain#! symptom
fr e over a prolonged period, subs qu nt lung volura measurements ar
within normal (Kraepelin, 1959)* Since then a number of pap ra
reporting the changes in lung volum s that occur luring acut asthma
and th period of recovery have been published (Wooleock and Read,
1965; " oolcook and Read, 19661 isner and Hugh-Jones, 1968; i.'eng
and L vison, 1969? Palmer and Pianent, 1969; Stan®son and. Tetulescu,
1970; Kayfield et al, 1971).
In general, the more sev re the degree of airway obstruction th
gr at r the amount of hyperinflation present, as shown by lsvat d
R.V. and F.R.C., and both indices tend to decrease following treat-
m nt. In son of the patients r ported by Woodcock and R ad (1965)
th F.R.C. during acute asthma was greater than the T.L.C. after re-
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covery. In th se patients tidal breathing during sever obstruc¬
tion was taking place at a higher lev 1 than the point of newimal
inspiration after recovery. Mead, I&lic-ddli and Turner (1963)
hold the view that inhibiti g r fl res normally limit the d gr e of
voluntary lung inflation; if this is true, t n one must presum
that such reflex s are modified in asihraa. Palmer and Moment
(1969) similarly found that as th airway obstruction increases in
asthma ther is a progr osive hyp rinflation of the lung and that
when th obstruction is r iuoei by a bronohodilator,hyperinflation
becoa s 1 S3. Of the indices of hyp rinflation they found that
only RV/TLC corr luted consistently with th dynamic lung volumes
and regard it as the b st single aeasur nent of hyperinflation in
asthma.
Cai- et al (1971) have inv stigated the mechanical prop rti s of
th lungs of five asy-ptoraatic asthmatics following provocation ith
nebulised aetacholine. Th re was an incr as in thoracic gas
volume in four of their subjects; th chang a r ached maoi.ium values
in a few uinut s.
Various studi s have not-.' been reported in which serial measure¬
ments of functional r aidual capacity by a helium dilution m thod
and thoracic gas volum by body pi thys-iography have b er. carried out
in asthmatics during the acute attack and in th subsequent recovery
period (Corb el, 1998; Keisuer and Hugh-Jon s, 1959} Stan sou and
Tecul scu, 1979; Woolcock b al, 1971)• In general, plethys10-
graphy yl Id d signific ntly larger values than did th helium dilu¬
tion 'nethod. The diff renee s v?ero greatest when the asthma was
42.
most e vere and d or asad during clinical rccov ry. As the
helium dilution method ccurat ly reflects the volume of ventila¬
ting paints of the lung, th re rust be significant portions of the
lung that fail to ventilate during the tin allowed for heliun
equilibration.
Hyperinflation may p rsiat in th© asthmtlc pati nt ven in
the asymptomatic phase, (B al et al, 1952? woolcock and Head, 19*56;
Gold st al, 1967? L vine et al, 1970). Weng and L Vinson (1969)
reported finding hyp rinflatod lungs in asymptomatic asthmatic pati¬
ents d spite normal maasurments of airway r sistance. Petit,
Melon and Melio-Cnili (1960) in a carefully controlled study in
asthmatics conclud d that airway resistanc my be doubled without
the occurrence of any significant ohang in F.d.C. There is as
yet little Air ct information on th relationship betve n inoreas d
airway r<sistance and pulmonary hyp rinflation in asthmatics (Bat s,
1lacklea and Christie, 1973)*
Th increase in F,3,C. toy bo compensatory to the decreased
branchial calibre found in asthma, and to a certain e tent this aay
hav a guy-rop effect in maintaining the patency of the airways.
This, however, is not obtained without con3iierabl cost to th pati->
ont, for as the lung volume increases, compliance diminishes pro-
gr ssively so that the further inspiration of a given volume of air
requir s the production of a higher tronspulraonory pressur differ-
oe because the subject is breathing on t fhitter part of th pr s-
sur -volume curv . The elastic work of inspiration will be great¬
ly incr m 1 and met .01'-. considerable contribution to the pntierrt*s
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sensation of dyspnoea. Asthmatic patients thus often find as
much difficulty with inspiration as with expiration (Woolcock and
Read, 1966).
(iii) The Lun vlastic recoil pressure in Asthma.
Macklera and Becklake (1963) and Ting and Williams (1963) have
both reported mean inspiratory static pressure-volume (P-V) curves
for normal subjects and for patients with asthma and those with
emphysema. In both studies the P-V curves for their asymptomatic
asthmatic subjects *were shifted upwards and to the left as compared
with the mean curve for normal subjects; i.e. it appeared that the
lung elastic recoil was reduced. Macklem and Becklake (1963)
corrected for the increased lung volume in some of their subjects
by calculating the "over-all compliance" (Mead et al, 1955)» i.e.
the ratio of T.L.C. to the maximum negative intrapleural pressure.
This correction reduced the difference between the normal group and
the group of asthmatics but accentuated the loss of elastic recoil
in the group with emphysema. Other studies had indicated that
patients with asthma have normal pulmonary elastic recoil pressures
(Wells, 1959? Tooley et al, 1965).
Several workers have since measured the lung elastic recoil
pressure in asthmatics both during exacerbations as well as in
asymptomatic phases (Gold, Kaufman and Ifadel, 1967; Woolcock and
Read, 1968, Pinucane and Colebatch, 1969). Gold and his associ¬
ates showed that the elastic recoil pressure was decreased at all
Tuns volumes in seven of their twelve asthmati r>. nnh ioo+o. a-p+^v.
a week*s treatment with corticost roids and bronchodilatora, th
increase in airway r 8istance and in lung volumea reversed to nor¬
mal and their P-V curv s moved back to th noraal range in all the
patients but on -. In the latter, a further we-■ k of tr at sent
finally r versed all abnormalities. Gold also intuoed broncho-
constriction in four asthmatics who had normal P-V curves and in
one normal subject with a 0.03 histamine phosphate inhalation.
Although this resulted in a jean airway resistance of 3?0 of the
control, the lung elastic r ooil regained normal. Acut hyper¬
inflation of the chest in a normal subject for an hour by a ans of
a negative pressure jack, t surrounding the thora also r suited in
insignificant ohang s in th' lung clastic recoil. It thus ap¬
pears that loss of lung elastic recoil is slow to i volop. In
a further pati nt whose treatment was disoontinu d for a week, Gold
and his co-workers found that th lung elastic recoil which had b en
reduced prior to treatment, remain d nor al, despit a r currence of
airway obstruction.
Ivoolcock and Read (1968) showed that during an e ac rbation
si- out of th: ir ten asthmatic sub j< cts had a decreased laotic re¬
coil. Unlike Gold's patients, howver, after intensiv th rapy
although the airway resistance r turned to normal in almost all of
th patients th© lose of lung elastic r- ooil and hyperinf1ation per¬
sist d in five subj cts.
Pinucane and Col©batch (1969) assessed the lastic properti s
of the lung in patients with asthma, emphysema and in normals by
m susuring the static ?-V curves of the luiig luring d flat ion from
r.L.C.oft- r a etaadard value history. The ?«»V diaracteristlos
of this Rtti\7 thus atinly reflect the elastic proportion of lung
tissu a aine th pulaonary retractive presour was ueasuretl during
deflation froa T.L.C. whan lung surfac force0 contribute 1 aat
(Radford, 1?64)« 7k'. y found that in asth. a compliance was eiadL-
lar to that in nor ml subjects but elastic retraction was reluc 4.
fh© P-V curves, showed that the » -tractive pressor of th lung vas
inversely relet d to T.L.C., b iag least iu th subject vith th
highest M-.C. r iitiv to the predicted I.L.C. and greatest in th
subject vith a norml f.L.C. In three of th four pati ats re-
stu'i d by Finucari© and Col batch, th re is a persistant r taction
of el -..stic r coil pressur lespite r 14 f of airway obst uotioa for
si oe a or longer. This finding agrees < ith that of Woeloock -nod
R. ad (1953) and it s-e-as likely that so « patients with eev re asthaa
ay hav a jot© or 1 ss pervan at reduction of el tstlo recoil pressure.
fb cause of the 1 ?ae of -1 vatic recoil of the lungs in asth-
mtio subjects is unknown. According to ?f«ad (19^1) th static
P-V curve is d pendent on tvo factors; the tension e rt 4 by sur¬
factant and the laatio propcrti 0 of pulnionary tiasu . 'Hie tic-
sue co potv nt of the elastic retraction of the lung resit s in th
iutimte association and arrange::ent of ooll.v* an ©lcstia fibres
in the r spirit or.v bronchioles, alveolar duets and alveoli .'.ffieroe
and i-Vrt, 190)• la nphya aa this fibre network is disrupted
( .'right, 19^0 and elastic r traction of the lung ' cull b- e pected
to b and is, in fact, r -iuced. In ssthaa the fibre a twork is
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intact (Sough, 1$55) h nc other factors . ust be responsible for
the loss of iastic recoil. Gold tt al, have suggested that pro¬
long d dierfc nsion of the conn ctive tissue of the lu gs causing tem¬
porary structural deformation is a possible c plauation. Other
alternative they put forward ar that th' changes could be relat 4
to the forces ©-: rt d by surfactant j or the changes say bo due in¬
directly to changes i perfusion of some alveoli which affects their
production of surfactant or scene other product important to th' nor¬
mal r tractile forces. Appur ntly surfactant is easily loot or
d srtroy i '.hen the segmental pulmonary art rial bleo1. supply is com¬
promised (~Jatt , 1951} Fcnley et al, 1954)* "tailor chang a are
r ported to occur with disturbances in arterial pK (Bergofsby et al,
1952) and hypo ia (3<vrgofoky et al, 1953; Soarpelli, 19?l). In
S or I, ho'-'ev r, such changes in surface t nsion would be c pected
to occur in short p rials of time and ill not require days or w eks
to tali" place.
Fimcane awl Col batch (1959) put forward th<- id a that th loss
of lastic recoil could be the r suit of 1 r luction of tiosu forces
du to tissue str ss-rela at ion (Fdrvrshr.il and "idlico .bo, 1951).
In asthma, stress-r la ation nay occur in those parts of t lung
h li inflat d by airway closure. Theoretically, the reduced re¬
tractive pressure in asthma, could involv increased recruitment of
surface-activ oloculf eonsenuent upon prolong! over-e p . .oion of
th lung (Tieraoy and Johnson, 1955)• The surfuc tension of a
liquid is known to b inversely relat d to th concentration of sur¬
face-act iv< molecules in the surfac ( avi s and Ride-1, 1951).
loolcock and Read (1969) suggested that hyperinflation of the
lung,oay itself, onus a reduction in lung elastic recoil, in a
manner in which they did not explain} they looked at th problem
from th© opposite point of view from that of Sold and his associ¬
ates, The latter considered the lose of lastic recoil to be
responsibl for th hyperinflation in asthma. If hyperinfl tion
of the lungs itself caue s a reduction in elastic recoil, th n a
residual abnormality in the airways sufficient to maintain a degree
of hyperinflation could accoutn for the apparent loes of lung elas¬
ticity in asymptomatic patients. This could possibly account for
the differ no 3 in results r ported by Gold et al, and the work re¬
ported by Tinucane and Golebatch, and Koolcock and Rrad.
patients report d on by Gold et al, all had normal lung volu® a when
the lung olastio r^ooil was i asured after a we -fc#8 th rapy, whilst
those r ported on in the other two studi s had p rsist at hyp rinfla-
tian. On other factor put forward by Wooloook and R'ad as a pos¬
sible contributing factor to the i or as i lung lastic recoil is th©
ff ct that prolonged corticosteroid therapy nay have on pulmonary
connective tissue. Thrr® is however, no viience to support this
possibility,
(iv) The pulnonary diffusing capacity (Th.) in fisthma.
There is some d gr e of controversy in the literature regarding
diffusing capacity valu s in bronchial asthma. Measurements of
diffusing capacity in asthma have now been performed during th asymp¬
tomatic phas- (Levine ot al, 197G) during an acut attack and in th
ensuing symptoa fr e p rioi (Weng and Levinsor,, 19^9) 11 as in
subjects in status a dh ~'ticus (Stan sou and Tecul scu, 1970)*
In a numb r of papers the diffusing capacity in asthma has
b en report d as normal. Among th<- first to r port normal valu's
were Bat e (195*5) and Hacklea and Becklake (1963) who used a steady
state method. ? .c. 1 ; and B okl&k reported that both the diff¬
using capacity and the elastic recoil ver well preo rv 4 in asthsaa
and contrasted this with th~ decrease in both parameters that occur-
r d in th emphysematous patients th y studied. Th y found a high
correlation between diffusing capacity and lastanoe in the sit en
asthmatic patients whom they studi d and interpr ted this as reflect¬
ing nor nl alvolar tissue. They found that at equivalent values
of conductance e iphyseraa is charactaria d by a considerably lower
diffusing capacity than asthma. Normal values for diffusing capa¬
city have also be -n r ported viv n this was easur i by th singl
br ith "ethod (3urrow3 t al, 1961 ; Kanagani t al, 1961; 'c?adden
and Lyons, 196®; isener and Hugh Jones, 1968; Daly, 1971 )• 'The
diffusing capacity was found to be normal even when th Flfy was
nark dly decreased (B dell -and Ostiguy, 1967; 1 cFadd n and Lyons,
1963; Ogilvie, 1968; * issuer and Hugh Jane;:, 1968).
On the other hand, ther ar now a nur.ib r of papers reporting
diminish-! valu e for diffusing capacity in asthma. Palaer and
Lfiataent (196>9» 1970) using the single breath method raeasur d the
diffusing capacity in all grades of s- verity of asthma and found
thst i* fel. 1 ei^i'ieently »« the «f asthma bcean"> more severe -
Thoy r ported a mean value for CO of 16.? + 7*3 ;;d/win/::dig
when the F'IT --^ns less than 40;- (the predicted being 26.1 + 2. JO ml/
nin/:: iHg) j this value improved T hen salbuta nol was administer d.
Wong and Levinsoa (19^9) nsasured the diffusing capacity by
the steady state a thod in thirty asthmatic children luring an acut
attach and repeated the oasur ate v en th y w-re sy pto —free.
Ph< y found that it was significantly reduced during an acut attack
but returned to the normal range, during the syopt :a free period.
The iodic s r'^ CO/TLC and QO/FRG vhich w re markedly r ducei lur¬
ing th attack remained significantly leer than nor:sal during the
symptom free period. Levin et al (1970) using a steady state
method report a lower than predict 1 valu in two of si asyuptoemtic
asthmatics.
Ctansscu and Teculesicu (1970) stulyi:-ig pati nts in status
asthuatieus and measuring the diffusing capacity by the single
breath method found this to be b- lav norra.il in thr.e out of el von
patients. Pollowing tr at went this indo increased in si patients
including two of thos with a lor initial v.lues. They attributed
the doorcase in diffusing capacity in thoir patients to the r lucoi
value of •effective• alveolar volume They consider d this de¬
crease of the diffusing capacity in their pati-mts with status asth-
aatioua is •apparent*, that is, not representing a true impairment
of diffusing capacity but m rely r fl cting a regional unevermesa
of function throughout the lung. The diffusion constant (r)j/^^)
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was normal in all their patients.
There have been a junb r of reports in which the diffusing
capacity has b en is our \ following the adainistation of broncho-
constriction aerosols. Boohuys est al (19®) acd Levis t ml (1961)
found a diminished diffusing capacity a asured by the steady state
ni thod following the administration of hiatal © and letacholine
a rosols. Bjur et al, (i960), hovev r, hav shown that th re
ic an increase m diffusing capaeity following the infusion of his-
taun. and attribut d this to the inoxv-ns in cardiac output that
occurs. Stanesou and T oulescu (19®) using a single breath
a thod ?. asurod diffusing oapacity before and aft r inducing broncho-
cocuBtriction with an acetylcuolin aerosol in eight asymptomatic
asthmatics and in five- normal subjects. Th diffusing capacity
wxs within norraal limits and fell in all subjects, returning to nor-
r«l in most of them ten to twelve .minutes lat r d spite a persistent
d or as in F3V^. It is prosu ed that this decrease is due to
Chang s in th distribution of diffusion in the lung to the alveolar
volume.
P cora, Berust in and Feldaan (196') measured the diffusing
capacity by tls sisigl br ath method in twenty si ohildr n with in¬
tractable asthma. Th-.y r ported that in si ic n children with
hyperinflated liuigs the diffusion capacity was gr r than predicted
whilst in the ten children who had no pulmonary hyperinflation the
diffusion capacity was normal. They suggested that this increase
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is du to a w derate increase in surface area of the lung and a
gr at r 1 cr -ase in the thiokn ss of the alveolar aerabrane.
Ggilvi© (196B)v too, reports higher than predicted values in a
nuiber of asth ; tics, and points out that an iabalanoo b t*»- en
antilat ion and p rfusion can so..:eti • n r suit in erron ously high
values. Kreuknit and Hiss r (1955?) showed that the steaiy state
diffusing capacity '.nay be rraieoualy high in astfcvu
?orster (1957) in hie classical review of the proc as e of
pulnonary diffusion and th ir ass ssnont refers to the rrors hioh
aay b introduc i by nan-uniformity of various ptranters. Al¬
though the cono pt of a diffusing capacity is not difficult to n~
visago, th details of its ae«suro: ent cd the interpretation of the
r suits obtain d by the various t ciiniques are far fro a straightfor¬
ward, specially in clinical conditions in which th re is non-ho..ao-
gn ous distribution of alveolar gas. Bates, hackle i and Christie
(1971) have £iscrib d the difficulty in sorting out the apparent dis¬
crepancy of th- diffusing capacity values in asthoa. obtained by vari¬
ous worl rs to four -sain factors - patient selection, variation in
degre of airway obstruction, iffar nc a in teohniqu- -and th uncer¬
tain interpretation of results obtained froa indue d bronchoeonstric-
tion. Bjub, th re is not infr quently difficulty hen selecting
patients, in differ ntiating between those suffering froa asthm and
those with chronic bronchitis with a d gr © of eaphysooa.
However, th interpretation of r-ports on diffusing capacity
in bronchial asrthna is perhaps oost curiously ha- ipf red by the
variety of sethods us i in its determination. It is obvious
that ^ach method r. eaaures something differ nt and probably none
a nsures th true :lffusing capacity of the *pulaanary tanmbran f.
fhe aocur cy of each arthod for a assuring this ind x of pulmonary
function dep ads on certain critical aasuoptions about the re-
lativ uiufor. dty of blood Iio->, v ntilntion and alveolar volume
and if one of th se assuaptioao is inoorreot th measures at bo-
co : a bias d (Forster, 1957)* Since th ' assumptions are differ¬
ent for each sethod of a-- ..assure <eat , a given type of noa-uaiforaity
in the luiig is apt to bi-i.8 the diffusing capacity .1 -sured by one
method oore than by another. dais possibility accounts for most
of the discr> paacy between th various reports. Ghana t al
(1972) xsasured the diffusing o&paoity in ten ay ptoaatio affth.v.i-
tics by both the single breath and steady stat methods b fore and af¬
ter treats* at. Jh- diffusing capacity xstsur d by th singl
br ath method was gr at r than predicted oa both occasions. fh-
mean pre-treat;a nt value obtained by the steady st it© ra thod was
51, of th pr<dieted and it vent up to 66, of th pr dieted following
therapy.
Hie oev rity of th- disease during which the measure' cat is
made is another important factor to Jeep in mind when assessing re¬
sults. Tests of diffusing capacity .mat b to a gr >t r or les-
s r o tent influenced by ventilation - p rfUsion abnormalities (Ap-
thorp and arshall, 1961).
53
Thus although the single breath method is sail to be less
• •
s nsitive to ventilation - perfusion (V,/Qc) abnormalities, in
severe cases an iiapaired distribution of inspired air, r gioaal
• • •
V^/Qc variations and the I)L/Q ratio can decrease the value of
th diffusing capacity obtain d by th singl raethod (Piip r and
Sikand, 1965).
The transfer of gas in bronchi -1 asthaa thus appears to br nor©
i ipoded by failure to d liver inspir d gas to th alveolar surfae
than by interfer nc rdth diffusion through the •pulmonary membrane*.
(v) /arterial blood gap tensions and pulmonary ma e chong .
Very littl attention was paid to th Chang s that occur in
blood gas s luring asthma until co .iporativoly r ceatly. Bates
and Christie (1954) stated that, "the patient with aoderat ly sav re
bronchospas*i but not in status asthmticus only rarely shovre any
significant abnormality of arterial o:<ygen saturation or carbon ii-
o id© t nsion". It had be n gnerally assumed that the PaCOp is
usually nor al or loir, due to hyporvsnti1ation until the terminal
stages of status asthaaticus, tshm the PaCOo rises rapidly and .res¬
piratory failur superven s (llarohand and van Hass It, 1956).
3efor the important paper of Tai and R ad in 1967 there had only
been occasional r ports of blood gas disturbances in bronchial
asthma (HerschfUs ct al, 1953; Williaas an Zofaman, 1960; Foldnan,
1962). Hrschfua ot al, studid fift on patients during attacks
of asthaa and found arterial o ygen Aesaturation in only two pati¬
ents. Similarly, h'illiasas and Sofcaan fount only slight desatttra-
tian - a lean of 8?;' - in el veil of their fift en patients. In
both series* none of th patients had a raised blood carbon die id
level.
Tai and Read (19«*7) «"» the firet to report carbon diaride
r tentioa, with arterial ?C0., values ranging up to 200 -r&l& and
narked respiratory acidosis* with a blood pH sub low as 6.81, in
t elve pati nts adrlttcd to their care in status aethrsetieus.
Urir data should that in other patients with only moderate clinical
e- verity oanaidcrr.br hyporaerla could also b pr sent. Similar
results have now been reported by a nuaber of tiff rent worV re
(Re s* Hilar and Ronald, 1968; roFadd n and Iyons* 1968? Meisn r
and Hugh Jones, 1968| Hiya-nota ©t al, 1978; R bud' and I'M, 1971)•
Arterial PQ, lev Is below CO rxM • nay b assooi&t d with PCS),, levels
varying b tvren 30 and 80 :x33g$ such a 1 vol of PafX, is cea 5oaly s en
vh n airway obstruction is sev re, with aa 18)7. b low 30' of the pro-
dieted normal value.
PIul y (1971) stat s that if -lid r cocoa ar included the
fall in PaOj 80 3 to b sr a roughly linear r lation to the ;
wraal PaO,, values being usual wh n th© is abov 2 litr s.
fai and Head (19^7) found a general corr latian b tw en th© degree <
of reduction of the F.J7j an! the art nt of disturbano of blood gas
tensions in th ir duly of si ty four patients with aoderately a vere
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asthm. Thay point d out that PdV^ levels of less than one litr
were especially associated with a significant r duet ion of arterial
POgf at the son- tine they ophasised that the corr lation was not
good enough to aahe PEIV^ lev Is greater than litre a reliable in~
d x of a fairly normal arterial o-ygen tension. The Ban- conclu¬
sion was reached by Hess ct al (1963) who Stat 1 that since incr as s
in KflTj w re not always aeooapani d by a rise in '?a0^f such changes
could not b relied upon to indicate irsprov d o yg nation. Pol¬
ler and diaiaent (196-3, 1969) report d a correlation b tw en PaO? and
the RV/?LG,', hypo; a la becoming progressively tioro a vere as hyper¬
inflation develops.
Rees, Hilar and Donald (1968) following th elinioal course
and art rial blood gas tensions of twenty four patients in status
asthmatious, found that hypo '.aenio was invariably present, was fre¬
quently quite narloed and persisted despit intensiv th rapy some¬
times for weeks, host patients -or - nomooapnic or even hypocap-
nio. Vihen sever hypercapnia - as present the patients gen rally
died. They found that changes in PaC0o w re inv ro ly related to
ahangea in pH and pati nte with s vere hyperoapnia had also a-- to-
bolic acidosis* The pulse rate correlated well with Pa0o and in
the sev' roly hypo aeraio patients the frequency e co ded 130 boats/
nin. McFnddon and Lyons (1968) studied ninety on patients dur¬
ing an -ncut asthmatic attach. All their patients had hypom *aia
but hypereapnia was only pros nt in olov pati Jits and was not found
till th FJ7^ f 11 to b law 20 of the predicted rnluo. Henco
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d spite the fact that (XX, retention is a prominent f nturo in sons
asthmatics with nark 4 airway obstruction, low ?00<, values indicat¬
ing hyperventilation .are frequently encountered. HypcKjapnia and
r spiratory alkalosis was present in about 80 of the pati nts
stuli d by IfcPaddsn and Lyons.
These studies tiav: deter dn d the facts that hypo aes&a, often
of dang reus d gr e, nay be pros nt in asthmatic pati nts, and that
sev re hyp roapnia is not usually pros nt xo pt terminally.
F Id'ian (1962) pointed out th grave prognostic significant* of an
inor as in PaOO, in adults vith s vero .sthrx..
i—
The sccoapanying disturbance in th aeid-bas balance -as re-
fl ct d in th arterial blood, sho> a that th© hyp roapnia in newt
of th so patients probably develops acutely. Flenley (1971) analy¬
sing the data from various authors (Heed et al, 19685 rithoef r et al,
1968 Tubb -and Ouorrant, 19681 Tai and R ad, 19''7? Sownos t al, 1968;
Simpson ot al, 1968)concluded that chronic elevation of PG0o is re¬
latively uneorar. n in aeth .a. The increased renal r absorption of
bicarbonate which is on important def nee against r spiratory acid¬
osis both in adults (Refsan, 19&9) and in children rith acuta lot: r
r spiratory tract inf ction (Simpson and Plenley, 19^7) tlais appears
to be too slot a n ohanisn to be of rent importance in acute asttoa,
in which dang reus hypercapnia my develop v ry .acutely. llithoa-
fer t al (1968) have found that corr ction of the r apiratory acid¬
osis by infusion of sodium bicarbonate wis valuable in tr ating in-
57-
tractable asthsa, feat ethers so ,n to have had 1 ss success with
this approach (Pleuley, 19T1)*
The mechanism of hypo aoraia, rith or without 00^ retention
i ipli s a oaldiartribution of v ntilatioci and perfusion in the
lungs which is shorn fey increased alveolar-arterial tension diffe¬
rences for ocxygen (A-a)POo and higher ratios of physiological dead
space to tidal volar* (VD/7T)# A higher than normal (A-a)DO,, and
VD/Vt has been shown to fe pr sent both during the acute attack (Field
1967? M- inner and Hugh Jones,1963} Valabhji, 1963)as well as during
th aaynptoa&tio phase (Levin et al, 1970; Wadd 11 t al, 1967)*
Valabhji'a data is at varianc with that of .,'add 11 t al (1967)1 for
in all his patients clinical recovery was associated with return of
A-aDO,, and VD/7T ratio to nearml lev Is despit spironetrie videnee
of persisting airway obstruct ion in about half of then.
Simpson et al (196B) report d a significant oorr lation betve 11
Pa0o and PaGO^ in children with acute asthma breathing air on adiais-
sion 1 -and suggest that alv olar hypoventilation might also at tiroes
aak- an important contribution to the hypo aesiia in ocut asthma.
Although uneven 'distribution of pulmonary ventilation in asthma
has tear cognised for a long tine in both the acute phas (Bates,
19525 Fowler et al, 1952; H rsohfus at al, 19535 Malmberg et al,
1963? Bat s et al, 1968) and in th© symptom fro period, (Beale ot
al, 1952), the offset of this on th distribution of pulmonary blood
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and the ventilation - perfusion relationships had until compara¬
tively recently received less attention. Single cases of asthma
• •
with V /Q disturbances had been reported by Donald et al, (1952) and
by West et al, (1957)• Leadbetter et al, (1964) in a stu y of
asthmatic children reported that an abnormally high percentage of
the cardiac output perfused the 'slow* or poorly ventilated compar¬
tments in the lungs.
The presence of adaptive mechanisms to divert blood flow away
from poorly ventilated region.- of the lungs were postulated by Bar-
croft, (1930); Anthony, (1930); and Haldane, (1935)* The observa¬
tion that hypoxia causes an elevation of pulmonary artery pressure
probably secondary to pulmonary vasoconstriction led von Euler and
Liljestrand (1957) to suggest that pulmonary hypoxia might play a
rols in controlling the distribution of pulmonary blood flow.
Recent work has in gen ral confirmed these suppositions. It is
now generally accepted that the concentration of gases in the alveoli
determine the resistance to blood flow in the adjacent vessels, and
that the chemical stimuli for this local vasomotor control are hypo¬
xia and to a lesser extent acidosis (Liljestrand, 1958; Fishraan, 1961;
Bergofsky et al, 1963; Fishman, 1969). Lopez-Majano et al, (1966)
produced unilateral hypoxia by means of a Carlens catheter using 100^i
W2 for seven minutes. By means of radioactive scanning following
131
the intravenous injection of I M.A.A. they showed that this was
followed by a marked decrease in pulmonary bloodflow to the hypoxic
lung. Evidence has also been .adduced by'other workers that a dec-
crease in bronchiolar PCOp will redirect ventilatipn,iiowards better
perfused parts of the lung, away
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poorly perftte d areas (S veringh&us and Stupfel, 1937? Arbore-
lius, 19^3). Kow vor, other mechanisms b aides hypoxia - induced
pulmonary vaeoconstricti on sight play a role in the r duet ion of per¬
fusion to poorly ventilat & areas of lu g (oolcoc et al 1936).
Although it see :s unlikely that local alterations in p rfosion
could possibly coapenoat for th un venaoaB of ventilation in
bronchial asthna, there is a lot of evidence to sugg fit that ouch
hemostatic mechanic is do e: iet in aefchna, and that th y t ad to r -
• »
•luce the V /Q d feet by deero-.aiiig tlx® blood flew of underventilated
lung units. Factors disturbing th so hora ostatie n ehanisne - ould
• *
b e-pectod to r suit in an increased V /Q abnormality. Thus the
adisiiniotration of o yg n presumably by abolishing pulnonary vasocon¬
striction in hypo: io r gioeis result I in a vers- ning of th ventila¬
tion - p rfusion imbalance in asthmatics as shown by -.n increase in
the (A-a)DO,, and VD/V? ratio. Breathing pur osygen has be n
« *
shown to hnv no ff ot on the patt m of V /Q in quality in normal
subjectk: or in patients vith chronic lung lis as (Riley, Courumd
end Donald, 1951? Larson and Severinghaus, 1962? Col© and Bishop,
1933). Such a A terioration occurr A not only in th® aout phase-
of their illness (Field, 1967) but also in the asynptonatio phaa
(Valabhji, 1968)5 sugg- sting that during th latter phase a compensa¬
tory r Auction of blood flew? to und rv ntilatel parts of the lung
right still bo pros nt. Supporting evil nc for th ©--1st no of
pulmonary vasoconstriction in asthmatics wh n syrapton fre has be n
produced by Irsr 11 and JJordgr n (1966) who infuse! aoetyloholin
into the pulmonary artery of ninet en asthraatios and observed a re¬
duction in arterial o ygen saturation in all but one. Yalabhjl
(1258) reports a v ry snail contribution of veno-art rial shunt of
3,7 + 1.4 to the hypo aenia present in their aout asthmatics,
fhio is perhaps surprising in vi or of th widespread uous plug¬
ging of the snail always that lias be n r ported in asthm.
Th absence of a significant vono-art rial shunt could perhaps bo
xplained an th© basis of a diversion of blood fin frosi noso-v n-
tilatod ar as of the lunge as a result of pul aonary vasoconstriction.
ik~} ■ r.: "jit ..
Sine tii introduction of radioactive gases i» th© study of
poison.°ry physiology a gro at i -al of information about the regional
vautil tion and perfusion of the lungs has b 00 k dlable.
The first gas to be use! was Xe 1 )_i in 1957 by Snipping and his c -
warders who ;:r -osurel local ventilation. . Radioactive •• non can,
of cours , also be used to v, asure regional blood flow as well as
ventilation (Ball t al, 1962? Dollery and Ifagh-Jcei 9, 1953).
Bentivoglio et al, (1953) studi d r gional ventilation and
perfusion in asthmatics during r . 4ssion using th radioactive
enon t chnique r od r ported th pr sense of hypoventilation but
a noma! distribution of p rfuaion. A large aunber of studies
using lung scanning following the inhalation of radioactiv gases
133
such as Xe , intravenous injection of 1 131 aacronggregat d albumin
new.
ae w 11 .as th© inhalation of an aerosol containing Tc - iron co a-
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pis , have nor.: b an carried oat in asthma both daring th /.cute
attack rand, in r mission (Woolcock et nl, 1966; aifcVit Wagner,
1957} laoKdn et al, 1968; HeGksoher t el, 1968; Wilson et al, 197D5
Be epos et a!, 19?0). Most ne-isur « rite she .-el '-ell d ';:wt d
local veutilatieu us! perfusion defects. Although the areas of
hypoventilation generally sho-.ed decrease I perfusion, sons • -ark -rs
(Wilson et al, 197°) r portal that the p rfusion as frequently less
» »
effect© than ventilation. hung scans Showed t! 'it tho 1 /Q in~
balanco frequently app -xen to be videspr -ad in nsthrn. In gen-
r 1, repent stttdi 0 during i .prove;. ;OTt of ay opto 'B ahou 1 norrail-
• •
sation of V /Q in or-as vhioh w re previously involved; houev r,
dof cts arising in no- or as hav also b -on obo rv 1 (fishkin et al,
1968; H ckochcr et al, 1968).
Hovcy -and his associates (1970) have studied erly v irtftvtion -
p rfusion clvang- s folio? dug tiie induction of ncih-ia, by »ans of pol-
• H
1-.-aetaehollm and -eroiso. lie r ported multiple focal V /Q
afcnor nliti 0 appearing -Ithin ninutcn of induct ion of asthma.
The r gioml ventilatory abnorsalities yore greater than those of
p rfuaion although similar in distribution.
Although hypo-ia ia generally accepted as h ing raainly reopan-
sibl for local puT-ornry vasoconstriction, other nochaaisia nay ilea
be involved, in the causation of r gioml oulnonnry blood flor- defects.
Th'- m includ jechnnical occlusion of capillaries by high intra-
alv olar pressor at sit a vher regional hyp rinflstion is pr sent,
(Tempos et al, 1370)* Pematt ct al, (1961) have shown that
blood flow throughthe capillaries of the lung is controlled by
alv olar pressor so long -as alv olar presour is greater than
pulmonary v nous pressur . toother possibility is th local
rol as of vasoconstrictive substances in asthma ( iddleton, 190) •
Plan of Study.
lbs study vac carried oat in t- o parts. In th first part
th patients v:er etudi & over period of four days. In order
to obtain pre-tr at cut baseline ssosur raento, to nsure that pnti-
nts were in a stable clinical state .ml to assess iiumal varia¬
tions, placebo tablets w re giv n at 0900 hours era the first two
days of the trial. Tho placebo tablets w re eruppli 1 by Rouss 1
Labor tori s Ltd and contain Potato Starch 3.?., Lactose 3.F.,
Preg latinised Starch, Talc B.P. and Idagnosiu;; St• orate 3»P.
Thy are indistinguishabl in app aaran.ee and teste fro-, th notiv
drug. On the third day, 40 ag of Prednisolone acetate "as odain-
ist r d as a single oral dose at 0900 hours and on the fourth day
placebo tabl to ver again giv n at th sarse tin . Repeated
roeasur cents of dynamic and static lung vols. - a, thoracic gas vol¬
ume and aimy resistanc and na liana e piratory flc -volvt-vc cur/ s
w re performed. Figure- ( 1 ) shows the a aswrenants and the
tine at which th y w re perf erred throughout th p riod of study.
Th© second part of the study was carried out over a p riod of
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on the first, second and fourth days and a single oral dose of 4-0 tag
of Prednisolone acetate given on the third day. On the fifth day
those patients received 200 rag of Hydrocortisone sodium succinate as
a single intravenous injection. The way in which the measurements
were altered from that in the first part of the study is shown in
figure (2 ). Thus tests vrere performed hourly for the first
three hours following administration of the active drug. Body-
plethysraographic measurements were also more frequently performed.
In this part of the study pulmonary gas exchange was investigated
at the times shown in figure ( 2). The drugs in "both parts of
the study vrere administered with the patient in a fasting state.
At the time of admission, the nature and purpose of the study
were e. plained to the patients and informed consent was obtained.
All drugs, including bronchodilators, vrere discontinu-d. A chest
x-ray, an electrocardiogram and tests of hepatic and renal function
vrere carried out. Three sputum specimens vrere examined for evi¬
dence of bacterial infection, Aspergillus fumigatus and eosinophils.
Absolute blood eosinophil counts vrere carried out on three specimens
of venous blood and sorum precipitins to Aspergillus fumigatus were
looked for. Immediate type skin hypersensitivity was tested to
a wide range of allergies, including those derived from mites of the
I):rmatophagoides species. Reversibility of the airway obstruc¬
tion to subcutaneous injections of 0.5 ag Adrenaline acid tartrate
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In order to carry out as complete a functional assessment
as possible of the pathophysiological changes brought about by
tho administration of prednisolone to the patients in this study,
a consich rablo number of pulmonary function testa 1 vs carried out.
Bearing in aind that obstruction to the flow of air is th hall-
narl of bronchi 1 osthra, it was this 'ispoct of pulmonary function
that was particularly investigatad. An essential factor that
was kept in mind in choosing the t sts was wh ther the subj cts
vrere likely to be abl or -illing to co-opcrat fully in their
performance. This factor was of sp cial importance because
the tests were to be p rformed on a number of successive occasions
t monitor tho therapeutic ff ct of the drug. Th re is no
definite answer at pres-nt as to which is the b st pul anary function
test to perform in order to let ot and be abl'- to valuate changes
occurring in response to th'rapy in bronchial asthirn, Ideally
the tost should hovjev r b valid, that is, truly measure the parti¬
cular aspect of pulmonary function one s ts out to t st; and it
should also be adequately senaitiv and reproiucibl (Sobol, I971)•
Many studies reporting the correlation between various in¬
dices of airway obstruction both in normals and in patients with
ohranic airway obstruction have been published ("ory t al, 19615
Pelser ani Thomson, 19661 Stein et al, 1965} Mitohell et al, 1967?
Sobol and Snrgil, 1968} Allen and Sabin, 1970* In gen ral it
has been found that correlations between such indices is signifi¬
cantly higher in subjects with airway obstruction than in normals.
The ratio of forced xpiratory volua in one second to the fore d
vital capacity (FSV^/FTTC) as veil as the raaxinxua ndd-e piratory
flow rate (MPR) have been found to b? highly oorrelat d, on a cross
sectional study, with the airway resistance. Hoievrr, they have
the disadvantage, that, on a longitudinal study, such as fallowing
the effect of corticosteroid therapy, any changes aff ct both the
numerator and the denominator <f th relationship; and under such
conditions a change in airway resistance aay go undetected (Cotes,
1971).
As previously discussed, an increase inbranohial contractility
aay lead to an increase in lung volume whioh has the ff ct of in¬
creasing th traction xerted by the lung parenchyma upon the airways,
hence pros rving, up to a certain point, th ir patency* Under
these conditions, t sts of forced xpiration, such as the FS7^, my
remain ncmsal or nearly so, but the P»R.C« and the R.V, are very
often increased (Woolcock and Read, 1966)* Such an increase in
th RV/ThC ratio with an appar ntly norrial FCV^ has also ba n r por¬
ted following clinical recovery in asthmatic patients (Veng and
Levinson, 1969)• Conversely, a dininution fcn lung volumes without
an associated use in has been described by lloolcook and Read in
in 1965* The measurement of lung volua a time for is an integral
part of any invstigation of pulmonary function in chronic airway
obstruction.
It is of course r olised that a considerable degre of disease
in the small airways can be present without th re being any 1 finit
abnormality of airway resistance or of the usual epiroa trie t sts.
Only avout 10? of the total airway resistance is contributed by air-
ays small-r than 2 rm in diar ter in normal subjects (Kaoklea and
Mead, 19^7)* flic det otion of changes in airway r sistance con¬
tributed to by the small airways depends on th ? proportion of the
total airway resistance which it forms and th degre of rev risibility
of each component. Thus changes in airway resistance occurring
in th small r airways following therapy could possibly go undet ct d.
Mackl a and Mead (19^7) showed that the time constants (resist¬
ance x compliance) of the lung units distal to airways smallr than
about 2 ran were in the order of 0.01 sec. They concluded that
under such circuastane s a four fold difference in tine constants
between these units would be sufficient to cause a fall in dynamic
compliance with increasing respiratory frequency. Wooloook t al,
(1959) found frcqu ncy dependence of compliance in five bronchitics
and four asthmatics in r mission and interpr ted th ir results as
indicating obstruction, in p ripheral airways. Frequency 1 pen-
dc-nce of complianc ai$it be assumed to occur bofor th re is any
d testable abnormality in resistance.
It Might thefore b e pected that fr qu< noy dependence
of compliance could possibly det ct changes occurring in the
smaller airways as a r suit of th rapy b fore and to a greater
extent than any of the mor conventional tests. However,
frequency depend ace of complianc has also b en report d in a
number of normal subjects (Woolcock t al 1969; Ingram and 0*
Gain, 1970 and this test is also a technically demanding measure¬
ment (Plenley t al, 1971).
The closing volume (G.V.) may be d fined as that lung volume
above residual volume at which the air*-ays begin to clos , and it
has been suggested that it .ight be as nsitive m thod of measuring
airways obstruction. Its measurement is based on th fact that
inspiration from close to residual volume produc s unev n distribu
tion of inspired air (l-Iilic-Baili et al, 1966). Following the
inj ction of a marker gas such as argon, during a slov? inspiration
the subject is then instructed to :pire slo-ly and smoothly.
The concentration of the marker gas measur & at th mouth is s en
to rise to a plateau as the dead space is washed out. This
plateau indicates emptying of mix d e pired alveolar gas. As
the residual volume is approach d the cone ntration of the mark r
gas rises sharply. This sharp terminal rise is attributed to
closure of the basal airways which ar gravity d pendent ("Dollfus
et al, 1967). has b en suggested that th index C.V./TLC
might be useful in d tecting minor airway obstruction. Howev r
where ther is marked regional inhomog neity, as in asthmatics,
neith r a satisfactory plateau mr a clearly defined terminal ris -
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is likely to be obtained (Clarke, 1971). Insuffici nt inforrsa-
tion is as yet availabl about the use and validity of this t st
in airway obstruction. It was thus thought that measuring
both the frequency d pendonce of ooapliance aa u 11 as the clos-
ing volur wore unsuitable tests for use in this study.
The t sts performed to ass as the therap utic effectiven sa
of prednisolone w re therefore :
1. direct sestsur aents of airway r sistance.
2. Me'isur ra nts of dynamic lung volumes.
3. M. asureneats of static lung volu «b.
4. Measur nent of blood gas s and assessn at of pulmonary gas
e chang .
JSASURm AIRWAY RESISTANCE
(a) T> velop-.eiit of various methods of ;c .curing resistance to br nthing
One of th earliest att rapts to measure airway r Distance vas
the classical study of Rohrer in 1915* H niade u ticulous am-
toaical measurements on th traoh obronchiol tree of a buaan lung
obtained at post mart i, using calibrated bougies, which he ins rt d
p ripherally whil dissecting proiaal branches, and calculat & the
total resistance to airflow of th entir system using Poiseuill *s
forrmla. H erron ousl.y concluded that th poriphor.al always
wer responsible for about 93' of th total resist nee. ' 0- •n-lar
t al, pointed out in 1952 that Rohrer nade an arithmetical mis¬
take in calculating Reynold*s numbers 1 ading to a tenfold ov r-
stimation of the velocity at which the transition from laminar to
turbulent flo* would occur. ''ore rec ntly, 1'eibel (19^3) showed
that Rohrer had grossly underestimated both the numb r and total
crosD-soctional ar a of airways smaller than 4 diameter, prob¬
ably because h studi d d flated lungs. I'nckl n and 1* ad (1947)
introduced th retrograde oath tor techniqu and showed both in
living dogs and e clsed human lungs that the p ripheral resistanc
accounted for a v ry small proportion of total aim-jay resistance.
The first e perin nt',1 study of total pulmonary r sistance
in the living aninal was oa.de by Von S ergard and airs in 19-7*
They reasoned that because of the large alv olar volume r lativ
to the airways, t.He pressur in the air ay following int rruption
of the stream should guilibrat in a very short time to the pr ss-
ur that o isted in the alveolar prior to interruption. Their
n thai was further -lev loped by Vu lieu iar (1944) -and us 4 by Otis
and Proctor (194^) and -Otis, P hn and Rahn (1950). The r.sBuop¬
tion on which the *int rruption technique* is baa d is only partly
valid. In practice the pressure measured during interruption
i© not a-actly th same as th alveolrr pressure b fore interrup¬
tion bocuaa th en rgy of nov ment of th lungs, and to some ex¬
tent that of the chest vrall and diaphragm, is oonv rt d into press¬
ure one th mover,1 nt is interrupted (.; ad and fhittenberger, 1954)*
This oethod was nodifi 4 by Ainsworth and dv leigh (1952) so that
flow was obtained from the pr soure drop across an xt mal r sis-
tanc of similar airflow charoct ristics to th lungs, ob iati g
a n od for a flow m tor. Later, Clo.: nts and dl&a (1955) in¬
troduced a rapid rop titive interrupt r that interrupted airflow
about ten tines a second. This giv s satisfactory r producible
and accurat results for total pul :ionary resistance.
Baylies and Robertson (1939) first ventilated isolated ani :al
lungs with gas a of different density a .& viscosity. They usd
hydrogen and air, and based th ir irrv stigations on th assumption
that airway resistanc but not tiscu resistance would vary with
the viscosity of the gases br athod. Bi y .uiartakenly concluded
that most of th 'lung visconce * is in th tiosu s. Pry t al
(1934) using an argon-o yg a d ture on human subjects reached th
opposite conclusion. Rcllroy t al, (1955) pointed out that th
pr vious studies base-l on this assu iprtion had under' stiaated the
ff cts of changes in the gas properties on Reynold's number and
hence in th distribution of turbul no in the air ays. They
str ss d the point that airtures of qnal idneraatie viscosity should
b us d to anour similar distribution of turbulence within th© air¬
ways, as a given flow. They astiaated tiasu resistance to be
about 30 - 4$, of the total pulmonary resistano . Kore rec nt
aeasur ments using diff rent t chni:ues (rnokl-m and II ad, 1957?
Bachof n, 1958?) indicate that tissue r sistance is probably neg¬
ligible. Probably a pr ssure differ nc iu to static pressure
volume hyst reels, which is not flow resistive in nature, vao in-
eluded in earlier measurements.
Buytendijk (1949) employed an oesophageal balloon instead of
an intrapl ural n edle to measure pressur ch&ng s in th intra-
pi ural spao . The introduction of th oeeophag } Ml loon to
stiznate intrapl ur .1 pre3sur (?ry et al, 195-? Head and Whitt n-
berger, 1953) and the ear fully vorked out technique of Milic-Hrdli
t al, (1964) *?er • major steps in th measure;."! at of lung mechanics
and provid d the physiologist vrith a safe n -sure ;ent of trans-pul-
aonary pr score. Several t ohniques are now available for 10 as-
uring non-elastic resistanc from intra-o sophagcal pr ssurc, flow
or volun tracings, but th y all d pend on th measurea nt of non-
last ic pr ssure by subtracting or lininating the pressure y rt d
against lastic resistance. Perhaps, one of th nost satisfact¬
ory jaetho&a for th r^vsuren. nt of airway r sistance from intra-
O'-sopiiag al pressure and flow tracings is by the subtraction a thod
of Head and IJhittenberger, (1953).
The introduction of body plethysmography in th study of
human pulmonary physiology is generally attribut 1 to Pflug r (1882).
He fa asured his own intrathoracic gas volume by applying Boyle's lav
to relate changes in olv olar pressur to sinultanoous changes in
lung voluTi . Pfluger design d a wooden cabinet in vhioh h could
ait and voluntarily compress th gas in his lungs, the volume change
being ra asured by a saall spirometer attached to the chamber and the
pressure at the nouth being simultaneously measured by a rnercury ma-
O'at r.
The method of a asuring alveolar pr aaoro indirectly from
- asurenante of alveolar gas compression and e panaion vaa again
proposed and att -pted by Soon in 1923, but its first practical
application was sad by Tu 3ois t al, (1956) who clev rly ov reano
the problems of taeasuring alveolar pressure. Hiey have provided
th only succ ssful technique at pres nt available for the saaoar
sent of alveolar pressure. With th ir nethod, alveolar pressure
at any instant can b ieduo d from plethysmography pr ssure changes.
S- veral descriptions of modified techniqu's have since appeared in
the lit ratur (Barg ton, 1959; Bartlett, 1939; C«.iro ©t al, 1939.
K ad, 1950? (Jeubell© and S3 nt rr , 1953? Ja ger and Otis, 1964?
Sackmr t al, 1964? Sobol, 1969? Ssaidt ct al, 1969) att ipting to
•.■ale th measure :t nts ev a nore accurate. Head (1960) reviv i
the original volum -diopiac raent plethys. .ograpb of Pfluger with
great success.
Another method which mensur 4 total respiratory resistaac
(airway, tissue and chest wall) is that in which fore d oacillatons
are g nerat d from a loud speaker at or near r sonant fr qu ncy of
the lung. fhe principle underlying this tocIaii.ru , vhioh was
also first introduc d by bu Boio et al, (1956) is that, at the res¬
onant frequency ; lastic pr ssures ar< © actly equal and 1A0 degr© s
out of phase with in rtial pressures, th reby cano lling ach other
out. Pr esuro and flow are th n in phase ad their r lationship
d scrib s the ptftasnsry lot resistarte-. It is of potential
value in neasoring reaistanc to "breathing of pati nts who cannot
undergo body plethysmography, such as th acutely ill pati nt
(Pishor et al, 1968). Ooldsian t al, (1971) hav eiaplifi d
the t chxicruo by using the fact that t-lc in very cycl thr rate
of ohang of flow is cero, ther fore the inertia! component of the
pressure is aero. These points to tin occur at positions of
equal volume, and th- refer equ 1 lactic pr ssures. H no th
chang in pressure over this tine interval can "bo related to the'
ollingo in flow to give the total r spiratory resistance.
(b) description anrl calibration of apparatus.
The construction and calibration of a constant volu-se body
pi thysaograph v-ac personally supervis d in our laboratory. It
was also nsured that r suits obtained frora it v re reliable and
r producible. Perhaps, as surested by Bargeicm. aa'. Barreo (19^9)
it should be call d a •closed bo * type of plethysnograph s the
terms constant volun and constant pressure plethy&nograph ar nis-
1 oding since in both typos th mass of air in the bo und rgoes a
volua and pr ssure change.
The pi thya.mograph built in this laboratory is bo~ shap-d and
made of Marine 0 ven-plywood - ith a htogless door that has a glass
•Indov; at face lev 1. The door is claeiped firmly to the boa- by
si ana of twelve etc 1 clips and made airtight by -jeans of a rubb r
gask t around the p riphory. Its volume calculated geooetrioally
is 347.2 litres, Comnunication t te «j the operator and the
subj ct is no probl m as th usual spoahing voic oorri s through
the valla of th bo .
Two !!*!)«C» laicrawionetera supplied by Foraoss Controls Ltd
hav- be n used to m -.sure changes in flc and sKJuth pressure and
changes in plethys aographic pressure. They ar connected to the
iouthpiec awl pn umotachograph by non-conprescible plastic tubing
about 3 ft. long. Th® nanoict rs ar© sensitive pressure n asur-
ing devices capable of leasuring a gas pressur dot 11 to 10*|m s p r
sq. on. for a full scale deflocrfcion. Tvj& uicraaanom tors*
aeasuring heat consists of two symmetrically arranged caviti s s p~
arotod by a netal diaphragn. Th diaphragm together ith a
?l~©d el otrod on ithor aid » for ss two condensers which ar port
of th tuning oapaciti s of two tuned circuits both qually coupl d
to .on R«F. oscillator. Mov uont of th-. diaphragv onuses a varia¬
tion in the capacitano betwa n it and eaoh adjacent el otrod , thus
unbalancing the voltage across the tuned circuits. Bios® voltog s
are compared by a differential rectified voltm ter, and the diff r~
nc is shown on a a ter calibrat d cliroctly in pressure.
The frequency response of th L&croaonoaetero v;as tasted by
coeziparing than with an Eloa Sohonander nanoaeter (5-15 anB20)
which was known to have an e collont frequency r spon3 . The
pressor in the pi thysaograph, was neasur d by both the K#P«C»
naaooet r and the Elna Schcmnder nnnon ter sinultan ously.
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Siailar lengths of tubing were used to conn ct both manometers, the
readings b ing fed into a dir ot writing laulti-chann 1 r ©order (80
El'isna Schonander Kingograf) and an oscillosoop . The 1-1,0.0. nano¬
meter had originally a sint red filter on each side of th- diaphragn
vhioh brings about a loss of frequency response by introducing a re¬
sistance capacitance filt r. The latter induces p as© shift b -
tween th tranoduc rs at iner asing frequeued s (rig. 3).
The r noval of the sint red filters corr ct d the M,D«C,fe loss of
fr qu ney response and phase shift shown by adding 35 ®1 at 1 - 5
Ha. (pig. 4 )»
Plot.' was sensor <1 with >. heated PI iaoh pneui ■ictachograph with a
linear r spons betv® n 0 and 2.5 l/c c.
The plthysnographio pr ssuro signal v-.a fed into th horizon¬
tal , and the flow and noutb pr ssure aignala, in succession, into
th vertical, a*is of a cathode ray oeeilloscop- (Solartron 0. ,
1400). The v etor loops produced by the subj ct*o panting nano-
uvr b v-? ro displayed on the oscilloscope sere n ( p^g# $ and tb ir
slopes obtain d by visual align nt with parallel lin s ruled on a
Perap x disc which rotated within a fi ed protractor scale in front
of the ocr en. Th visual .nethod wae us 1 for conv ni nc since
it has previously boon claim d to agree adequately with th© nor® x-
penciv nethod of photographing th- vector loops and then measuring
th ir angles (fu Eois et al, 19:36 b; Dutlor t al, 1960). Tills
H 6
PLETHYSMOGRAPHIC VECTOR LOOPS
photographed from oscilloscope screen
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ttVttatti WAS found to bo a very satisfactory one.
The body plethysupgrapfc was calibrated by a. oao of a .sir.pl
pa .p xlth a strok displacement of 35 >1 of air. This was a t
to produce a deflection of 5 oa oa the oscilloscope. The bor
calibration factor is th refor ;., -2
a ^ ^ ii/ea d fi ction.
6e»
As the pl©tbysr.K^graph was always calibrated when enpty, th- cali¬
bration is adjust 4 to th s nil r volu ie of air which is pros at
vfaea there is % subject sitting in the. pi thyaaogrnph, by ocaas of
th following relationship!
*« " "1 th- -
— / Vplcth.
1,0? )
"hor Pj « initial calibration factor, 5«S5 l/oa d fl ction.
1,07 « Assured av rig© d nsity of the huaan body,
V. ploth,- volune of body plothys:lograph.
A probl n that occurs in th© n-aoarcaent of th© signal fron
th pi thywaograph is outside pressure changes. Th re are differ¬
ent methods that xre uaol to stabilise the neasur nont, of the pros-
sore in a constant volune plethycaogmph. If th input in th©
diff rontial pressor transduo r that is not conn ct -d to th: pi thy-
onograph is left op n, all changes cf the outsid pr 'ssure, as can
occur in op aing and closing doors or in windy v ather, will intcr-
f re rdth th signal (Co too t al, 19591 Snidt et al, 1969).
■Pirns to ninlaise such pr ssuro disturbances fron outsilo a 500 1
TABLE I
R si stance off red by raouthpiec and pneumotachograph hrad to various
rates of air flow.
V(l/min) P(:nmH20) R.(cm HpO/l/sec).
pOL/min 2.16 mmH20 0.26(fcmHpO/l/sec.
60l/rain 2.6 0 " 0.262 "
751/ain 3.36 " 0.268 "
100l/min 4.3 0 " 0.258 "
150l/min 6.5 0 " 0.260 "
2001/rain 8.65 " 0.26 0 »
Each valu is the average of three cons cutive measurements.
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bottle vas attached to the second input of th traas&uc r aa a
clos d v. fere/ice pressor . All doors and vdnda-s in th lab¬
oratory • or kept clos d luring the a neuremnts.
. iouth pressor was c libr ,t _.d by aeana o ; si tple vat r aaae-
raeter; 4 ca of vat r pressor being used to giv a d fl ctioa of 3 aa
on the oscilloscope. Tlx© oouth pressor calibration factor (P^)
is thus, 4c~- H^o/3 <aa » 1.33 en B^O/ca deflection.
Plot was imisured by a-ano of a Fl iech flov -.set r, ■ Mcli was
previously calibrated by neons of a rotaaet r. A flow rate of
60 l/nia to give a deflection of 2 c on the oscilloscope.
Th-i flow calibration factor is therefore:
t l/eeo/2csi « 0.5 l/e c/cn d fl ction.
Th resistance offered by th© xouthpi ce imi pnsu. ot.chograph
head was fours! to be : 0.26 oa 11.,0/l/sec. (s o Tabl I).
(c) Frincipl s i-svolvad in ...c-.suri:i.;; : i.r ,y rooisl men by Ibly
rictus
Airway resistanc depends for its calculation on th© si .ulta-
n sue oeaeurea at of the rat of th flow of air as w 11 as the
presour difference b tv, on the .lv oli aid th icuth.
•in;: ty resist arc© (n..*) « Alveolar to . south prcscur difference(PA)
The rate of airflow can be easily m r.gorol by a pn urKrtachograph at
th KJUth. Alveolar pressure cannot however be twasured during
airflow; bit it can b derived by making us of the compressibility
of the air in th lung ant applying Boyle's law, to calculate it
from »asur /onto of changes in plethysnographio pressure. The
relation b1- en alv ol n* ml plethysmography pressure is defined
by measuring «outh and piet 1ynr/ographic pr satires -luring a panting
manoeuvre against a elos d abutter. During this proo lure ther
is no airflow through th respiratory system and outh pressure is
assuael to equal alveolar pressure. With the subject sitting in
an airtight olianb r, the voluoe change owing to co;;pr onion and y-
pansion of ir inside the thor , occurring during expiration raid
inspiration, proluo/sscanoonitant and r oiprooal changes in ttl pletliy-
s 'Ogr -phic air outside the lungs. Banco, at any instant, th re¬
sulting pr enure change in th; boo: rust be opposite in sign to th
pr ssurr change in the lung. 3uch changes in plothyamcgrophie
pressure oaa b quit/) osily caDur i continuously during tho r s-
piratory oycl . Changes in air flow ore plotted sinultan ously
against pi ■thyanographlc pressor chaag a which in turn, .-is has
be n shown, are proportional to chang• s in -.lvcol.ir preenure.
I.T.iodiatoly after, changes in plethysnogrophic pressure /re plotted
against mouth pressure aa the subject pants against a closed shutt r;
this step serves to relate changes in pletfcysnographic pr ssure to
changes in alveolar pr nature. Therefor', alveolar pr■enure is
affectively measured during fir.', sine- the alveolar pressure for a
givan plethysnographic pressure is th suae whether or not flow is
interrupted provid d the ratio of lung to piathyssiographio gas
volua is constant.
The differ ne betve n this method on- previous interrupted
methods is that the interruption of flow of the pie thya.aographio
raethod is simply the aeons of calibrating the changes in plotkysao-*
graphic pressor in terns of alveolar pressure; the values for air¬
way resistance are always obtained daring unint rrupt d flov.
Boyle*s law only applies if the condition of the liunuu lungs .
.* "-.i > . •••
can bo asaaraed to be isothermal. If the conditions arc adiabatic
then th e precniaa P.V. » k, no longer holds. Under adiabatic
conditions P.?. » k, wher « Cp/Cv (Cp « specific heat at constant
pressure; Cv * specific h at at constout volu: ). Ifolte (19-95
investigating this probl m found that th r was no differ nc in F«*L»
C. ' -hen this was n&esursd with subjects br athing air ( « 1.40) and
breathing a heliuV0 VSpn * ture ( • 1.61). He concluded that this
was avid no of appro inately isothrml conditions in the lungs,
thus justifying th application of Boyl *ts law.
Panting rmy b? consider 4 as a rath r unusual physiological
raanoouvr to pc-rfor. as far as spontan ous br athing patterns are
concerned. It was the ay, howev r, in which TJu Bois at al (1956)
sol ad the problem of thsvtail /change vhioh oocuro wh n normal tidal
voltt™ br aths are used. Warming and v< tting of the inspired air
1 ads to an increase in th© volun© of thoracic gas and canse<iu©ntly
to an increase in the picthys-.ographic pressure which is sup ri.iposed
as r..i .artefact on the signal flu® to actual changes in lung volu-ie.
Cooling and cond nsatian of th oypir d air also has an effect but
to a 1 as r V gr e; the resultant ff ot of nor;; 1 quiet inspiration
and -piration being m iner is in pr ssuro inside the plethysmo-
graph. Panting through a heated pneumotachograph reduces the
sis of this artefact.
A re hav- be a other attempts to overeo..;- the artefact pro¬
duced by thermal : change to allow neasur roents to b made during
breathing patt rns rather than panting* Among these was the
sugg stion put forward by u Bois t al, (19'X>) to make the subj ct
rebroatte from a rubber bag containing hot water, this cold t net to
k ep the rospir d air at const ant temperature and saturation.
Sartl- tt t al, (1959) 1-signed a plethysuograph with elaborate
air conditioning. Jaeger and Otis (1964) asked their subjects
to rebreathe from a 13 litre rubber bag that was filled with 3-5
litres of a 5! 00^/95. /02 gas i tur- and ah., x. ith 20 al of hot
water, the bag b ing us d when its temperature was 40°C-
Du Boia et al, (1952) suggested, an theoretical grounds that
the rat of orygen transf r across the alveoli is probably con¬
stant , wher.as the rat of carbon dio id elimination varies
throughout th respiratory cycle. The two gas s b have differently
b cause of the diff rent slop n of th ir dissociation curves. Th
cyclic variations of COp production that take place during the res¬
piratory cycle produce similar Chang s in the rate of volun displace-
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cat of tli© pi-sthye lograph (Jaagr and Otis, 1964). Th- latter
authors found that a decrease in breathing fr qu noy increased th
aaplitud of the variations of CO,, transfer. "She variations of
the respiratory .. ehmg ratio during the breathing cycle are ini-
nized by panting ("\t 3oir: ot al, 1956? Xwq r r! iJouhuys, 19'9)*
The resistance of tlx upper airways increase appreciably during
an ordinary qui t o piration and oontribut o a substantial fractio n
to the total r sictoncc. So, parndO'ically, it n ens that spon¬
taneous breathing r suits in an increase in upper airway resistance.
Such an increase can be avoid 1 to a groat e tent by a panting aaao-
euvre "hen th upper airway resistone tends to d cr oa and becon
fi ed. Therefor , n asareaents of air-ray resistanoo, are said to
be raore satisfactory and loss variable than those nad during span-
tanous br athing (?' ad, 1971), In ord r to get a truer value of
airways resistone it is n sensory to -dniraise the elastic .id in r-
tial components of total lung raistanoe. Panting r suite in a
decrease of th elastic component and during this manoeuvre, th in~
ertial component is snail (itc^ernott, 1971). Hence the panting
technique which started the develops nt of body plethysmography,
appears to be still the b st practical approach for most applications.
This has rec ntly b en confir c-! by the work of Stan ecu et al (1972)
who found that th-' glottis was definit ly rid r during panting than
during quiet breathing.
(d) '■etail 3 ' - "hod.
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She subjects wwc instructed in th test pro© dure and \>r r®
taught how to pant. Tb y then at :red the body pletbyeuiograph
and the door was ©laape.1 down. Bie subj cts set comfortably in-
sid the bo and could osily eaasmie&te with theoperator outside.
Th y had the acuthpi ee adjust i to th ir height; this ensured that
th ro as no crouching, • Mch can oaas fl .xiosn of th nock end com¬
pression of th upper Airways (Guyatt and llpers, 1$G8)* The
ris in plothysiaographie pr ssure that too* plae as the subject
:nr:ad and fcunidifi d the air around hia was equalis A to aabiont
rooa pressure by repeated venting by neons of a larg bore solenoid
controll d velv until the pressure 'drift with the v nt closed was
so slight that it did not interfere with Jteasur- u uts. This usu¬
ally took b tv en two to thro niuut a. The subject was th n ask
d to put on a nose clip, place the lips tightly round th .outh-
pi ce, support Ms olieeks in order to uininis any variation in the
voltwe of the buccal cavity and carry out a panting nanoeuvro through
an open glottis. The subjects v re ash ■& to pint through the
heated Fleisch pii' uaotachogrsph at the- end of & nomal expiration,
that is, s lear F.R.C. s possible. Flo: was plotted against
body pltthysnographic prcssur• and the angle proiucd on th- face of
the oocilloGcop was measured as 1. Tb op rator then actuated
the shutter to bloc! off the louthpi oe and the subject was asked to
continue to ask sb-llos? panting fforts •'••gainst it. "During thee
efforts south pr ssure ■ as plotted against the bo pressor mi th
angle record i as 2.
Five leter inations wer- saada for each subject, at a breathing
frequency of ibout 1 - 2 cyolee/seo sad at flow rates of 0,5 l/aoc.
The initial reading was discarded and th neon of the last four
tab a. "Chert body plothyc tographie c iaur s nts %»r carri -X
out luring thia study, these w re always the first t sts perforated.
•Kds procedure was adopted because forced inspiration, or a for¬
ce". expiration, carided out, for e ample, during on. Id?. uuaoeuvr ,
could possibly alt r the v.lu s for aim-ay resistance, tm shea by
Butler et al,(1960)» STadel aadTi-rrry, (1961;); dloyd,(1963,) Bron¬
chial obstruction induc-d by spirometry has also been recently
anstrated by Qia no t ol, (1972) in patients ith ahroaic airway
obstructian. Joolcook et al, (19<S9) hav recently shown that
total pulnonary v sistaaoe at a giv n lung volume is high r vhen
that volu is attain I by inspiration than by . pir itioa and that
this differ ac is reduced by atropine, They suggest that the
ff at of volute history on the airways is d pendent on offer-at
vagal 1'pulses modifying smooth zusol tone. Ihe subjects in
this study were instructed and eJio-u how to reach their F,R,G,
through a normal quiet aspiration. Uith a little training most
subjects xor- cble to proluco clear ami repo. .uoibl< vector loops
cad changes in airway resistano and thoracic gas volume or easy
to foilow.
( ) Choice of an ind ; to reflect ch "•ageo in airway r oistaace.
The Impartanoo of the r elationship b tw en airway resistano
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(Raw) and the lung volum (Vtg) at which it is m asured is self
evident, and Rav? should be standardis d for the Vtg at which it is
obtained. Briscoe and Ru Bois (1953) stated that when Raw is
plotted against Vtg the r lationship is a curvilinear on-.
When how ver Vtg is plotted against the r ciprocal of Raw, i.e.
airway conductance (Oavi), they claim that the relationship appeared
to b linear and relatd Gaw, rather than Raw, to Vtg;
obtaining specific c nductance (SOaw) by dividing Gaw by the Vtg
at which it was measured. The r lation botw n Gaw and Vtg has
b en sho-Ti to be not so p rf ctly linear, and it has b en suggested
that Gaw is more linearly related to intra-oesophagcal pressur
(Butl r t al, 1950; Linderholm, 1963). However, th validity
of specific conductance has been e a,mined and confirm d by various
work rs (Pclzer and Thomson, 19&9; Guyatfc et al, 19"7» 1953, 1970?
Bates, Maokl m and Christi , 1971)• No grounds for using ..tore
sophisticated corrections have been found.
Normally both th flow-plethysmographic pressure (v/?b)and
the mouth prossure-pl thysaographic pr ssure (Pra/Pb) r lationships
are rectilinear an1 can be displayed on an oscilliscop ■ as lin ar
closed loops. HSteover, in some oases of nark d airway obstruc¬
tion, the P :/pb v ctor loop is splayed out. This is probably due
to inco- pi to quilibration betwe n alveolar and mouth pressure during
the clos d shutter manoeuvre. In such a case ♦looping* --ould in¬
troduce inaccuracies in the m asureaent of the angle and the calcu¬
lation of both Vtg and Gaw; but would hardly affect SGaw sinceiit
can be calculated that th measurement of SGaw is obtained
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from the v/Pb ratio along (Pelzer and Thomson, 1969)•
Because of th systematic increase in Vtg in patients with
poor Gaw, e.g. asthmatics, the fall in Gaw is proportionately
smaller than the fall in SGaw. Consequently SGaw is the more
discriminative index.
(f) ilormal values obtain d "by body plethysmography.
In order to establish a set of normal values for our body,
plethysmography and to find out how these compared with values in the
literature, measurements were carried out on twenty-si: subjects.
The latter were either members of the department ore nodical students,
and xirere divided into three groups; females non-smokers; nales smokers
and males non-smokers. (see Table II). Individual values are
included in Append!. (Table 1).
In order to try and discover how variable the body plethysmo¬
graphy measurements may be, ten of the previous srbjects had. the pro¬
cedure repeated on five different days, at approximately the same time
of day. Ai analysis of variance has been carried out on the values
obtained (Table III). Individual values are included in Appendi:-
(Table 2). This shows that the source of variation within subjects
is errfcremely small compared to that between subjects (P more signifi¬
cant than .0015' level). Hence it may be assumed, that st least
in normals, this test is quite repeatable.
PA3L ■ II
Body pi-thyaaograpliic valu s for 26 normal subjects.


























I.48+D.O7I 0.70+0.035 3.69+0.134 0.19+0.01
The individual values are included in the Appendi (Tabic 1). Th •
values obtained vrer very similar to thos - obtained in other normal
series (Pils r and Thomson, 1956; Guyatt and Alp rs, 1968; Guyatt t
al, 1973 and Alia and Sabin, 1971)* Values obtained from data
report 4 by Allen and Sabin are r produced overleaf for comparison:-
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2. MMIG :AJI:J yjujmi,
(a) Develops-.at of Physiological . Mhods for ..o -curing static hung
Volunos.
Borelli, in 1580, is said to be the first to hav. measured the
inspiratory volu:..e of the lung and to call attention to the residual
volume. Davy, in 1800, Pleasured his mm residual volume, which
he then described .as "residual air", by introducing a m thod based
on the dilution of a known volume of hydrogen, which he made himself,
by the *r sidual air* in the lungs. The stubj ct was ask d to take
5-7 deop ;md rapid breaths after forcibly emptying Ms lungs.
In 1345, John Hutchinson, a surgeon, attempt d to name the various
sub—divisions of the lungs and measured vital capacity, using a spiro¬
meter. In i860, Greliant calculated th volura of gas left in the
lung at the nd of a normal inspiration - P.U.C., basing Ms study on
Davy's method. Davy's ra; thod was modified by various workers dur¬
ing the following century, including Bohr (15X>7)» but it was difficult
to perform and poorly reproducible.
Van Slyfcc and Binger made th© next real advance in 1<?23 by using
hydrogen dilution without Jbrced breathing, ni.: ing being accomplished
by quiet respirations from a spirometer, for from 5-7 minutes.
Their method was thus more suitable for clinical application.
Difficulties arose with th analysis of hydrogen, and moreover, the
dangers of e plosion and poisoning ith arsine due to the impurities
in the sine used in the production of hydrog n were serious draw¬
backs. Christie (1932) reviewed no less than forty-seven pap¬
ers dealing with methods available up to that time for measuring
lung volumes. He concluded the th; nethol of Van Slyke and
Singer was tho best but suggested using nitrogen as the "indicator
gas* instead of hydrogen, the sub j ct breathing from a spirometer
with a known volume of oxygen - the oxygen dilution method.
Lassen, Cournand and Richards, (1937) pointed out an "o.yg n
storage ff ct * which thoy believed introduced errors in the cal¬
culation of the volume of the lung by Christie"a method. 'They
modified the latter*s calculation to allow for observed differenc s
in th concentration of nitrogen between alveolar air and the spiro-
aetric circuit at the ond of the rcbreathing period. H rrald
and KcHichael, (1939) modified Christie*s method by matching the
oxygen consumption of the subject with a controlled inflow of oxy¬
gen through a calibrated ne die valve, so that the volume of the
lung - epj oraeter system reaainc-d constant during the rebreathing
period. Thoy proved that this alteration abolish d the "oxygen
storage effect*. Christie*s o?-ygan dilution method proved to b
unsatisfactory in patients with uneven ventilation because equili¬
bration between subject and circuit was delayed. HcMichael
(1939)i continuing the constant volume feature of his earlier
m thod, re-introduoed the foreign gas principle, mploying hydrog n
the analysis of which was made rapid and simple by a thermal con¬
ductivity analyser.
Ifena ly and Kaltreider (1941) replaood hydrog n with hcliua
becmis it had all the advantages .and none of th* dangers of th
hydrogen method. Gileon and Hugh-Jonee (1949) report d a si-A-
lap closed-circuit method using helium with o yg n as the diluent;
this requires a long p riod of orygen br athi; sg befor the measure¬
ment# w re nad . Mane ly and Kaltreider (1949) us d air instead
of o yg n in th circuit. Whin r and Coop r (1956) comparing the
ra tnods of Oilsoii ..uri Hugh-Jones (1949) with that of Bh-ne ly and
Kaltreider (1949) showed that the 1 vtt r*9 method, is simpler, con
b performed more r adily, is osier for the patient and is as r -
liable as th Gilscoi and Hugh-Jon s -aethod.
In th© cloa d-circuit helium dilution method, lieneely and Halt—
reiier (1949) recomsnded the subtraction of 110 ml from the deter¬
mined value of the lung volume as a corr ction for absorb d h Hum
The authors, however, pr sent d no data to support th derivation
of this corr ction and ver not convinced that it was correct.
Holagr a (1954), on th© other hand, claiming that the eatharoaeter's
s noitivity was too lor to det ct the small quantity of helium that
would be absorbed, introduced no corr ction. Birath and Sw nson
(1956) -again proposed a correction factor for the small amount of
helium absorb d by th blood; this however has not been universally
adopted (Bates, I-Saoklen and Christie, 1971)* No corr otion
factor has been appli d in th calculation of lung volumes carri A
out by closed-circuit h liura dilution in this study.
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A new principle for the ueasur ment of lung volume had b en
introduced by Darling, Cournand and th..ir associates in 1940.
Their method known as the open circuit nitrogen clearance techni¬
que involves the displacement of nitrogen from the lungs by oxygen
breathing, and calculation of the volume of nitrogen expired by
analysis of the nitrogen content of expired air. As the
method depends upon multiplication of a large gas volume by a value
for nitrogen concentration, small analytical errors in measuring
nitrogen concentration will result in considerable error in the
calculated F.R.C. The open-circuit technique is simpler in the
sense that it requir s less in the way of equipment than the closed
circuit method. The results of both methods have repeatedly
been shown to be comparable (Gilson and Hugh-Jones, 1949? Motley,
1957? Boren et al, 1966).
Lamphier (1953) indicated that it would be useful to have a
method that would require a single breath as the test procedure
and therefore allow rapid and easy measurement of lung volumes.
Forster et al, (1957) described a modification of the closed-cir¬
cuit, helium dilution method. In this method, a maximal inspir¬
ation is taken, from residual volume, of a gas containing 10/
helium. This breath is held for approximately ten seconds and
then expired completely so as to provide a sample of alveolar gas
for analysis. Ogilvie et al, (1957) considered the value ob¬
tained by this technique as unreliable. Mitchell and Renzetti,
(1968) evaluating the 3ingle breath method for measuring T.L.C.
found that it correlated very well with the closed-circuit helium
dilution method and body plethysmography in 22 normal subjects.
In 52 patients with pulmonary disease, they found that both gas
dilution methods measured similar volumes which were significantly
less than those measured by body plethysmography.
As has been mentioned in the previous section on the measure¬
ment of airway resistance, body plethysmography also yields measure¬
ment of thoracic gas volume. In fact, when it was first used,
it was measurements of lung volume that were obtained rather than
measurements of airways resistance. Paul Bert (1868) seems to
have been the first to observe changes in pressure simultaneously
with pulmonary ventilation in a closed chamber containing an animal,
which were described in a paper entitled "Ghangements de pression
de l*air dans le poumon pendant le deux temps de l*acte respira-
toire" read at the *Societe de Biologie de Paris1 under the chairman¬
ship of Claude Bernard. In 1870 he wrote, "c'est un moyen fort
commode d'enregistrer la respiration des animeax". In 1882,
Pfluger in a paper entitled *Das Pneumometer* re-stated Paul Bert * s
findings; he went on to measure his own intrathoracic gas volume by
a ♦decompression method*; whereas the voluntary compression method
had been described by Gad, (1881) as cited by Bass, (1925). It
is perhaps not sufficiently appreciated that Robert Menzies in his
thesis, 'Tentamen Physiologicum Inaugurale de Respirations* submit¬
ted for the degree of M.D. in Edinburgh had actually managed to
measure tidal breathing in man, using a water filled plethysmograph,




Homo fanus et valens, pedes quinque digitof-
que otto procerus, circuitu thoracis tres pedes
trefque digitos explens, in dolium A B C D, uti
in figura 4ta delineatur, artte inclufus eft, quod
aqua gradum thermometri Fahrenheiteani nona-
gefimum temperie adaequante repletum eft, do¬
nee ad cam colli, quae ad afcenfionem et defcen-
lionem metiendam maxime accommodabatur,
partem alcendit. Haec autem ex digitis 1.25
attingere notata eft. Pulfus arteriarum, et an¬
te et poftquam immerfus eft, 64 aut 65, et re-
fpirationes 14 vel 14E ut frequenter ante fuerat
r.otatum, ftngulis minutis, fuerunt. Et omni-
no eadem duas horas et amplius manferunt, per
quod fpatium in dolio moratus eft, ne minimam
quidem moleftiam in fpiritu trahendo vel emit-
tendo, vel in re qualibet alia, fentiens. Quin-
etiam, per omne id tempus afcenfio et defcen-
fio digitum unum partefque ejus viginti quinque
centelimas, ad minimum, adaequare conftanter re-
perta. Infpiratione vero profunda fatta, tantum
aeris in pulmones irruit, quantum ut aqua vafis
cylindrici labra tranfgrederetur fecit. Cum area
vafis cylindrici fuerit 55.41 digiti quadrati, et a-
rea colli 18; 55.41—18 x 1.25=46.76 digitos cu-
bicos, u^Sjutjrititatem, quae ab hoc viro refpirari
folebat, acris habemus. Idem experimentum
cum eodem fere exitu ter rcpetitum. Ne quis
error vcro ab aliqua caufa ortus fuiftet, refpira-
tiornim ejus per aliantoidem periculum facere
duxi elfe neceftarium.
Fig 1
£ x p f. r i me n t. ii.
Ho mo fanus et valens, pedes quinque digitof-
que oifto procerus, circuitu thoracis trcs pedes
trefque digitos explens, in dolium A B C D, uti
in figura 4ta delineatur, ar&e inclufus eft, quod
aqua gradum thermometri Fahrenheiteani nona-
gefimum temperie adaequante repletum eft, do¬
nee ad cam colli, quae ad afcenfionem et defcen-
iionem metiendam maxime accommodabatur,
partem afcendit. Haec autem ex digitis 1.25
attingere notata eft. Pulfus arteriarum, et an¬
te et poftquam immerfus eft, 64 aut 65, et re-
fpirationes 14 vel 14E ut frequenter ante fuerat
notatum, ftngulis minutis, fuerunt. Et omni-
110 eadem duas horas et amplius manferunt, per
quod fpatium in dolio moratus eft, ne minimam
quidem moleftiam in fpiritu trahendo vel emit-
tendo, vel in re qualibet alia, fentiens. Quin-
etiam, per omne id tempus afcenfio et defcen-
fio digitum unum partefque ejus viginti quinque
centefimas, ad minimum, adaequare conftanter re-
perta. Infpiratione vero profunda fadla, tantuin
aeris in pulmones irruit, quantum ut aqua vafis
cylindrici labra tranfgrederetur fecit. Cum area
vafis cylindrici fuerit 55.41 digiti quadrati, et a-
reacolli 18; 55.41—18X 1.25=46.76 digitos cu-
bicos, ut'^rjrititatem, quae ab hoc viro refpirari
folebat, aeris habemus. Idem experimentum
cum eodem fere exitu ter repetitum. Ne quis
error vero ab aliqua caufa ortus fuilfet, refpira-
tionum ejus per allantoidem periculum facere
duxi elfe neceftkrium.
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The lung volume measured by the body plethysmograph is known
as the thoracic gas volume (Vtg). This is the total volume of
gas that lies inside the thorax whether or not this is in communi¬
cation with the airways. Body plethysmography thus yields higher
values in some patients with lung cysts, emphysema or severe asthma,
than do gas dilution methods. Such differences may however be
reduced if the gas-dilution or gas-clearance methods are continued
for a sufficiently long time (Dramamel et al, 19615 Schmidt and Cohnt
1961j Tiemey and Badel, 1962), Though it may be thought that gas
in the gastro-intestinal tract, especially a large gas bubble in the
stomach, could possibly contribute an artefact in the measurement of
the thoracic gas volume, Du Bois and his associates showed this not
to he so (Du Bois, 1959). This was confirmed by Reichel (19&9)
who found no change in the Vtg in 11 subjects following the introduc¬
tion of one litre of air into their gastro-intestinal system.
There was a long period of confusion in the nomenclature of the
subdivisions of lung volume. Some, like Hutchinson's 'vital capa¬
city* have been retained, whilst others like Davy*s 'residual air'
have been slightly modified to 'residual volume', and still others
completely discarded. The confusion was brought to an end in
1950 with a suggested standardisation by the Federation of American
Societies for libcperiraental Biology. Their definitions have been
v&dely accepted.
(b) Details of methods used to measure static lung volumes.
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Measurements of static lung volumes were carried out by
(i) constant volume body plethysmography - as described in the
previous section.
(ii) closed-circuit helium dilution technique.
A Reapararaeter MK II (P.K. Morgan Ltd.) and described by
Reynolds et al, (1965) was used to measure the various subdivisions
of lung volume. A measured concentration of helium is introduced
into the water spirometer section of the Resparometer, which has a
seven litre bell. The dead space of the apparatus is determined
by observing the dilution of helium after about 2 litres of air
have been drawn into the spirometer. The Resparaneter is equip¬
ped v/ith a pump for circulating the gas through the helium catharo-
meter, .and a pen recording kymograph. The catharoraeter is a
Cambridge indicator supplied by the Cambridge Instrument Co. Ltd.
Initially, enough helium is added to give almost a full scale de¬
flection on the catharometer. The gas flowing to the catbaro¬
meter is first passed through soda lime and calcium chloride to
absorb any CO^ and waiter vapour, as the catharoneter is slightly
sensitive to these gases. The dead space of the apparatus was
calculated each time before use :
V x He „
Dead space (D.S.) *
He1 - He2
where V =* volume of gas in system
He.j m initial concentration of helium
94.
He
2 » concentration of helium after addition of air.
The subject is then switched into the circuit at the end of
normal expiration during quiet breathing with subject relaxed and
sitting upright. During the procedure, the subject wears a
nose-clip and is carefully watched to see that the mouthpiece fits
snugly and that the lips are kept tightly sealed around it to pre¬
vent any leak. The Resparaaeter has a small rotameter for moni¬
toring added oxygen and a soda line canister for absorbing carbon
dioxide. Sncrugh oxygen is added to keep the expiratory baseline
level without rising or falling. The end point of equilibration
is taken when the catbarometer reading remains steady and the read¬
ing does not alter after the subject is instructed to carry out a
series of slow deep breaths. In some of the asthmatic patients
studied this sometimes took over fifteen minutes. Before the
subject is turned out of the circuit he is asked to perform two or
three relaxed vital capacity manoeuvres.
The functional residual capacity is then calculated in the
following manner:
Functional residual capacity - (V + D,S.) x (Heg - He.)
He3
hhere He, is final helium concentration.
3
The volume of the mouthpiece being deducted from the final
results.
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(Silson and Ba^-Jan a (1949) pointed out that there were five
sain sources of error in gas exchange methods for assuring F«R«C*t
(i) incomplete nixing of qaaoc in the lung - this can only be oorw
pl«t«ly obviated by body plethytsoogr phic techniques. As has
been shown by various workers, this factor is of special importance
in patients with severe respiratory disease. In the present
study, special attention was given to ensure that a true final
equilibrium point was reached. Mixing of gases in the lung was
tided by asking the patients to t doe a number of slow deep breaths
before the final equilibration point wis recorded.
(ii) innccur-.te esttrtion of the resting expiratory level - this
presented no problem, as this point could easily be determined by
watching the subjects closely on?! switching then free br® thing -air
into the Reapar.uioter rod the end of a quiet expiration,
(iiO X. * v, •••:;-■•.•.„■•, ;-v-,-;
r,a :.n indie tor-, ocpspl ftly in mi ticm to thr-oe of blood,- Itensely
end associates, (1942) estimated that 8 tal to 13 *al of hellun would
be absorbed in a soven-atrarte rebrenthing procedure. Birath and
Swsnson (195^) suggested that 195 al» BfPS from the lung volume
ueasurenent should be deducted to ask© up for the amount of helium
absorbed. As boo already bean stated, it wns not felt necessary
to make this correction in the values presented.
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(iv) the so-called "nitrogen lag" or "oxygen storage effect" -
described by Lassen et al, (1957) confimed by Ibneely et al,
(196O). This refers to the assumption th t when helium equili¬
brium is achieved, there is equality of gas concentre*icas in all
parts of the luig-spirometer systemj this assumption was shown to
be incorrect in a closed-circuit system of decreasing volume duri-ng
re-breathing. This source of error was overcome by keeping the
volume of the system constant by adding oxygen at approximately tho
sane rate as it was being taken up; thus ensuring that the resting
expiratory baseline remained level.
(v) faulty estimation of gas concentration - as has been pre¬
viously mentioned, GOp and water vapour interfere with the correct
estimation of helium concentration by the catharometer. These
gases were removed by the addition of absorbers for these gases at
the inlet of the catharometer. Besides interference from C0o
and water vapour the thermal conductivity of the analytic cell in
the catharometer has been shown to be affected by the presence of
different concentrations of oxygen and nitrogen at the final read¬
ing compared to the intial reading. However, it has been shown
that if the volume constancy of the system is maintained this should
not introduce a significant error in the calculation (Hathirat et al,
1970).
(°) Comparing F.R.C. obtained by closed-circuit helium dilution with
Vtg determined by constant volume body pleth?/Baographyi
TABLE IV
Co tparison between leasurextent a of F.R.C. obtained by
heliui dilution with values of Vtg a< isurei by body plethysmography
in 16 normal subjects.
Nana F.R.C.(nl) B.T.P.S. Vtg (al) B.T.P.S.
1. J.S. 4850 4980
2. A.R. 3280 3450
3. A.M. 4580 4730
4. R.F. 3398 3500
C ?* T»
jl* * 3350 3970
6. TUB, 3440 3300
7. J.R.S. 2950 3190
8. G.S. 3900 3990
9. R.C.B. 4-209 4400
10. GUI). 4590 4630
11. A.P.P. 3520 3690
12. H.O. 3200 3400
13. F.W. 2800 2950
14. J.I. 2930 3150
15. P.F. 3650 3300





There have been a lumber of studies comparing FRO and Ytg
both in normal and ia patients with respiratory disease. In
order to find out how Vtg obtained by body plethyaniogr&ph cod-
par d with F.R.C. by helium dilution method, values for the two
methods have been determined in 16 healthy young volunteers who formed
either port of the departsuental staff or were medical students.
Results are iM in 'Pablo jrf overleaf, and in Fig. 8.
(3/ mtaraio :isin TOIUMIB -ixa dir. r :u-..
The single expiration measurements carried out in this study
arei-
(i) Force! expiratory voluae in one second (FdV.) and forced
vital capacity (F7G) •
(ii) Relaxed vital capacity
(iii) SSasjjaiPi aspirate.: y fla. volume curves
(iv) Peak expiratory flow rate.
(i) FT? and FTC
(a) revel op:,-«ont of test.
The origin of these tests nay be traced back to Hutchinson,
who invented the first spirometer and publishod the results of
vital capacity measurements in 2130 subjects in 1846, Hutchin¬
son*3 original inert remained unaltered for ft long tine and no attest
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was nude to relate it to time. Sturgis et al, (1922) put forward
the idea that maximum ventilation was achieved in the last minute
of exhausting exercise. Hernunnsen, (1933) discovered that the
highest ventilation was achieved by maximum voluntary effort and
showed that this exceeded ventilation on exercise or in response
to COp. He introduced the maximum breathing capacity test (if.B.
C.) which was popularised by Cournand and his associates (1939i
1941). It became widely used following the establishment of
normal values by Baldwin at alf (1948).
The M.B.C. however imposes a somewhat severe strain especially
on the patient who is unwell (Shepherd, 1956)* The search for
an alternative and less exhausting procedure lead to the introduc¬
tion of the timed vital capacity (Tiffeneau et al, 1947» 1949)*
The fast vital capacity manoeuvre as it was first known, was orig¬
inally mainly considered as a means of predicting the maximum breath¬
ing capacity. Various factors were put forward for measuring the
"indirect" M.B.C, Thus Tiffeneau et al, (1949) suggested multi¬
plying the FLTj by 30| Gnndevia and Hugh-Jones, (1957)5 by 35;
whilst Cara (1953) multiplied the FiT/^ by 37«5 and Kennedy, (1953)
used the PHVQ and multiplied this by 40.
At the same time, however, there were also pleas for a more
direct interpretation of the FVC tracings (Bernstein and KazantsiS,
1954; Shepherd, 1955)* The forced expiratory volume in one seo-
cond appears to have been introduced independently by Tiffeneau in
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Prance and Gmensler in the U.S.A. The ideal time interval re¬
mained under discussion for a long tine; Kennedy, (1953) suggested
measuring the P37Q BPC Beedhan et al, (1954) BQC an<3-
lliller et aL, (1955) preferred FdVn K The volumes whichU#2 S^Co
can "be expired over tines "between 0.5 seconds and 3 seconds are
highly correlated and PUV"^ gQC is now universally accepted.
In 1951» Gaensler introduced the concept of measuring the
FEV as a fraction of the vital capacity, and showed in two separate
papers that it could he used to differentiate between patients hav¬
ing "obstructive ventilatory insufficiency" and patients with "re¬
strictive insufficiency"; two terms which had previously been in¬
troduced by Baldwin et al, (1943) to differentiate between under¬
lying pulmonary patho-physiological meciia iisms.
terminology for measurements of the ventilatory capacity was
introduced by Gandevia and Hugh-Jones in 1957» following which, the
fast vital capacity became known as the forced vital capacity.
(b) Physiological basis.
The FEV.J, which is probably the commonest pulmonary clinical
test in use, and is the simplest to perform, has perhaps the most
complex underlying physiology of all the pulmonary function tests
(Pride, 1971)• It is what night be termed a polyvalent test and
reflects very well the interdependence between the airways and the
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parenchyma of the lung. It depends, especially, on the factors
which determines
(a) the maximum expiratory flow at a particular lung volume,
i.e. lung elastic recoil pressure and airway resistance.
(b) the change in aaxirauru expiratory flow with lung volume,
which reflects pulmonary compliance and the change in
airway resistance with change in lung volume.
fhe Pis thought to be relatively independent of the resis¬
tance of the upper airways and of the effort applied (Khan and Kam-
buroff, 1970)* It nay be regarded as integrating a substantial
amount of information about the mechanical properties of the lung
(Pride, 1971).
mocsDuas.
A Gaensler type water spirometer (Gaensler, 1951 b) which has
a light bell and an autoraatic electrical timing device was used.
The spirometer provides a direct reading without the necessity of
analysing a paper record. All the patients could be considered
as "experienced subjects", in that they had all previously undergone
quite a number of spirometric tests. "Gach patient was instructed
to take as deep an inspiration as possible, put the mouthpiece in
his mouth in order to make a good seal with his lips, and then was
actively encouraged to blow out into the spirometer as hard and as
far out as possible. Three measurements were carried out at
intervals of about thirty seconds with the patient sitting down
and not wearing a nose-clip. Meticulous care was taken to ensure
that the patient started the raanoeuvre from as near his total lung
capacity as possible, as the FIJ^ is susceptible to the depth of
the preceding inspiration, which determines the diameter of the air¬
ways at the start of expiration (Cotos, 1965; Kemm and Ihmburoff,
1970).
Hutchinson in first describing his test in 1846 wrote "Each
of these individuals breathed three consecutive tines into the
Spirometer because either fron timidity or inexperience, the first
observation is frequently not a correct experiment, but by three
observations the point sought for is accurately determined. If
more than three observations are consecutively made at one time the
number of cubic inches of air will, from fatigue, g nerally be found
to decrease". There has been some controversy as to which is the
better estimate of the individual performance, the highest value of
FJV.J recorded or the mean of three technically satisfactory attempts.
Cotes, (1965) suggests carrying out five measurements at 30 second
intervals, of which, the first two are rejected, and the mean of the
last three is taken as the definite reading. Preednan and Prowse,
(1966) point out that in ill patients, the nay fall off with
successive expirations, as this makes them tired or because forced
expiration makes them cough; this is often the case with asthmatics.
They suggest in such cases, the peak value may be more relevant than
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the aearu Karan and Kanburoff (ip*f0) found that the.*e was no
significant difference between tho anadaua nd the jsan whan
effort, as estimated by oesophageal pressure, was (jrcatcr than 73'
of maxima, and concluded that either value is acceptable. In
the present study the best T obtained from three successive
efforts is ohosen. All the patients had narked airway obstruc¬
tion and wore repeatedly euteaittc' 1; :■• largo .umber of tests.
Sub;nittin^ then to five forced expirations each ti;ae was oaxsidsred
unnecessary. Cough was not infrequently indue®:! by forced as¬
piration and a substantial number of the patients recorded pc-ik
values an their first attempt.
(ii) mj h.Uh.D .-.-Pl-hhh::! WOlJJl,..
In normal subjects, increasing tr nspulao«:iry pressure during
expiration tends to nsnw tho airways. iinthoven (1892) was
the first to appreciate tho importance of "dynamic compression" in
tho pathophysiology of airway obstruction disease. This narrow¬
ing effect has been shown to be increased in sane patients with
chronic obstruction (head et si, 1935? Dayman, 193^5 (K^bell et al,
1957)♦ -lien excessive caqriLratory narrowing of the airways Units
flow in patients with airway obstmotion, changes lh the peripheral
airways, such as those produced by a bronchodi1ator, nay not be de¬
tected by tests of raaxliaaa ©spiratory effort. This is because
collapse of large central airways can raaak tho peripheral changes
(llacklen, 1965)*
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The patients in the second part of the study were therefore
asked to perform three relaxed expiratory manoeuvres, preceding
the forced expiratory ones. The subject was asked to inhale
as deeply as possible and then to let out all the air with a deep
and heavy sigh. It was emphasized that force was not to be
used but that the subject was to concentrate on a sigh or a relax¬
ed expiration. The best reading was again taken as the final
result. Some subjects found it more difficult to carry out
technically satisfactory relaxed expiratory manoeuvres than the
PS7<j •
(iii) k&anajk -ixpiiiatory fwj vousia cukvus.
Physiological basis and development of tost.
(a) iso—voiLHi PUJbbmid^Low auras.
Pry and his associates in 1954t showed that a functional re¬
lationship exists between transpuliaonary pressure, respiratory gas
flew and the degree of lung inflation. These workers introduced
isovolume prossure-flow (I.V.P.F.) curves to express the relationship
between these variables. Isovoluae pressure-flow curves have been
used very successfully by a number of workers (Fry, 1958? Hyatt et al,
1958; Fry and Hyatt, 1960; Head and Backlem, 1967; Head et al, 1967;
Pride, 1971)•» "to analyse mechanisms limiting flow during forced ex¬
piration. These curves are obtained by getting the subjects to
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perform a series of expired vital capacity manoeuvres, slowly at
first, and then more rapidly up to one of maximum speed and effort.
The volumes are expressed as percentage of the vital capacity.
Instantaneous values of oesophageal pressure - reflecting trano-
pulnonary pressure, are plotted against simultaneous expiratory
floirs at the sane lung volune. liach vital capacity nanoeuvre
yielding one point at a given volume. A family of isovolune
pressure-flow curves can thus be obtained at different degrees of
lung inflation.
Although this technique is too tine consuming for routine
use, the information obtained from such I.V.P.P, curves is absol-
utely fundamental to an understanding of what is happening during
a forced expiration. I.V.P.F. curves show that at high lung
volumes, usually above 75/' of the vital capacity, flow goes on in¬
creasing as the alveolar pressure rises and no easily defined limit
to expiratory flow exists at volumes around total lung capacity
(T.L.G.). As lung volune is reduced below about 75/' of the
vital capacity, expiratory flow maxima can b© shown , beyond which,
a plateau is reached where flow no longer increases with increase in
alveolar pressure. Plateaus of flow occur at lower and lower
alveolar pressures with further reductions in lung volume.
l&mdmal forced expiratory flow lias been shown to be determined
by a number of factors, which include, the relationship between the
degree of lung inflation and the transpulinonary pressure (Fry et al,
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1960), the magnitude of small airway resistance (Macklen et al, 1965)
as well as the lung recoil pressure (Stubbs and Hyatt, 1972) and, at
times, the collapslbility of the large airways (l-Iead et al, 1967).
Although, as pointed out by Dayman as early as 1951# compres¬
sion cf large airweys is responsible for limiting expiratory flow,
it lias been shown that it is not the only cause of an increase in
resistance with increasing expiratory effort. The increase in
the rate of flow of air will of itself bring about other changes.
I,'hen Reynold's numbers exceed 2000, especially if airways are irreg¬
ular, flow becomes turbulent (Mead et al, 1967); as turbulence
develops, this increases the pressure drop from the airways.
Besides the effect of turbulence, as the airstream moves from the
alveoli, through, the bronchioles and up to the larger airways, its
linear velocity increases because the large airways have a smaller
tortal crass-sectional area - this is known as convoctive accelera¬
tion of the flawing gas (Hyatt and Wilcox, 1963)• Convent ive
acceleration has the effect of reducing the pressure within the
airways, the Bernoulli effect (Macklam and Mead, 1968), and this
naturally increases the compressive effect of the high extra airway
pressures found during forced expirations. The pressure drop
associated with the components mentioned above will thus d pend on
the geometry of the airways andthe magnitude of flow (Head et al,
1967).
(b) TH30RES HXPLAIITDC EXPIRATORY FLQU LPHTATIQHS.
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Fry (1958) was the first to attempt a detailed physiological
explanation of the mechanisms limiting expiratory flew by applying
aerodynamic principles to events occurring along the whole airway.
He developed the concept of the "flow-limiting segments", which were
the first to narrow sufficiently to limit flow. Analysis proved
complicated due to the difficulties in accurately describing events
occurring along the whole of the compressed segment.
Pride et al, (1967) suggested that when maximum expiratory
flow is reached in an I.V.P.F. curve a "waterfall" or Starling re¬
sistor effect develops in the airways. This concept was first
applied to pulmonary blood vessels by Permutt and his co-workers in
1962. Using the Starling resistor model they developed simple
equations relating the roles of lung elastic recoil, airway resist¬
ance and bronchial collapsibility in determining maximum expiratory
flow, driving pressure during this flow and airway resistance.
They regard the airways as two rigid tubes connected in series by a
collapsible tube. When the transmural pressure in the collapsible
segment falls to a critical level, below Pleural prassure (Ppl) a
"Waterfall" effect will develop and that part of the airway will form
a flow limiting segment; i.e. flow becomes dependent on the differ¬
ence between driving (alveolar) pressure and the surrounding (pleural)








elastic recoil pressure of lung
critical transmural pressure of collaps¬
ible segment at which a waterfall devel¬
ops.
resistance of segment between the alveoli
and the outflow end of the collapsible
tube.
Mead et al, (1967) developed a different but complementary con¬
cept of events occurring during a forced expiration. They put
forward the idea that during a forced expiration there must be some
point or points in the airway where the intra-luminal pressure is
equal to the pleural pressure. They referred to these points as
the "equal pressure points", (EPP). Such a locus divides the air¬
way into an upstream segment between the alveoli and the EPP, and a
downstream segment between the SPP and the airway opening. The
pressure drop from alveoli to SPP is the drop from alveolar pressure
to pleural pressure, that is, the lung elastic recoil pressure.
At maximum flow at any given lung volume, the lungs may be regarded
as a fixed resistor (the upstream resistor) in series with a vari¬
able resistor (the airways dynamically compressed downstream from the
EPP). Maoklem and Wilson (1965) showed that the EPP were in the
segmental bronchi on forced expiration in normal subjects.










= lung elastic recoil pressure
resistance of upper segment
Both Pride et alf and Mead et al, regard maximum flow as re¬
sulting from a fixed driving pressure operating through a fixed re¬
sistor in series with a variable resistor. In the equal pressure
point theory, the fixed resistor is regarded as extending frora the
alveoli to the equal pressure points; in the analysis of Pride et
al, it extends from alveoli to the flow limiting segment. I«Iead,s
concept has the advantage that fewer assumptions are made; it igno¬
res the compressed segment and thereby simplifies the analysis further.
In practice Rus is much simpler to measure than RB (Pride et al,
1967)* Pride's work takes into consideration the exact mechanism
by which flow, is limited and the use of their equation would allow
an estimation of Ptm* which might provide information about the col-
lapsibility of th~ airways and possibly, the magnitude of smooth
muscle tone.
In many respects the analysis carried out by Campbell, Martin
and Riley, (1957) is similar to Pride's, but Campbell and his associ¬
ates did not use the simplifying assumptions of the waterfall pheno¬
menon. They used oesophageal pressure at which peak flow was
reached during forced expiration, "Pt max. off." - the maximum
V
E max.




effective intrathoracic pressure in an attempt to distinguish
differences in mechanisms of airway obstruction in patients with
emphysema and asthma.
(c) MAXIMUM EXPIRATORY FLOW VOLUME CURVES.
As from can be seen from I.V.P.F. curves, during forced ex¬
pirations, the rate of air flow cannot increase beyond certain maxi¬
mum values. At large lung volumes, these maxima are mainly set
by the amount of expiratory effort, that is, by the force developed
by the expiratory muscles which, in turn, depends on their speed of
contraction and velocity of shortening (Agostoni and Penn, i960).
This driving pressure, is opposed by the total flow resistance of
the entire airway, as well as that of the tissues, chest wall and
any resistance of the measuring equipment. As flow rises, the
SPP move rapidly upstream. As has already been indicated, at
lower lung volumes, flow is independent of muscular effort as long
as this is above certain levels, and may be considered as being
determined by the lung elastic recoil and the resistance between
the alveoli and the EPP.
Since the degree of lung inflation is a main determinant in
flow-limiting mechanisms, maximum expiratory flow rates are per¬
haps best studied as a function of lung volume . Maximum ex¬
piratory flow volume curves (M.E.F.V.) were introduced with this
aim by Hyatt, Schilder and Pry in 1958 and have proved to be a
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very useful tool in a number of physiological and clinical
studies (Takishima et al, 1967} Lapp and Hyatt, 1967? Bouhuys
et al, 1969; Van de 'rfoestijne and Sapletal, 1970)•
Maximum expiratory flow volume curves can be derived from
iso-volune pressure-flow curves by plotting the maximum flows
against the volume at which each was measured.
The plotting of I.V.P.F, curves, however, remains a labor¬
ious procedure, certainly not one that lends itself easily for
frequent and repeated measurements on asthmatic patients.
Fortunately, M.E.F.V. curves are easily obtained by plotting
instantaneous flow against lung volume, instead of time as in the
F.E.V.during a vital capacity manoeuvre. In normal M.E.F.V.
curves, flow increases rapidly to reach a maximum at about 80/! of
the vital capacity, and then decreases, reaching a value of zero
at the residual volume. Hie curve consists of essentially two
parts, an effort dependent portion, which as indicated is that
part at higher lung volumes, and an effort independent portion.
According to Hyatt (1961) the effort independent portion extends
to 60/! of the vital capacity. Later studies by Mead et al,
(1967) shewed that it extended to at least 79/! of V.C. Me11-
ins et al, (1968) reported that I.V.P.F. curves of healthy children
reach plateaus at lung volumes up to 90/! of V.C. These data at
first seem to suggest that children might reach the effort indepen¬
dent portion of the M.E.F.V. curves at higher lung volumes than
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adults. It la now howevert kno-ti that there is not a consistent
relationship between lung size arid the volume at which I.V.P.F.
curves first reach a plateau. Van de Woeartijne and Zapletal,
(1970) showed that the effort independent portion extended to an
average level of 82$ of V.G. in normal subjects. Many adults
achieved a plateau at lung volume levels which were similar to
those at which children achieved theirs. Thus, maximum expira¬
tory flow in about the lower 75$ a? V.G. is thought to reflect the
physical properties of the lower airways and is determined by the
lung elastic recoil, the resistance of these airways and the col-
lapsibility of the flow-liniting segments.
Recent work by Clement and Van de Koestijne,(l97l) has how¬
ever cast sosa® doubt on the "effort independence" of M.S.F.1. curves.
They measured maximum flows in the "effort independent" portion of
flow-volume curves and showed that these had a coefficient of vari¬
ation of 9$» This lack of reproducibility was looked at by means
of a polynomial analysis, and they showed that it was not only re¬
lated to technique and to slight differences in volume at the maxi¬
mum inspiratory level proceeding each expiration? but that a third
source of variability can be attributed at least in part to effort
dependency. Clement and Van de Coestijne (1971) claim that lin¬
ear regressions constructed in the gateau region of I.7.P.F. curves
(at 55$ T.L.C.) do not demonstrate real horizontal flow plateaus?




A Wedge Spirometer (Model 170 Med-Science Sleotronic3 Incorpj
St. Louis Missouri) with a maximum volume of ten litresj was used
to obtain both flow and volume. It is a waterless spirometer
and does not depend upon a water ahamber to maintain an air seal,
instead an extremely compliant bellows is employed to allow motion
of the output member with absolute assurance of zero leakage.
Both volume and flow parameters are available as electrical sig¬
nals, each generated as a function of the instantaneous rate of
displacement of a core in a transducer. Bach core is coupled
to the moving output member of the spirometer. Its frequency
response is claimed to be flat within 55® up to 10 cycles/sec for
both volume and flow. 2rfcreraely lot? resistance characteristics
are achieved in this instrument. The signals from the spiro¬
meter were fed into a direct writing multichannel recorder(80 Slema
Scholander Mingograf). The spjfctoraeter was carefully calibrated
for both volume and flow immediately before each set of measure¬
ments were performed. Hyatt et al, (1958) originally suggested
a method using multiple expirations of varying effort to 'fill in*
the flow-volume curve with true maximal flows at each volume.
It was Branscomb, (i960) who introduced the idea of using a maxi¬
mum forced effort in plotting flow against volume.
Three forced vital capacity efforts were recorded with the
subject seated, with a nose-clip attached, at intervals of about
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thirty seconds. The effects of flow and volume history on maxi¬
mal expiratory flow rates are complex and not well understood
(Bouhuys and Joneon, 1967; Bouhuys et al, 1969)* All the sub¬
jects studied had an identical flow and volume history before
attempting this procedure. The best of the three efforts was
later analysed.
As can be shown by analysing I.V.P.P. curves the maximum
flow especially over the lower half of the M.E.F.V. curve does not
correspond to the greatest transpulmonary pressure produced by
maximum effort. In this respect, the curves obtained from the
subjects in this study are really maximum effort flow volume curves
as first described by Fry and Hyatt in 1960. However, by making
the subjects carry out F.V.C. efforts, an identical volume history
was ensured and the tests were repeatable and comparable, each sub¬
ject serving as his own control.
The significance of alveolar gas compressibility and its
effect on the static pressure-volume diagram was described as
early as 1946 by Rahn and his co-workers. Jaeger and Otis,
(1964) studied the effect of gas compressibility on the dynamic
pressure-volume relationship by simultaneously measuring changes in
thoracic gas volume and volume displacement at the mouth. They
found that the volume displacement at the mouth was less than the
volume change of the thorax and this difference increased with in¬
creased airway resistance, respiratory rate and lung volume.
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Their work was confined to the study of alow and rapid cyclic
respiration.
In their original I.V.P.F. curves Hyatt and his associates
(1958) represented flow as decreasing from maximum levels as pleu¬
ral pressure increased. Ingram and Schilder (1966) studied the
effect of gas compressibility on the forced vital capacity manoeu¬
vre and the flow-volume relationships. They showed that the
decrease in flaw from maximum levels reported by Hyutt (1958)» is»
at least in part, an artefact related to the fact that, a spirometer
at the mouth was used to measure volume. During forced expira¬
tions the gas in the lungs is coopr ssed and lung volune decreases
progressively below that shown by the spirometer. In this case,
reductions in flow are to be expected since as lung volume decreases
maximum flow also decreases. If a volume-displacement body ple-
thysraograph is used, where all volune changes, including those of
gas compression are measured, the I.V.P.F. curves usually show
flatter plateaus. The larger lung volumes and high airway re¬
sistance found in patients with airway obstruction, will of course,
magnify the effects of gas compression when flow and volume are
measured by a spirometer at the mouth. Although ideally, as
shown above, changes in flow should be plotted against absolute
changes in thoracic gas volume, as no volume displacement body
plethysmograph was available, both flow and volume had to be
measured at the mouth. The effect of gas compression on M.E.
F.V. curves however, is said to be less than on I.V.P.F. curves
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(Bouhays, 1970).
(e) Indices derived from flow-volume curves.
There have been various suggestions regarding the data that
can be derived from flow-volume curves mid the indices to be used.
Gander and Comroe (1955) surested .measuring mean maximal expira¬
tory flow between 0.2 and 1.2 litres of a forced expiration.
Hie aean aaxiiaal expiratory flow between 25/< and 75/- of & forced
vital capacity effort (MMSP 25 - 75/-) was first put forward by
Leuallen and Fowler, (1955). Franklin and Lowell, (1961) sug¬
gested using the expiratory rate during the third quarter of a
maximal forced expiration, (MMEP 50 - 73/ ) t as an index. Lloyd
and Wright, (1963) Pleasured maximum flow rate at a lung volume 1
litre above the residual volume; this describes the average slope
of the last portion of the MSFC curve. The ratio '•-/ j _\\j over
the volume range }Q;> - 75/- of the vital capaoity was used by Lapp
and Hyatt, (1967)? this ratio has the dimension of time and repre¬
sents the reciprocal of the i-InFV curve slope over the volume in¬
terval chosen. Lapp and Hyatt considered this index as a measure¬
ment of the time constant of lung emptying. Hyatt, (1965) sug¬
gested that when comparing subjects of different sizo, it xaay be
worthwhile dividing the maximum expiratory flow rate at 50;« V.C.
by the thoracic gas volume corresponding to 5^ of the vital capa¬
city. Bouhuys et al, (1969) studying the bronchoconstriction changes
induced by inhalation of pharmacological agents and cotton dust,
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showed that mxuaua flow rate measured at 60/C of T.L.C. was the
most sensitive index in detecting relatively slight degrees of
bronchocconstrict ion. The maximal expiratory flow rate (ICIFR)
is another index obtainable from an M.3.F.V. curve.
Evidence has been produced that a maximum inspiration, which
is such an important stop in performing a forced vital capacity
manoeuvre, alters lung compliance (Ferris and Pollard, 1960) and
may change airway resistance (lladel and Tierney, 1961! Lloyd, 19*53).
Frank and his co-workers (1962) first suggested that expiratory
flow measurements after a less than maxiimri inspiration may be very
useful. Bouhuys et al, (1969) introduced partial expiratory
flow volume (PJFV) curves, made after inspiration to mid-vital capa¬
city instead of the T.L.C. and reported that changes of flow rates
on P.E.F.V. curves were usually larger than those of flow rates
on M.E.F.7. curves, in a series of patients in whom bronchoconstric-
tion had been indiced. Interpretation of P.3.F.V. curves however
requires the measurement of thoracic gas volume to establish their
volume level.
The indices that have been derived from the M.E.P.V. curves
in this study include M.E.F.R. and maximal expiratory flow rate at
50fo V.C. Maximal flow rates obtained at 80,1, 60/*, 40% and 20%
of the vital capacity were also compared.
Hyatt, (1965) suggested that in chronic airway obstruction
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where increases in residual volu/ae are an integral feature of the
disease process, the value of maximum expiratory flow volume curves
my be decreased by analysing the foread vital capacity manoeuvre on
the basic of vital capacity alone. He suggested that it would be
sore logical to relate saaxinaua expiratory flew to absolute thoracic
gas volumes, and this should relate uore directly to the underlying
anatomical and physiological abnormalities.
Bouijuys at al, (19&9) believe that the aaxinua expiratory
flov/ rate at a defined, absolute level of lung volume is a uore
satisfactory aeasure of expressing changes of M« *F»V» curves than
indices proposed by previous authors. They shewed that changes
in M. J.F.V. curves are most impressive when the curves are plotted
on an absolute volume scale. As no volurso-diaplaceuvant plethy-
saograph was available, the absolute volume scale was obtained from
separate measurements of total lung capacity obtained by the closed-
circuit haliun dilution technique. As shown further on , relat¬
ing maximum flow rates to an absolute level of lung volume, made
the changes in flow rates obtained, uore striking and awe mean¬
ingful, than when the &xm changes in flow were related to percen¬
tage of vital capacity.
(iv) Peak expiratory flow rate
Following the introduction by "fright ami KoKsrrow in 1959 of
a new portable instrument for measuring maxima forced expiratory
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flow in litres per minute, the peak expiratory flow rate (P.S.F.R.)
has become another popular single-expiration measurement.
According to Donald (1953) J "The physician of the last cen¬
tury who asked a patient with respiratory disease to whistle or
blow a candle out was crudely assessing the maximum respiratory
velocities". He suggested that a "simple whistle-like instru¬
ment" might be developed and might become a standard clinical tool.
There had been previous attempts in the past to measure flow rate
on expiration. Thus, Hadorn, (1942) used an aneroid manometer
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connected across a simple orifice, the deflection of the manooet r
level being judged by eye. VJyss, (1950) used the same type of
orifice but recorded the pressures photographically. Hildebra-
ndt and Hanke, (1956) used a "pneumometer", incorporating an aner¬
oid manometer fitted with a device for recording the maximum flow
rate.
The Wright peak flow meter has a variable orifice which is
initially closed by a vane. The latter is deflected during
expiration, through an angle which is a function of the rate of
flow. This instrument is calibrated in litros per minute and
records flow over the first ten milliseconds of a forced expira¬
tion.
As the peak flow rate is a measurement occurring very early
on in the vital capacity, it depends to a great extent on full co-
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operation from the subject. A position of full inspiration
was carefully ensured and the subject was coaxed to empty his
lungs in a short, sharp expiration of maximum effort. The
best of three efforts was accepted as the final value. The
Wright peak flow meter was calibrated against a rotameter and the
values obtained were well within 10$ of the values reported by
Cotes, (1965)«
ASSSSSMEMT OF PWLMDWARY CAS EXCHAHSS.
(1) Arterial blood gas analysis.
Development of methods.
(a) Arterial oxygen tension (PaO^)
Direct estimation of the partial pressures of gases in whole
blood was first attempted by Pfluger in 1872 who introduced blood
into a tonometer containing gases of known concentrations and anal¬
ysed the gas phase after equilibration between the blood and gas had
taken place. Haldane (1898) first noted the ability of ferricya-
nide salts to displace oxygen from its chemical combination with
haemoglobin. This led to a rapid improvement of vacuum extrac¬
tion methods which had been introduced by Magnus in 1845i culmina¬
ting in the manometric method of Van Slyke and Weill, (1924).
Riley and his associates in 1945» introduced a method in which
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a snail volume of blood is equilibrated with a gas bubble.
The gaseous cDeposition of the bubble being determined by chem¬
ical absorption in a capillary tube where the length of the bub¬
ble is proportional to its volume before and after absorption of
each constituent. In their latest development, Riley et al,
(1957) were using 1 ml. of blood and a bubble of 5 - 10 micro-
litres. The Riley method is slow and tedious and requires
variable, empirical correction factors.
Of course, PaO^, may also be determined by interpolation of
the saturation in the oxy—haemoglobin dissociation curve, once
the pH and the PCO^ are known and the body temp rature is not
significantly different from 37°C. The oxygen content and
capacity of the blood may be obtained by the manonetric method
of Van Slyke and Neill (l924)i but this is too time consuming.
A quicker determination of oxygen saturation could be obtained
by the spectrophotometry method (Hilsson, i960).
Danneel (1897/1898) was the first to use the platinum cath¬
ode for oxygen tension measurements; demonstrating a linear re¬
lationship between oxygen tension and the recorded current.
However, its use was somewhat limited, because when immersed in
biological media, it rapidly lost its function because of the de¬
position of a protein film on the surface of the electrode.
Modern methods of Pleasuring arterial oxygen tension are
based on the principle of Polarography introduced by Heyrovski in
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1925* Essentially the system consists of an anode and a cath¬
ode made of a relatively non-ionisable metal, such as mercury or
platinum, in an electrolytic cell; oxygen being reduced at the
cathode when a negative potential is applied across the anode and
cathode, causing a current to flow. The current which flows
is a function of the rate of reduction of oxygen at the cathode.
Baumberger, (1938) first used this principle to determine the dis¬
sociation curve of oxyhaeaxoglobin. The cathode of this elec¬
trode was formed of drops of mercury. This dropping mercury
cathode was later used by Sferggrsn, (1942) for his classical ex¬
periments on venous shunting in the lung. However, the tech¬
nique was difficult to master and had to be carried out on anaer-
obically separated plas;aa, and not on whole blood. Contaminar-
tion by films of protein and variation in mercury drop size pro¬
duced unr liabl results.
The problem of deposition of protein films on the electrode
was finally solved by Clark in 1953, who isolated tin platinum
cathod by cov ring it with a cellophan membrane, which only
allowed access to o:cygen and carbon<5.oxide. It was further
improved by incorporating the platinum cathode and silv r anod
in a solid cell, isolating the e posed lectrode by a hydrophobic
aembran- (Clark, 1956). This type of lectrode requir d active
motion of the blood sample to ensure a continuous and adequate
supply of oxygen to the electrode surface. Th re have been
many ways in which stirring has be n produced, such as the use
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of a stainless steel blade (Rooth et al, 1959) and a glass coated,
soft iron sing (Bishop, 1960). elimination. of the stirring or
motion of the el ctrod- has now be n obtained by reduction in size
of the platinum cathod and increasi.-g the thickness of the cover¬
ing membrane. Th introduction of the Clark mmbrane- - covered
polarographic oxygen electrode has enormously facilitated the
measurement of PaOg making it a routine laboratory investigation;
no other method is now in regular use.
(b) Arterial carbon jio:-ide tension (PaCCu)
Geveral of tho original methods described above for the
determination of Pa0o, e.g. the Van Slyke technique and the Riley
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bubblt: method, also yielded values for PaGOg. Another method
of deterraining the carbon dioxid- tension in arterial blood makes
use of the linear relationship between ph and log PCO^ - the Astrup
procedure (Astrupf, 1956, 1953, 1960). In this technique the
sample of blood is divided into three parts, the pK of the first
part is read directly with a pH electrode; the other two portions
being equilibrated with two gas mixtures of known PCO,
tonometers. The pii of the two equilibrated samples is m asured
and plotted against log PC0?f the points b ang joined by a straight
line. The PC02 of the original sample being obtained by inter¬
polation on the line at its a-asured pli. 5iggaar4--Andersen et
al, 1960 introduoed a ndcroaethod based on the Astrup proc dvire,
using a microtonometer and a micro pH electrode for the d teraina-
tion of pil, PC02, base excess and standard bicarbonate using capil¬
lar/ blood.
A method which has gained a gr at deal of popularity since its
introduction is the direct determination of PGO^ with a CC>2 elec¬
trode. The principle of this electrode was discovered independ¬
ently by Stow and his co-workers (1957) and Gcrts and Lo send. ,
(1953) and the method Ixaa bean extensively d velop d by Severinghau3,
(1958, 1960, 1962). The el ctrod< consists saentially of a glass
pll electrode with a reference lectrode surrounded by a bicarbonate
buffer and separated from the blood sample by mea. s of a Teflon neza-
brane which is permeable to CQ2 but impemeabl to oth r ions.
C02 diffuses from the sample across the membrane altering the pH of
the bicarbonate solution. The change in pH is d tected by the
electrode; the voltage output of the el ctrodc is dir.ctly related
to pH and is therefore a log function of PCO,,. Th pH is a lin¬
ear function of the logarithm of the blood PCOg over the rang from
at least 7 to 700 amHg (Severinghaus, 1960)*
(c) pll *>£ blood.
Sorenscn (1909) introduced the logarithmic pll notation for ex¬
pressing the concentration of hydrogen ions. He developed dec-
troaetric methods for determining the pll of the blood. Using thes
methods, Hasselbalch and Lundsgoard mad-. the first accurate mexsure-
aenta of blood hydrogen ion concentration in 1912. 1 capillary
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glass alectrodo was first used for measuring pil in the 1930's.
This typo of -loctrode cnolos .d in a water jacket for temperature
control was ro-introduc-d by Sans, (1957) and has virtually repla¬
ced the bulb glass electrode for blood analysis which had been used
b fore. Idcro--.dectrodes, such as that described by Siggaard-
Andersen and his co-workers (19o0) have also bean introduced in the
u. usurenent of blood pH.
A potntial differ no., is set up when fluids of different
hydrogen ion concentrations are on either side of a thin glass uen-
brane. Tho potential difference is aeasurel by combining the
glass ol .ctrodi. with a reference electrode, such as a calomel loc-
trod: and measuring the voltag© of the systan.
(ii) Procedure.
Hie o:cygaa el . ctrod us .d in this study is a Radioaet r P0?
electrode type EfKHo. It is a Clark type 0^ el ctrod and con¬
sists of a platinum cathode and silver/silv-r chlorid anode placed
in an el .ctrolytic solution behind a polypropylene maabran . The
electrolytic solution is a phosphate buffer to which some potassium
chloride is added to stabilise the potential of the anode. A
polarising voltage of about 650 m.V is applied across the two el c-
trodes. The electrode was carefully calibrr.t d b fore each blood
sample was put in. ""..hite spot" nitrogen was used as the aero
refer ncu point and atmospheric air was used as the high ref rence
point. Tonometry, using r tonometer of tlie swirling flask type,
(Schoeller and Co., Eloktrotechn. Fabrik, Frankfurt) was regularly
carried out to eheok the oxygen electrode over the P02 range 15 to
120 nnllg and the values obtained from the electrode were suitably
com - ct d by use of calibration graphs.
The carbon dioxide c-1 ctrod used is a Radiometer PCO, el c—
troie type 35036. It is a S< veringhaus U0o lectrode co:isisting
of a combin-.d glass electrode and silv r/silver chloride electrode
mounted in an electrod jacket surround d by a IfaHCO.-lTaCl solution
and separated from the sampl by means of a Teflon membrane. Cal¬
ibration of the el ctrod- was carefully carried out, before ach
blood sample was put through, with two gas s of different CO^ con¬
centrations; ni-rtur- s of appro inately y/ CC^ in 17/ 0^ and in
CO,-, in 17," 0-. were used.
The composition of all the gas mi tur s used ither in the cal¬
ibration of tho 0o and 00p blood electrodes or in the calibration of
the infra-red C0p -and paramagnetic o yg n analysers which were used
to a asuro expired 02 and 00o concentrations was carr'.ed out using
a Lloyd-Haldane (Lloyd, 1959) or a nicro-Scholand~r (Scholaader, 1947)
apparatus. Analys- s were duplicated to within 0.03;'. Those
electrodes, if scrupulously calibrated, have a high d gr- e of accu¬
racy, as shown by Flenley and his co-workers (1967)*
The pH electrode us -d is a Radiometer pH electrode typo np021
with a pH meter typo Ik 7. The unit consists of a glass el c-
trod that is made of a pH -sensitive glass capillary sealed into a
glass tube vdth a reference liquid , and an AgCl inner electrode
is mounted in this r forence liquid. The electrode is mounted
in a glass water jacket through which heated water from a circula¬
tion thermostat, flows, keeping the electrode at a oonstant tempera¬
ture. The glass electrode is connected to a saturated calomel
reference electrode also surrounded by a glass water jacket. The
interior of the calomel el.ctrodo is connected through a porous pin
to a small pool of saturat d KCL solution, which is used as a salt
bridge. The pH electrode was carefully standardised just b fore
use by a prepared buffer solution of known pH. Although it is
realised that red blood ells create a potential at the boundary
between blood and satur te&JCGL, equivalent to about 0.01 pH units,
making the blood pH appear lo- <?r (Severinghaus et al, 1956; Siggaard-
Andcrs'n, 1961), no correction for this was applied to the pH values
reported.
(2) Pulmonary Gas Bwchange.
Gepp rt and Sunt 2; in 1885 were the first to suggest th
effect of uneven ventilation on pulmonary gas e-change. Advances
in the field wore held up for a tine bcause of the controversy over
how oxygen entered arterial blood. Bohr (1891) toiginally pro¬
posed the hypothesis that pulmonary epithelium actively seoreted o:y-
gen under certain circumstances, such as during exercise and at high
altitudes. Haldane and Lorrain-Smith (1895) supported his vi^w.
On the other hand, August and Ilarie Krogh firmly believed that diffusion
was the only process concerned with the pulmonary exchange of oxygen
and carbon dioxide, and published their work in a series of papers
(1910a; b, c, d, e, f). They stated: "The absorption of oxygen
and the elimination of carbon dioxide in the lung takes place by
diffusion and by diffusion alone". (191°,?) However, Haldane and
his colleagues (1912), in an expedition to Pike's Peak (14,100 ft.),
obtain:! evidence that th alveolar oxygen tension was about 35 araHg
low r than the arterial during e ercis at this altitude. Th y
again concluded that under such conditions oxygen must be secreted
by the pulmonary epithelium. The 'Diffusion' versus 'Secretion*
controversy was shoxn to be the result of methodological problems
and was finally laid to rest by Barcroft in 1920, in the "glass
chamb' r" experiment which he carried out on himself. He showed
that under similar conditions of hypoxia and e: ercis.. to Haldane»s
1912 expedition, the oxygen saturation of art rial blood was always
less than that of blood exposed to alveolar gas obtained simultaneously.
Th se findings were later confirmed in the C rro de Pasco pedition.
Krogh, (1910, d) clearly established that unevenness of
ventilation is important only as related to pulmonary blood flow
and that both the absorption of oxygen and the elimination of car¬
bon dioxide dep nd on the ratio of alv olar v ntilation to perfusion.
Haldane and Priestley, (1935) subsequ*ntly r cognised and mphasised
• •
the effect of ventilation-perfusion (V^/Q) inequality on the oxygena¬
tion of arteriil blood. A quantitiative approach assessing the
off: ct of Va/Q inhoraog&neity on the overall gas xchange in th. lung
was brilliantly worked out in a number of fundn..; ntal papers "by Riley
and Courna.il, (1S49» 1951)» Rahn, (1949)i Ril-y, Cournand and Donald,
(1951) and Donald ct al, (1952). They finally established the role
of uoov.a distribution of pulmonary vontilation and blood flow as a
major factor determining the partial pressur s of oxygen and carbon
dioxide in arterial blood. Form, Rahn and Ft is, (1945) had oarl-
ior introduced the 02 - diagram for the graphic representation
of the total effects of lung gas e ohang , which proved to be a very
useful analytical tool. It relates the tensions of o.yg .1 and
carbon dio:nde to the haemoglobin saturation and the total cos.it nt
of GQg in the blood and is constructed from the dissociation curves
for o.ygan and carbon dioxide. Two sets of co-ordinates, r pr s-
nting the respiratory e. chang ratio (R) and alveolar ventilation
ar superimposed on this diagran. A curved distribution line
demonstrating the various 00 ibinations of 0? and (X^ t nsion which
• •
occur for diff rent V^/Q ratios is also drawn up. The distribu¬
tion lino is defined at its upper end by the composition of .aimed
venous blood (v) and at its lower end by that of the inspir d gas.
Riley and Cournand (1951) in their analysis of factors affecting
the oxygon and carbon dioxide partial pressures in pulmonary gas
and blood extender the Og - CC>2 diagran into a four quadrant system
in which thepartial pressures and concentrations of oxygen and car¬
bon dioxide in alveolar gas and capillary blood can be visualised
simultaneously. The four quadrant diagram was again used by Ril y
and Permit, (1965) to discuss the distribution of gas and blood in
two and three oorapartiaarrt models of tho lung.
(b) Indices use ! to acq so ffici ncy of pul -xircy ;; .a xclvnge.
The liffar- nc in partial par ssuro bet x-en alveolar gas and ar¬
terial blood io regarded as the siipl at in&er of impaired gas eov
cir.ng ('J&st, 1970)1 cud it is now universally accepted that th
alveolar to arterial 0 mygen tension difference, (A-a)DQ2; and thn
determination of th- physiological d ad space to tidal volume ratio
(VD/VT) are sensitive indices of the ffici ncy of pulmonary gas
exchange.
(i) (A-a)D02
Farhi and haim in their classical paper in 1955 reviewed the
theoretical causes r suiting in an (A-a)D09. Three possible
factors or© reoognised; a distribution component due to imperfect
matching of alveolar ventilation and perfusion; a diffusion com¬
ponent, resulting from incomplete equilibration of end-capillary
blood with alveolar gas; and a shunt component .hie to blood flow
bypassing gtts-o. olumging alveoli - the v nous admixture effect.
'The det ruination of the proportio.sal contribution of these throe
factors to the total (A—a)30o difference has been att apted by vari-£
ous workers. Haldane in .is Silliman Manorial Lectures fifty
y ars ago dearly reasoned that unev- .n distribution of ventilation
or blood flew or both would produce an (A-a)lX>2. Lilicntkal et
al, (1945) tried to determine the diffusion component of (A-ajDOg by
studying the effects of breathing 11 - 13, o: ygnn. Their work
was has d on th assumption that the diffusion coupon-nt would be¬
come asier to demonstrate at a lower 9SL and also that the ratio
of venous al ii tur would be unaffected by breathing the low o yg n
drfeure. However, it was later shown that if the ?IC9 is lecreas-
• by breathing a low oxygen :X ture, the increased proportion of the
inspir d inert gaoe3 nay increase the distribution component of the
(A-ajDOg (Tarhi and Ilahn, 1955? Ov rfield et al, . fheir
conclusions have there fore not been generally aco pt d. Haab
et al, (i960) using anaesthetised dogs tried to . asure the dis¬
tribution component, but their results are inconclusive. Farhi,
(1965) showed that th diffusion factor becons of any importance
only at la-; o:yg n t nsians. L nfant, (1963; 1954) measured
simultaneously the A-a, 0 ygen, carbon dio id and nitrogen differ¬
ences. Canfi ld and Rahn (1957) had earlier d aoaistrat 4 that
• •
the sua of the 0o, C0o and lb, differences duo to V^/Q distribution
would be sero if it w re not for the non-linearity of the osyhaeno-
globin dissociation curve. benfant raised th inspired P0o and
by using 0o - enriched mi: tur s under hyperbaric conditions was able
to bring the PAOg in all alveoli to a point wher ha oglobin is cars-
pletely saturated. As a r-suit, the osyhaeraoglobin dissociation
curv will rafl ct only the quantity of dissolved o ygen and becoran
linear. He showed that the (A-a)TO^ exceeded only by a small
amount the sum of (A-n)l)N0 and (A-a)DGO^; proving that the normal
« »
(A—a)IX)g is due mainly to the distribution of V,./Q. Lenfant's
conclusion is supported "by the calculations of best (1JC2, 19->3» 19^7»
1959)» based on rgional leasuren nts of ventilation and perfusion.
Ov rfield and Kylstra, (1969) Cohen ei al, (1971) have b .on able
to jatimte the (A-a)D02 components attributable to diffusion and
distribution in unanaesthetis d :i n. They compared the (A-a)l)02
in the presence ami absence of 3!2 by getting their subjects to
breath 100 0o, tiiuo virtually li inating the distribution conpo-
n nt and any shunt component was minimised by lowering the pressure
in an altitude chamber in which the subjects wer seated. They
concluded that in healthy men at rest, breathing 13 - 14,' orygen,
there is no neasurabl diffusion component. Thoy showed however,
that during hypo-ic 0: rcioo at 100 watts a component attributable
to diffusion li itation was pros nt. Their work bears out the
theoretical predictions which had been earli r work- d out by Staub,
(1963) using a *forward int-gration' procedure which was the r verse
of the classical approach. Ho start d at the arterial end of the
pulmonary capillary and calculated the PC>2 of the capillary blood
progr ssivcly along th capillary until he could estimate the remain¬
ing alveolar/capillary PO^ gradi nt at the nd of th capillary.
K 11 rrgaard, (i960) had estisaatod the shunt component to be about 3;""
of the cardiac output in normal subjects.
(ii) F)/lTT
The concept of pulmonary dead space is said to have been orig¬
inally introduced by Sunts in 1882 (Ealdano ad Priestley, 1935)*
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Several workers estimated, the anatomical dead space directly from
casts of the tracheo-bronohial tro . Loewy, (1894) was the
first to determine this. He found a value of 144 1 in a
Plaster of Paris cast of the tracheo-bronchial tro- in collap¬
sed lungs. Rohrer, (1916) reporto value of 152 -1 for a
similar specimen. Sum t al, (1959) measured the volu of
the extra, and intra thoracic portions of the anatomical d ad space
by filling the airways with water. /hey found an averog lead
opac i of 138 ml of which about 50, was due to the extra thoracic
airways. In 1390 , 3ohr introduced his equation for calculating
respiratory deal space based on the concentrations of gas a in al¬
veolar and expired gas. /mother controversy follow d, between
Douglas and Haldane, (1912) who found that the de :1 spac increased
by up to six tines during exercise, ami krogh and Lindhurd, (1913)
who failed to find such an incr as.. /he difference in results
was once again duo to discropoaci s related to the proble.: of sampl¬
ing alveolar gas. In th Halfane and Priestl y alveolar sailing
teohnique the neasur d alveolar PA00o is ..iuch higher than that in the
alveoli at the start or end of a normal expiration, as 000 output con
times into a rapidly decreasing lung volume. Since the alv olar
PAOOp is too high, the calculated 7^ value is also too high.
fixe physiological dead spac is thought of as r pr sonti:xg
•wasted" v ntilation and the deadspac to tidal volume ratio is an¬
other inde that can b us d to indicate impaired gas exchange,
/he difference h tween the physiological deadspac - and th^ onaioro-
ical dead spac. is a direct relation of "wasted" ventilation and
had 'been ter led " arallel dead spac " by Palklov; and Papp nh iu r,
(1955) and now usually laicwn as "alveolar dead apace" ( b. vering-
liauc and btupfel, .1937)*
fhe apparent change in physiological d ad apace that occurs in
disease was Aev loped by dossier t alt (1953) as a t st of puluon-
ary function. ho used the tern "functional dead space" for physi¬
ological doad space and arly r .-cognised that an incroci.se in V,. could
• •
r. cult from uneven V^/Q ratios. is incr as.d whan there are
• •
significant valutas of th-. lung with a high V- ratio, i.e. with a
ventilation that is licproporticmtely higher than the corr .spending
perfusion,
(iii) Venous acLoixturo -fi' .ct (C^/
Ing>aired pulmonary gas exchange say also be described in terras
of "wasted" perfusion, termed venous adnrfature or shunt. Venous
adrdr-tur effect reflects both th true right to left shunts as well
as the shuntlike effects resulting from blood that is inadequately
orxygenated by going through poorly ventilated areas of lung, i.e.
♦ •
regions with low V./Q ratios. In nor .ml subjects the true shunt
is mainly duo to communications between bronchial and pulmonary v ins
(Verioop, 1943) and the fhebesian veins which drain from th' rayocar-
diua directly to the left ventricle (Thebesius, 1708). Bronchial
pulmonary venous communications drain a fraction of the bronchial
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circulation that is distribut>:d to the more peripheral part3 of the
lung (llarchond ot al, 1950)* Potential coixaunications, in tho
form of pre-capillary anastomoses, betwe n bronchial and pulmonary
arteries, known as "spcrr arteries" have also b en described (Van
Hayek, 1960), Ravin ct al, (1965) calculated that in normal
subjects the component due to Thebesian veins is about 0.3/' of the
total cardiac output. Ihe contribution of the branchial- pul¬
monary venous anastomoses is probably loss than 1£ of the cardiac
output (Jtan, 1971)» ISollemgaard, (1966) has estimated the true
shunt to be about 1 - 2,3 of tho cardiac output in normal seated
subjects, whilst the total shunt is about %> of tho cardiac output.
(c) Prooedure and calculation.
The subjects sat comfortably in a chair with tho left arm
supported and br athed through a low resistance valve for five
minutes before the procedure was carried out. Each estimate
involved a two minute collection of mixed expired gas into a Tis-
sot spirant ier and simultaneously a collection of arterial blood
from a previously sited needle in the brachial artery, the sit :
having beun carefully anaesthetised. The blood was withdrawn .
in heparinised 10 .al glass syringes. Immediately after collec¬
tion the syringe was sealed and the blood and heparin uere mixed
by rolling the syringe. The first f ;w millilitree of blood
w re discarded before the sample was analysed. The disappear¬
ance of o:ygen from shed blood is a woll recognised phenomenon
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and das been tits subject of a number of studies. It is thought
to be due to the metabolic activity of the c llular components of
the blood, (Booth et al, 19391 Asmssen et al, 1961} Hodley-4Jhite
et al, 19641 ^lridg. and Prr-tw; 11, 19-63; Gro nbaun ~t al, 1967).
The samples of blood obtained fro... the subjects during this study
were therefor* analysed as soon as eoll.ctud.
Expired air was audo.-rtically collected and continuously
analysed and recorded on a direct writing aulti-channci rt carder
(80 i-jngograf Gchouan&er). Carbon dia-ad- was analysed by a
rapid infra-red Ct0 analyser (Uras 4» liartaam and Brawn) and oay~
gen, by a paraaaguotio analyser (Servo jox C, analyser Type 01. 150).
Calibration of the instruments was carried out by gas a previously
analysed using a .aicro-hcholan&er gas analyser. The whole pro¬
cedure was performed very carefully with a view to nsuring as
st, ady a state as possible. As. aaaeiaia has boon shown to Cana ¬
an increase in (A-ajDQg (Bprculc ot al, i97)| Housley, 1967) this
was excluded in the subjects studied. They all had nor.jal haemo¬
globin concentrations and haenatoorit values.
(d) Calculations.
(i) (A-a)DOg
The determination of the arterial oxygen tension presented re-
lativ ly few problems ae better and quicker techniques for its
neasur -iaenta were evolv .d. The leasur aeat of th alveolar oxy¬
gen tension, haw ver, proved to be a different matter. lialdane
and Pri stley, (l$K>5) usc-d end— xpiratory air, making their subjects
rpire quickly and forcibly down a long tub;' with a side arm and
collecting the last portion of gas for analysis. Rahn, (1949)
pointed out that the alveolar gas xohange continu s during the
prolonged epiration resulting in a higher ?C0o than average, th
FOg being correspondingly lower. The alv olar gas composition so
analysed, will also depend on the depth of the prec oding inspiration.
Rahn mid Otis, (1949) developed a method by which a few aillilitres
of gas Tver withdrawn at the nd of each nOrrnl atpiration. The
accuracy of such a method is obviously li:dt d by the un venness of
gas distribution in the lungs, a feature which becon s even nor
prominent in the presence of airways obstruction.
Two groups of workers tried to get around this probl m by deriv¬
ing an averag value for PAG0 indirectly. Riley and his colleagues
in the TJ.C.A. (1946, 1949) and Rossi r, (1949» 1953) in Switaerlaad
explored this possibility at about the sane tine. Th ir work was
based on the assumption that th carbon dioxide t nsion of arterial
blood is equal to the alv olar carbon dioxide tension and substitut¬
ing PaGOp for PACOp in the alveolar gas equation. There is evi¬
dence from the work of Lenfant, (1963) that a small (A-a)r>C0o nay
exist in normal subjects; if this were the case, th- PAO^ calculated,
assuming quality of PACOp and PaCOp would be lower than the true
PAOp, resulting in an und r sti.aation of the (A-a)"X>p. 3ecaus
of the shap of the blood dissociation curv e the (irro~ introduced
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in using the arterial POOg is generally very snail. Riley and
Command (1949) called the alvolar orygon t nsion so obtained "ideal"
becaus it repres nts the value present if the V\/Q ratios were equal
throughout the lung and no diffusion limitation was present. The
PAQp used in the computation of the (A-a)DO,, in this study, was there¬
fore obtained from:
PA02 " PI02 ~ P'C°2 + (0.2093 x PaGO^ (1-R)
R R
(ii) YD/7J.
'The ratio between dead space and tidal volume was first intro¬
duced by highoff in 1931• In 1933, he suggested that the dead
space be' measured by substituting PaCO^ for PAC0o in Bohr's equa¬
tion, introducing the modern cone pt of physiological dead space.
He use! the terra "Toluien iirffioa: " to stress its functional nature.
The physiological dead spac- reported in this study was calculated:
VD » ITT s (paC0o - P^CO^)
— - (App)
( paC02 )
A correction was mad. for the dead spac of the .iouthpiec
which was .aeasur & by water displaces at and all volumes corrected
to 3# ir.P•3#
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(iii) Venous aflrai ture (shunt)
The shunt was calculated from the standard quations
CcO,) — Ca,0-
» l nrrnli ir imp
Qt Cc0o - Cvo^
assu-.iing an a - v o.xygen content diff ronoe of 3« 5 and 5 >4#
• •
Where Q /Qt is the ratio of venous adrairture to total blood
flow? CcO,. is the o-ygen cont at of pulmonary end capillary blood
and is in praotic calculated on the basis of end capillary PO^ be¬
ing equal to ideal alveolar PO,,; CuO,, and CvO? being, the arterial
and nixed venous o.-ygon contents respectively.
Fa® patients studied all fulfilled the definition of chronic
asthma on clinical grounds. Th duration of their illness rangd
from si- months to thirty-four years (ae Tables V and VI)
'Their disease could no longr b controll d by broachodilator drugs
and they were admitted to the DcpartKont of Respiratory Diseases for
a trial of corticosteroid thrapy. In none of thes patients had
such drugs beon us d previously. Th' study was conducted in two
stag s, cloven patients b ing initially admitted to the study in the
first stag" and twelve patients to the second stag . B-sides the
TABLE Y
Clinical and Spirometric data on patients studied during the
first stage of the investigation.
Patient Age Sex Ht. Duration of Initial FEV^ Predicted FEV^
Disease.
M.T. 41 M 1.75m 34 yrs. 700 ml. 3150 ml.
S.D. 39 F 1. 62m 13 yrs. 1060 ml. 2050 ml.
B.R. 62 M 1 .75m 2 yrs. 1400 ml. 2600 ml.
M.E. 43 F 1 -73m 12 yrs. 825 ml. 2750 ml.
M.J. 76 F 1.59m 6 mths. 950 ml. 1800 ml.
R.M. 73 F 1. 62m 5 yrs. 625 ml. 1800 ml.
H.N. 24 F 1 .55m 4 yrs. 2550 ml. 2650 ml.
S.B. 47 M 1 -72m 5 yrs. 2430 ml. 3400 ml.
D.M. 51 F 1.57m 6 yrs. 880 ml. 2200 ml.
Predicted values for the forced expiratory volume in one second
for males are derived from Kory, R.C. Callahan, R.,Boren, H.G.
and Syner, J.C. (1961)., Amer. J. Med. 30: 243 and from Ferris
B.G#, Anderson, D.O. and Zickmantei, R. (1965)«» Amer. Rev. Resp.
Dis., for females.
TABLE VI
Clinical and Spirometric data on patients studied during the
second stage of the investigation.
Patient Age Sex Ht. Duration of FEV^(initial) FEV^(predicted)
Disease
B.H. 14 F 1.57m 10 yrs. 2000 ml 2850 ml
K.H. 38 F 1 -54m 9 mths. 600 ml 2620 ml
M.V. 50 F 1 -52m 4 yrs. 625 ml 2200 ml
M.N. 44 M 1 -78m 3 yrs. 2300 ml 3650 ml
A.L. 25 F 1.53m 14 yrs. 1600 ml 2700 ml
F.G. 43 M 1.59m 24 yrs. 700 ml 2900 ml
G.W. 14 M 1 -47m 11 yrs. 950 ml 2350 ml
S.J. 47 M 1 -58m 6 mths. 1175 ml 2800 ml
B.W. 38 M 1. 64m 1 yr. 1600 ml 3400 ml
G.A. 68 M 1.58m 15 yrs. 540 ml 2250 ml
L.R. 63 M 1.58m 10 yrs. 1635 ml 2500 ml
M.R. 32 F 1 .52m 3 yrs. 2350 ml 2500 ml
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patients with chronic asthma, two patients who w re known to suffer
from chronic bronchitis (II dioal Roe - arch Council, 1965) wer also
studied during the first stage. They were shown to have a degre -
of rev rslbl airway obstruction when tested to subcutaneous injec¬
tions of Adrenaline and Atropine and th-.y wore therefore givsn corti¬
costeroids to find out whether those drugs would be of -any thorapou-
tic benefit to then. All the patients had normal hepatic and
renal function (Tables VII,VIII )st normal electrocardiogra-.s•
Their chest -rays reveal;d a aild to mod rate degree of hyporinfla-
tion but no other abnormal features. Iho results of sputum ore-
inophils, and absolute blood eosinophil count ar- shown in Table IX.
Precipitins to Aspergillus fu igatus wore absent in all cases.
Prick skin tests uer positive in five of the fourteen patients who
completed the study (M.D»t IVT.f G.VJ., H.B., and A.L.) Those
pati nto all demonstrated hypersensitivity to some or all of a wide
variety of poll ns, house dust mite, animal fur and Dernatophagoidos
pteronyssi ns.
'•ftafl8, 5
In the first part of the study, two patients II.IT. and S.B.
i -proved spontaneously soon after admission to the trial and were
therefore occluded from it. Patient B.M. b came e;tr noly
wheeay and dyspnoeic on the second pr -treatment day and iraoodiate
therapy for acute asthma was instituted. The two bronchitic
pati nts (A.::, and A.IT.) showed no response to the corticosteroids,
th ir results are included in the Appendix. The results of the
TABLE VII
Liver function tests
Serum Bilirubin S.G.P.T. Alk. Phosphatase
M.T. 0. 6 mg 12 units 7 K.A. units
S.D. 0.5 mg 10 units 6 K.A. units
b.r. 0. 6 mg 15 units 10 K.A. units
m.E. 0.4 mg 16 unit s 12 K.A. units
m.J. 0.8 mg 13 units 7 K.A. units
r.m. 0. 3 mg 17 units 9 K.A. units
h.n. 0. 3 mg 6 units 9 K.A. units
s.B. 0.5 mg 10 units 10 K.A. units
d.m. 0.4 mg 11 units 9 K.A. units
b.h. 0.4 mg 10 units 12 K.A. units
k.h. 0. 2 mg 12 units 7 K.A. units
M.V. 0.4 mg 14 unit s 7 K.A. units
m.n. O.4 mg 14 units 11 K.A. units
A.L. 0.6 mg 12 units 8 K.A. units
f.g. 0.6 mg 10 units 13 K.A. units
g.w. 0.8 mg 8 units 12 K.A. units
S.J. 0.8 mg 12 units 11 K.A. units
b.w. 0. 8 mg 11 units 10 K.A. units
g.A. 0.6 mg 9 units 11 K.A. units
L.R. 0-7 mg
_
16 unit s 19 K.A. units
M.R. 0.5 mg 12 units 6 k.A. units
TABLE VIII
Serum Urea Serum Sodium Serum Potassium Serum Chloride
mg/100 ml. meq/l. meq/l. meq/l.
M.T. 25 140 4.1 106
S.D. 23 140 3-8 107
B.R. 25 139 4-1 108
M.E. 33 139 4.3 107
M.J. 40 143 3.9 110
R.M. 39 141 3-9 107
H.N. 23 136 3.6 103
S.B. 30 142 3.8 106
D.M. 28 138 4.2 107
B.H. 25 135 3-5 98
K.H. 36 142 4.2 106
M.V. 39 140 4.0 103
M.N. 24 141 3.6 103
A.L. 21 140 4-2 107
F.G. 29 140 3-4 102
G.W. 21 135 4-3 100
S.J. 37 143 4-1 103
B.W. 24 139 4-1 101
G.A. 4 141 3-8 103
L.R. 29 141 4-9 103
M.R. 30 140 3.8 105
TABIE IX
Sputum
Eos. Asp.Pum. Blood eosinophils Asp. f. precipitins
I. T. +— 1 170 600 660 -
S.D. 860 720 880 -
B.R. 1400 750 800 -
M.E. +— ++- 440 430 624 -
M.J. ++- 500 710 540 -
R.M. 350 400 320 -
H.N. 1000 700 960 -
S.B. 300 250 280 -
D.M. —1~ 250 280 300 -
B.H. 250 200 400 -
K.H. 660 60 5 500 -
M.V. 200 300 250 -
M.N. -+- 300 340 194 -
A.L. -+ 460 400 480 -
E.G. 200 310 280 -
G.W. 940 870 850 -
S.J. 666 620 936 -
B.W. 120 580 450 -
G.A. 180 200 250 -
L.R. 960 1000 940 -
M.R. 550 220 280 -
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pulmonary function tests presented in this part of the study, there¬
for , r fer to tho first six patimts shown in Table y . T«i:.«
was unable to perform the last set of measurements 36 hours after
Prednisolone adlinistration becaus of an acute attack of broathless-
noss.
iinor fluctuations in all the measurements w-re obo rv i dur¬
ing the first two days of tha trial, but no consistent pattern was
seen. In particular, no significant diurnal variation was obser¬
ved, nor could any r spans to placebo tablets be dononstratod either
within individuals or the group as a whole. This applies to both
groups of patients studied in the two parts of the investigation.
Individual results are iucluded in the Appendix. In ord r to
reduce the effect of individual variation all measures-- nts were a: -
pressed as a percentage of tha pre-tr ^ataeni value. Statistical
significance was tested in all lactone s by n ana of Stud at*s "t"
t st (Snodecor and Cochrane, 1971)•
Prednisolone proluc d consist nt changes in dyna.de lung voluios
F,V.C,$ P#S®F#R») which were evident end statistically
significcurfc from the pre-tr ataent measurements within three hours
(P 0.05? P&05? P 0.25). In the group as a whole the peak effect
was obsorvod at nine hours, after which there was a d cline towards
pr—treatment l vels, as shown in pig. af 10, and 11.










foil "by sir: hours of pr-diiisoaaa «ci lustration as ahem ia^., 13
At this ii: lu the group as a wbal-. tk fall la . ,•'■/• a»il ,,»Y
was signifioaat (? 0.025? P 0.0:?) bat the ohaages ia T.I*0» and
F»h,o« wr© not. la ace patiout, S«D»„ tfc oad .'•h»C,
lid her ov r fall to 55*4 -aid 79, of the pa?«Mtr«'-ataeat valaoo.
i/hsa the aart maa*rc^:ijfeo mhm pcrforaoel, twelve hours after th
drug hai b on gtv a, there x*as a -lot rioration ia ;JLl the lu v;
volua a ia the group aa a whole, &ieh continued ovor the aor-rt tw 2*fcy~
four hours. Pwp of tine patl ato» . :.J« an.*. -'»$», 'jiwvw, shows1
farther laprevcojeat at tw iv* hours. la #*a<cral , the .ajcailty of
patients, found that this test ves the ..,ost difficult to perform
All pati -ats had evidence of hyperinflation, their pr ---trout, a-ast :
C. ranged hot?-*' a tip - sad 21(5,.* of the prolict d, the :jeaa and stan¬
dard error being 136 and 16'. Although thbir Ytg tsse concision-
tiy and fidgnifioautly greater than tlx ir IV..c. (? >.301), the dif¬
ference I) tv on the two itiicoe ssa not very big ( .
Fig. 15).
3octy pi'thyeoographio :.v asureraonts ahcr- d sssrh d af logoo at the
tin® of their first ..sjaaur aaettfc, sir hoars after ?r daisoloti (
Fig. 15,1'
3Caw rising and Vtg falling ooipesrod -,4th th- ir pre-tr itaent values.
'3io nost notio abl ctvmg m» found twelve houtre after th ■ drug had
boen giv n. J5» changes ia Raw and SCtew wore stgaifioaut at si:
hours (? 0.01 j ? 0*03) hut the change in Ytg v:m not (f 0« t).
The latter was cw var oignificaatly 4 cr is d by tw Iv hours.
-assure:.; :4s porfor ■>*. tw Iv • hour© aft r th ad;4ui*tratiaa
Prednioolc**? ah&<el a return of all these para.»t rs totnirte pr -
►
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% of p re-treatment Vtg and Raw.
 
pre-treatraent 1 eve 1 s.
Three hours after Prednisolone administration both the M.E.F.R.
and the M.M.F.R. wer significantly greater than befor durg admini¬
stration (? 0.05; P 0.05); improvement reachivig a peak at nine
hours, after which a decline occurred. At nine hours th mean
M.B.F.R. was 176 of the pre-treatraent value and the mean K.K.P.R.
was 213.5a (Fig.18,-'20.) Individual patients showed parallel
changes as shown in Pig. 21-23. The maximum expiratory flow volume
curves for subjects S.D., M.13., and R.M. are repr sentative of the
whole group. Only four curves are reproduced on each graph for
the sake of clarity. When aim-ray obstruction was severe the peak
flow was r ach early on in th- vital capacity and then the rate of
flow fell off quickly, making the curve concave to the volume axis
throughout. Following therapy, the curv s became more convex
upward and airflow at any given lung volume increased. Flow was
also plotted against the absolute lung volume obtained from helium
dilution measurements. Fig. :24-26 show this for patients 3.D,, M.S.,
and R.K.
Therefore these six pati-nts, both individually as w 11 as a
group, showed a similar pattern of response. A statistically
significant improvement was detectable within thr e hours of Pred¬
nisolone administration. The peak effect was reached within
nine to twelve hours, aft r which there was a return towards pre-













and SOaw was still statistically significant twenty-four hour aft r
the drug had been given (? .005? ? 0.05? P 0.05;»? 0.05).
Fh mean change in F.V.C., c.V./f.L.G. and il. .F.R. was however no
long r significant by this ti a. fhe .mean chang in P.G.F.R.
and F.J.V.^ t had returned to non-significant 1 vels by thirty-six
houra. SOaw was how ver still raarkedly improved by this time
in four patients, K.3., M.J,, S.I), and B.R. i'hes patients had
values of 161 , 141 » 19? and 175 r sp otively, of their pr--
treatment m asureaents. No statistical analysis was attempted
on the m asurenents obtained at this tine as patient K.'P. failed
to carry out this t st becaus of an acut oat of br athlessn ss.
Stage II
Of th tw lv patients initially admitt d to th study only
a ;3t lanaged t complete it. . . i prov< I spont leously lthin
a day of being admitt- d to hospital whilst patient A.O. and L.R.
became acutely br athless soon aft r admission. Patient 3.3.
was able to complet th first two days of the trial but d spite
having had 40 mg Prednisolone orally, d velop 1 an acute attack, of
asthma eight hours aft r the drug had been given. ?h' results
pres nt -d in this part of the study hence r fer to the first eight
patients in Pabl VI . As patients O.W. and H.B. w re und r the
age of consent it was felt that art rial blood should not be with¬
drawn from them.
In this part of the study the FUV^, PVC and PEFR were m< asured
hourly during the first three hours following the Pr dnisolon
administration in addition to the measur .nents performed at times
similar to the previous stage. This was done in an attempt to
establish whether chang could be d tected at an earlier time than
that found in the first sir patients. Body pi thysaographic
aeasureiaents w- re also carried out more frequently. Pulmonary
gas e:> chang was studied on two occasions, at 0300 hours of the
third day, i.e. an hour befor Pr? dnisolon was given to the pat¬
ients, and at 1800 hours of the same day, wh 'n the p ak <ff ct was
expected to be present. The effect of an intrav^nous injection
of Hydrocortisone sodium succinate was followed hourly for twelve
hours using a Wright•s peak flow meter on th fifth day of the
study.
In th' group as a whole statistically significant improvement
in the could b detected one hour after Prednisolone administra¬
tion (p 0.025). Although both the P.V.C. and the P.S.P.R. show d
an improven nt at this time, this was not statistically significant.
Significant improvetaent in both t sts did howev r occur two hours
after the drug had been given (P 0.005; P 0.001). In the group
as a whole, the p ak fleet in all three parameters occurred at nin
hours, as shorn in Pig. 27-29* How ver, in some pati nts th peak
effect was d tectablc at six hours(Valuesin Appendix). The dif¬
ference between the measurements of these tests performed six and
nine hours after Prednisolone administration was not statistically
% of pre-treatment P.E.F.R,
 
 
significant. A parallel change was observed in the relaxed vital
capacity measurement as shown in Pig.30 5 a significant change was
observed after an hour (P 0.05). This measurem nt was generally
greater than the F.V.C. (Table ).
Vtg and Raw d creas d and SGaw increased to significant levels
when they v;er first neasured, thr e hours after the drug had been
given (? 0,01; P 0.005; P 0.005). The maximum ff ct on Raw,
Vtg and SQaw, in the group as a whole, was found to occur at nine
hours as shown in Pig. 31,32. However, there were individual vari¬
ations; thus the lowest Raw was found at twelve hours in four pati¬
ents (H.3., G.W., S.J,, arid M.V. ), this vras also true for the Vtg
and SGaw. The mean values measured nine and twelve hours after
Preniaolone administration were in fact not significantly different.
Pulmonary gas exchange was studied in six of the eight patients,
in one of th .ee, K.M., collection and analysis of e.pired gas was not
successful because of breakdown in quipment. Although R values
were on the high side, ranging between 0.88 and 1.20, the pre-tr rai¬
ment and post-tr atment values tirere comparable, as shown in Table XI.
Mean pre—treatment R. value was 1.04, the corresponding posh-treat¬
ment value was 1.05. The arterial P0o rose in all patients and
the alveolar-arterial oxygen difference d cr as d as shown in figures
and tablesjjiilboth changes being significant (p 0.005; ? 0.001).
Doad space:tidal volume ratio and PaCO,, showed little change, as can
be s en from Tables XIII f XIV . Table XV shows the change in
 
TABLEX. R.V.C./F.V.C.°]o"





































































































•/of pre-treatment Raw. andVtg.
 
TABLE XI
VCO^, VO^ and R values
Patient Pre-Prednisolone Post-Prednisolone
VC02 V02 R VC02 V02 R
K.H. 197 207 0-95 179 203 0.88
M.V. 206 173 1.19 184 180 1.02
A.L. 249 230 1.08 325 254 1.20
F.G. 271 275 O.98 202 215 0.94
S.J. 232 226 1 .02 245 225 1.09
TABLE XII
(A-a)DO^,(mmHg)
Patient Pre-Prednisolone Post-Prednisolone Predicted
K.H. 27 11 11
M.V. 36 26 13
A.L. 29 20 8
P.G. 36 25 12
S.J. 32 18 12
TABLE XIII
Dead Space:Tidal Volume ratio
Patient Pre-Prednisolone Post-Prednisolone Predicted
K.H. 46/o CO 31%
M.V. 49% 45% 33%
A.L. C\J 40% 29%
P.G. 41/0 40% 32%
S.J. 44% 39% 33%





















































K.H. vo 1 3 - 4$
M.V. "ftC\J1o 7-9$
A.L. 11 -16$ 4 - 7$
P.G. 12 - 16$ 9-12$




K.H. 4.25 l 3.90 1
M.V. 5-23 l 4.4O 1
A.L. 5-65 1 7.79 1
P.G. 6.15 1 4.50 1
S.J. 5-40 l 6.20 1
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venous admixture effect; this was also significantly decreased
(P 0.01).
Following the administration of 200 sag of Hydrocortisons in¬
travenously, in the group as a whole, the P.E.F.R. was significantly
increased one hour later (P 0.05). The overall peak effect
occurred at five hours after the injection. There were however,
individual variations. Thus in patients H.3., M.N. and F.G. the
maximum change occurred at four hours and in patients M.N., S,J.,
and M.V., this took place at sir hours. : igure 35 shown the
mean effect of hydrocortisone on PHFR and Figure 36 compares the
ff ct of plac ho tablets, prednisolone and hydrocortiaon , on the
sane test.
The r versatility tests to adrenaline and atropin ar shown
in Tabl s XVII - XX. Both adrenaline and atropine produced
statistically significant irapwem nt in FCV^ (P 0.001; P 0.001).
The chang in FMV^ produced by adrenalin- was markedly and signifi¬
cantly gr at r than that produced by atropin , (? 0.001).






PEV^ reversibility to Adrenaline
Pre-treatraent Post-treatment
M.T. 650 ml 3000 ml
S.D. 980 ml 1790 ml
B.R. 1040 ml 1 65O ml
M.E. 820 ml 2060 ml
M.J. 1030 ml 2150 ml
R.M. 500 ml 1630 ml
B.H. 1350 ml 2450 ml
K.H. 750 ml 2000 ml
M.V. 750 ml 1350 ml
M.1I. 2150 ml 3800 ml
A. L. 1800 ml 2300 ml
P.G. 1000 ml 1730 ml
G.W. 780 ml 1100 ml
S.J. 900 ml 1850 ml
TABLE XVIII
FVC reversibility to Adrenaline
Pre-treatment Post-treatment
M.T. 1800 ml 3400 ml
S.D. 1270 ml 2850 ml
B.R. 2450 ml 3200: ml
M.E. 2200 ml 2650 ml
M.J. 1530 ml 2700 ml
R.M. 1630 ml 1950 ml
B.H. 2200 ml 2650 ml
K.H. 2050 ml 2500 ml
M.V. 1025 ml 2075 ml
M.R. 3700 ml 4650 ml
A.L. 2950 ml 3075 ml
P.G. 2600 ml 3450 ml
G.W. 1700 ml 2300 ml
S.J. 1950 ml 3150 ml
TABLE XIX
PEV^ reversibility to Atropine
Pre-treatment Post-treatment
M.T. 650 ml 2650 ml
S.D. 1030 ml 1270 ml
B.R. 1150 ml 1350 ml
M.E. 820 ml 2000 ml
P.M. 950 ml 2000 ml
M.J. 1000 ml 1900 ml
B.H. 1550 ml 1975 ml
K.H. 720 ml 1100 ml
M.V. 600 ml 925 ml
M.N. 2375 ml 3100 ml
A.L. 2000 ml 2400 ml
P.G. 800 ml 1250 ml
G.W. 750 ml 850 ml
S.J. 1150 ml 1450 ml
TABLE XX
FVC reversibility to Atropine
Pre-treatment Post-treatment
M.T. 1730 ml 2880 ml
S.D. 1500 ml 2680 ml
B.R. 2375 ml 2650 ml
M.E. 2300 ml 2460 ml
M.J. 1390 ml 2430 ml
R.M. 1350 ml 2050 ml
B.H. 2525 ml 3100 ml
K.H. 1900 ml 2480 ml
M.V. 900 ml 1300 ml
M.N. 4125 ml 4925 ml
A.L. 2850 ml 2900 ml
P.G. 2575 ml 27OO ml
G.W. 1550 ml 1850 ml
S.J. 2300 ml 2800 ml
DISCUSS IPS.
Sir John PIoyer, in his book, •Treatise on Asthma1 (1698)1
wrote, "Th Asthma is a long disease, and it requires a long
Observation to give a true Account of its Symptoms, Changes .and
various Causes, which common Patients cannot nicely observe".
Floyor*s observation is of course p rf ctly corr ct, and his
suggestion that "a long Observation" is n cessary for the under¬
standing of asthma perhaps applie s most appropriately when the
therapeutic value of drugs i3 being assessed in this condition.
It is common knowledge that it is difficult to evaluate the
effectiveness of anv therapeutic measure b.cause of the psycholo¬
gical effect of th© new procedure its If and the increased att na¬
tion that the patient frequently receives. When corticosteroid
therapy is used the evaluation i3 p rhaps all the nor difficult
because of the frequent effect of this drug on mood. The diffi¬
culty of drug evaluation in such a variable and complex disease as
asthma is illustrated by the fact that the Medical Res arch Council
in 195^ concluded, on the basis of a controlled trial, that cortico¬
steroids have no long tern value in the treatment of chronic asthma.
The report is based on 96 patients, 49 °f whoa were given Cortisone
ac tate and the r st placebo tablets; 19 of the patients failed to
complete the trial for various reasons. Assessment was carried
out fortnightly by means of a physical examination, an valuation
of exercise tolerance using fivo arbitrarily defined grades, an
arbitrary assessment of incapacity for work and a single nensur rent
of vital capacity, over a period of thirty-six v eks. Almost all
the patients were also receiving bronchodilator and other drugs dur¬
ing th. study.
It is essential that a homogeneous group of patients be s leoted
when the value of a drug is to be assessed in bronchial asthma, in
order to ensur that r suits obtained in individual patients ar cor*-
parablo. Asthmatic patients oft n show changes in the sov rity of
th ir dio as cither spontaneously, following hospital admission, or
as a r spans. to placobo pr parations. These patients often o:-
hibit significant day to day, as w 11 as, diurnal variation in air¬
way obstruction.
definite day to day fluctuations in tests of pulaonary function
have been demonstrated in pati nts with chronic airway obstruction
by various workers, (Spicer et al, 1962; Beerel t al, 1963; kr ad¬
man, 1963). MoDermott, (1966) pointed out that airway resistance
in normal subjects nay have cyclical changes throughout the day.
She found a decrease in airway resistance of about 13/ in the aorn-
ing (between 10 a.m. and 3 p.m.) which was follow d by a slight in¬
crease in th evening (from 3 p.m. to 11 p.m.). Zuidema, (1965)
measuring airway resistance by an interrupter technique found a simi¬
lar diurnal variation in ten asthmatic patients. Sedda and hart-
oreHi, (1971) using a body plothysmograph reported that bronchitic
and asthmatic pati nts allowed an increase inairway resistance in th
afternoon* on the other hand, CSuyatt and his co-work rc (19-7)
failed to find any significant variation Curing- the day, or fro;;
day to clay in th ir study on normal subjects. Lowiasotm et al,
(19«?0) det.'sonsfcrat' 4 r lativ ly large spartan, ous variations in F37-
and SVC b tw en 6 a.n. and 10 p.a., with lowest values occurring
early in the morning. Fuleihan and Abboud, (1963), however,
found no significant ohsng in £bC, if/, FhV^ and F7C b--tv en " -?.,nu
and 4*30 p.m. in their pati nto with aim;ay obstruction.
Bar.» and Ckurlovin, (1957) "-id Ha- sari '?i;ys Joaos, (19CO)
doscrib d a 'response curve' in isthrvvtic patirrts, wfaor , during
an cute pisod , thar is elicit iaprov -.mat following ieoprena-
line therapy, the r spaas increasing as th patient's elide CI con¬
dition irapraves and finally d or aaiag again as th patient's clini¬
cal state approaches nor--l. fh • hell-shaped response ourv of
Hu." and G-uadevia was however not reproduc d in Pain -ad ad's
study (1963). An important poi.it pbasia< 1 by the lottor orkars
is that th degre of improv .aeot also ep nds on - .bother th pati¬
ent's condition. is inpr-oving -or dot rtarating wh a the inivial pro-
tr-ataeat PhV^ is assured.
Or at car was ta »n to ensure that the pati-nts solacted for
th pr sont 3tudy had a stobl dogre of airway obstruction. Any
significant d«gr & of diurnal variation, spontaneous improvement or
placebo effect was cr--olu&ed by p.rforsdng asasur lartta at identical
tines during th .lay in which the pati nts were on placebo tabl to,
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as wt 11 an when they received the actual drug. Although minor
fluctuations in the various parameters could he observed during the
placebo lays, th' se were not significantly diff rent from the pre-
trcat ont values. Touring thee two days, thr e patients improved
spontaneously and a similar number dev loped acute asthma and wore
therefore xclud'-d from the study an grounds of instability.
It is often both difficult and hazardous to base the interpr ta-
tion of th th-rapeutic response to a drug in bronchial asthma by
employing isolated tests of pulmonary function. Similarly, it
is frequently misleading to make subj ctivo assessments of tho degre
of breathlessnccs or e: reioe tol ranee without performing objective
pulmonary t sts. It was for these reasons that th effects of cor-
ticoct o is in the patients investigated in this sfculv were car fully
monitored using a wide range of pulmonary function tests.
All the pati nts were sere ned for Respiratory tract infection.
They all had thre sputum specimens nrgativ on cultur for ordinary
pathogens, and sputum which was macroseopically mucoid. There was
no concomitant cardio-pulmonary disease in any of the pati nts, an
el ctrocardiogram and a chst -—ray taken at the beginning of the
study v;ere all normal.
It has bren demonstrated that the clearance of corticosteroids
from th- plasma maybe abnormal in patients with either renal or hepa¬
tic dysfunction (j.ickmr an and Toich, 1953; Brown et al, 1954? V/illar-
150,
dson et al, 1955: Wallach and Si.ions, 1958, Peterson, I9^0)i
ous congest ion of the liver in cats has "ben Bhown to lead to decrea¬
se.. efficiency in the inactivation of deoxycorticost rone, cortisone,
Cortisol and aldost rone, which iay last for as long as nine months
after the ons- t of congestion (Yat s, 1953; Yates, Urqui irt and Her-
bst, 1958). Hench had reported the observation that patients
with rheumatoid arthritis who developed jaundic often showed remar¬
kable improvement in their symptoms. This phenomenon he lat r
attributed to a decrease in th rate of inactivation of air 110cor-
ticosteroiis by a deranged liv r ("each, 1952). Pet rson, (1959)
reported a plasma half-life for preinisoloneof 200 minutes in nor¬
mal subjects and 240 minutes for patients with hepatic cirrhosis,
th corr sponding values for hydrocortisone being 80 - 100 minut s
and 300 minutes. Hugent and his co-workers found very similar
values for prednisolone; 214 adroit s in normal male3, 241 minait s in
patients with hepatic disease and 223 minutes in patients with renal
insufficiency.
In all the patients studied, there was no evid nee of hepatic
or renal disease. istiaations of serum ur a and electrolyt s,
plasuia bilirubin and serum alanine aminotransferase and alkaline
phosphatase w re all nor mal (Table Hyperthyroiiism lias
also been shorn to enhance hydrocortisone turnover through incr a-
sed formation of conjugated A-ring reduced products, (Levin and
Doughaday, 1955; Brown et al, 1958). Hon of the patients stud¬
ied had clinical vilenco of increased thyroid activity.
Evidence is availabl that a number of drugs arc cap ble of
activating pituitary-adrenal s cr tion. Amongst these are chlor-
pronazine (Sgdahl and Richards, 1956), reserpin (Rgdahl, Richards
and Hume, 1956) and thyro~ine analogues (Melby t al, 1960).
Ther have also recntly benr ports that certain drugs can en¬
hance the hepatic metabolism of corticosteroids. Thus '-Jerk .and
his coll agues (1964)» Conney and his associates, (1955) and Jubiz
et al, (1970) point d out that the anticonvulsant diph nylhydantoin
enhanced hepatic microsomal hydroxylation nzyae .activity, resulting
in an increased cl aranc1 rate of corticosteroids both in rats and
in bu .an subjects. Their work has be n supported by that of ILoque
t al, (1972), who found that dip enylhydantoin hastens removal of
dexa.nethason from the plasma .aainlv by increasing its conversion to
or . polar .a tabolites. Burstein and Klauber, (1965) reported
that barbiturat s too incr as d the clearance rate of corticosteroids.
Brooks et al, (1972) hav recently studied the effect of pheno-
barbitone therapy on corticosteroid metabolism in elev n patients
with bronchial asthma. The pr vious work had be n done on normal
subjects or patients on long term anticonvulsants. Brooks and
Ms co-workers found a m an decrease in half life of 44, and an in-
creas in metabolic clearance rat- of 88, , of the intrav nously ad¬
minister d dexaiethasone following the administration of 120 og of
phenobarbiton ■ in four dai y divided doses for thr e weeks. Three
pr dnisolon -dpendent pati nts d teriorat d clinically .and showed an
increase in blood osinophilia and a fall in th and ?!MFR follow-
ing phenobarbiton . Uhen barbitals • *s stopped, tb.es chang- s
w ro rev rs i. Jho patients in th pr sent study, ther fore, re¬
ceived no other 'rugo besides corticosteroids during the trial.
It was insure I in this vvy, that as f.ir as possible, no rfc raal
factors int rf red with corticosteroid aetaboliaa, and the changes
observed in pttlsaonary function could reasonably be attributed to
th corticosteroids .dndnistored*
The rate of r noval of hy&roeortiaon fro i th bloodstream of
noraal subjects iaas b.on impart d to bo faster in children than in
adults (Done and Kelly, 1956) and fast r in th adult than in the
aged (Tyler et ad, 1953)• It has becMSugg st d that this is due
to the diff rent t .bolio rates pr sent at th different stages of
lif . Gollins t al, ( I'/p) on th other hand, r ported finding
no statistically significant difference in th handling of intra-
v nous hyirocortison betwe. n young and elderly h althy individuals.
Age hex? var appeared to have no effect on the time course of res~
pons I of oortxcosfc roids in the asthmatic patients stuii d in this
inv stigatiati. Thus two fourteen year old pati nts two pati-
ats who wart over aev nty years old had a siailar r. apoas to that
of th© middle jgo adult patients.
Although various tine intervals have boon suggested -3 1 psing
b tv an the .id;ministration of corticost roids and th one t of i;,im¬
prove; .ent in patients ith brouchi1 astkaa, no systematic physiolo¬
gical studies have as yet be n carried out. Jh o tin -Intervals
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have been variously reported as two to three hours (Cop , 197-)» five
to nin hours(Schwartz, 1950) and twenty-four to forty eight hours
and longer (Her h in r, 19')» The relief provid d by cortico¬
steroids has a so been described as iinrn diate, (Son "la, 1966).
It is not surprising that conflicting results of this natur have
b en report d, becaus th degree of sev rity of th disease, the
patients studied, th drugs giv n find the dosages and routes >f admin¬
istration have been widely different. All too oft n, subj ctive
clinical observation so as to have been relied on when conclusions
ver being drawn, instead of syst natic physiological ass nsvent.
Port r and his coll agues (1970), who were studying th effects of
corticosteroids on th" distribution of histamine in th blood of
asthmatic children, r ported se ing very rapid clinical improv raent,
in two pati nts two to thr e minutes aft r the administration of a
singl corticosteroid los . Indo d, so rapid was th ■ effect that
the authors commented that it "se med to be psychologic 1 rather than
pharmacological(Slick and Pre hrm, (1969) usi.- ihtr ruscul-n
oorticotrophiu in pati nts with acut asthma have r ported signifi¬
cant changes in P.3.P.R. (P <0.001) at the tin of the first a asure-
nicnt, si hours after th injection.
In the patients studied the arli st effect produced by the
administration of pr dnisolon that was statistically significant was
th chang in PSV^ and th chang in rela. d vital capacity that occurred
in the s cond part of the study. Thss chang s occurred on hour
after th drug had b cn giv n. In thes pati nts, th ohang s in FVC and
P. ,,i. . be©-. statistically significant at the m: t tisa they --er
..leaeurecL Sp cific conductance was also signficontly iaprov d
when first aswrel, thro hours aft r the drug had been aduinist* red
She avijtt peak effect of all tests for both groups of pati- nts occur¬
red nine hours after prednisolone had been given. 'fhereaft r,
there was a dot riorrticm towards pro-treat ; at lev Is in all t arts.
Xhe changes in P#3#F#E» and FhTTj w. ere still statistically signifleant
wiv u thee were ^csured thirty-thre* hour© aft r ad. sinistral ion of
prednisolone in the e.cond group of patients (;•' 0. Op I P 0.03)» but
had fallen to nosv-signi.ficant lev Is by thirty-six hours. fhe
chaise in F/0 was lot significant when measured tw- nty-four hours
after the drug hod b en giv n. How ver specific conductance
when last .*osur 1, thirty-si hours aft r treatuicat, * -•© still
significantly increased in the s oond group of patients ( f 0.05) •
In contrast the s,;ia change in . •.<#. #.»« was significantly iaorae d at
the tin© of the first oe&sure^ent, on: hoar after th iotr voaoua in¬
jection of hydrocortisone, the peah effect being attained in five
hours. fhe o -iw change in iVU«Fvi« was no longer si. tisfically
significant at th© time of the last rae-sursneati v.. Iv hours oft r
the injection (? 0.10),
Payne tot, (196?) ritlng about the investigation, o bronchial
aathaa, stated: "fit© inability to repro&uc patterns of airway r s-
ponaiv nests to test a dications in the saa? subjects at diff rent
tines illustrates the co iple smtur of the biological syste.-.: being
.©aour d. In addition, failure to duplicrvt individual r -
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spouse patterns at different tinea should not cause dismay".
33ic fact that consistent changes in tests of pulmonary function
hav be.n d.nonstrated in this study following th adhnistra-
tioa of corticost„roids, -net be attributd to careful initial
selection -and rej ction of patients who failed bo aeot th. strict
criteria laid down. ho pati nt was admitted to th: study whose
clinical history lid not suggest that stable airway obstruction
was present during the p.riod immediately prior to hospitalisation
and none were allowed to con.pl te th study if th disease showed
evid nc of significant improvement or deterioration during th .
first two days of the trial. Collins et al, (197^) have recen¬
tly reported failure to detect significant improvement in putiants
with asthma following intravenous hydrocortisone-■ assessing response
by :n asure..ient of the d.h»F»r{. However, the patients they, stud¬
ied were ..cutely ill, uiiereas in the presoxit investigation such
patie :ts w re .xclud d.
fho differ at ti..< -course r spons o of pr.dnisolon;. and hydro-
cortison. in the subjects studied could perhaps be best ascribed to
the different routes of aduinstration used and the fact that these
two corticosteroids art known to b metabolised at different rates.
Absorption of orally adxainist rod corticosteroids is thought to occur
by passive diffusion chiefly from the proximal half of the snail irtos-
tine since for any given corticosteroid, absorption in terns of weight
per unit tine is directly proportional to th concentration, (hch &1,
"(965). One of the earliest indications tixat adr nocortical hor-
mama could be absorbed from the latestinss was Osier* s report in
1096 of a patient with Addison*s disease who showed signs of im¬
prove ient after oral administration of a glycrol extract of hog
adrenal glands. Many years later, Freyberg, (1930) first
showed that cortisone is absorbed from the gastro-intestinal tract,
when he d scrib d its effectiven ss in the treatment of rh uiaatoid
disease. In contrast with the parenteral administration of cor¬
ticosteroids whose absorption dep nds on their water solubility,
the rat of absorption of orally administered corticosteroids ap¬
pears to be MT« related to their lipid solubility; since as the
number of hydromtyl groups increases, absorption becomes slower,
the pore aiz- in the snail intestine is only four A units and the
corticosteroid molecule is thus too big to simply flow through tho
poras. It would appear likely that sorae ehang oust occur in the
lipoidal surface of the cell membrane ii order for the steroid iiole-
cul to pass through, (bi ?al«ja, 1971)*
ILan changes in F.J.F.R# following oral prednisolone became
statistically significant one hour later than they did when intra¬
venous hydrocortisone was administered. However, although it
might be t npting to conclude that this di for nco could be solely
ascribed to the slow r absorption of the orednieolone, data is now
available that absorption and biological activity are not necessarily
directly related. Indeed, Sch dl, (1965)» has shown that sometimes
they ;may be inversely related; tntis progesterone, one of the best ab¬
sorbed steroids is almost inactive orally, and triamcinolone, which
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is the most poorly absorbed compound is quite active clinically
whan given by the oral route*
Ibe differ nt tiaes when aaxisu® effect was achieved using the
two corticosteroids and the different duration of action is very
probably das to their different biological activities and rate of
m tabolic breakdown. Collins st al, (1970) reported a plasm
half-life of 125 - 133 minutes wh n intravenous hydrocortisone was
administer d to a 2m.1t r of patients with acute asthma. The
plasma H-oJi.C.S. lev-.l r ached a aaoldnu after 60 minutoe.
Nelson at al, (1952) had prvioualy publielied similar figux a for
orally administered hydrocortison in a marml oubjet. l*r:4-
nisolone is Imam to b more slowly r mowed from tit circulation
than hydrocortisone. Its half-life is on; on aar rago 'double that
of hydrocortisone in normal subjects (alaunwhite and Sandbox's, 1955f
nly et al, 195a* andberg and alaunwhite, 1957; £&tg set t al, 1959|
Di Palma, , 1971)* It appears likely that it is th longer persis-
t- no. in the plasma of free unconjugated, and th r for pr sunably
phar.-iacologioally active, prednisolone which accounts for its longer
activity. Using isotope lab 11 d prednisolone it has bo a found
that all its ntdbolitas aru excreted within 43 hours of its admini¬
stration.
fh re are saa conflicting reports about how corticosteroids
are uetafr Ideally dealt with in asthmatic patients* Buyer et al,
(1967) found that steroid treated patients with acute osthm achi ve
a low plasma Cortisol response to intravenous hydrocortisone* Thus
r;i«tabolic ol araac rate of hydrocortisone -*sm how-rver nor-.**! la
those pali ato who had svot pr viously r ©eivod corfcicoaierai&s,
Schwarts t al, (1968) reported finding a aor ;-apid pl&sim oloor-
aac of byirooart inane in astha&tis patients vho showed no olinioal
response to cart ieosteroida* It i» not known whether th- ir pati¬
ent* had a i aigaifioant heputi© or r-aal dysfUastion or whether Ibsjr
wore taking othor drugs as w li. On the eth t band, Uollias at
al» (I 970) in a wall controlled trial fall A to find my ss itistio-
ally signifioaat • differ m in tb® kindling of intravenous kylrocor-
tiacsie betwes nora&l subjects and asthmatic patie&i#* Plasaa
11-u#iUC«3# leeia v-tc also unaff et d by rfc th v the aot2x.^.tio
pati ate had be a r.©siting oortioooteroi is or not.
ILfei- so- raa to b* reason to b©li<w-, that am» of too biologiesl
ff ot» of ooriiooot roils reprea at indirect rather tlaai direct
tfttnsi (diddle, In gestural, the pharmacologics! -.wad thera¬
peutic ff otivv nose of a drag is a function of its concentration
within th< b*ijr at a given immiit. 2hia how ver lo s not appear
to be the ess- with oortlsosteroids, vhsrc a significant l«Unt
p riod : into b tti ©a ihe tin- of a . Just* concentration in th.- piassaa
or tissues ani th- tine of th ir peak affect (if lean ot kL» 1952).
'Ibait although it would be expected front previous studi- a that the
aaarjyasra concentration would be one hou- after the i&jectiaa
of hydrocortisone, the eu peak effect in the eight Sethisatio p&ti-
«-rrtr. studied occurred five ben. « aft- r the drug had. been adninist red.
?he boa fioikl therapeutic ff at of corticosteroid© would appear to
hmm persist • d for a long tin' after th pi is m lev la of hw»»a««fc.
tisane would have b» en >pct d to return to baa line values•
The effects of corticosteroids on tests of pulmonary function
in tu-. asthnatio patients studied in the preo at inv stigation appear
to follow a si dlar tin) oours to that of other biological r-ff cts
of cortieost roi&a. Thorn and hie oo-wor ere (1953a) reported
that the ra tabolic and clinical eff cts of a oingl dose of intra*-
■aiacular conrtison were evid nt in thr to four hours, although
pex. xtivity usually occurred ight to tv, lv hours aft r the injac—
tion and the ff otive duration e -tended a* r period of twenty-four
hours or slightly longer* R<nal ercretioa of leotrolytes hae been
shown so bo 1 frait ly off ct d viithin t' a to faux hours of the ad¬
ministration of intrataiaoular, (Fouroann et al, 1952) as well as
intravenous, (Thorn et al, 1953b) do so ycorfcisone. Fouraaan and
his oo~- or era found that potassium loss in the urine reached a nar-
i:u:i tw Iv hours aft r the injection. hills and his co-workers
first noted th- fall in th m. iber of circulating oninophils fol¬
lowing , end this soon b 'oaae a standard t ss for ma ssing
corticost raid activity* falcon et al, (1952) found the maaitaau
chuxge in circulating eosinophils four to ight hoars after the ad¬
ministration of 200 sg of oral hydro ycortioosteron . This lag-
god behind peak steroid lev Is by tlxre to sev n hours. Mnasure-
irjeats wer only oarai;?d out one, four and eight hours aftor th drug
had b on giv a. ( p>„, (1972) roport d a aarliaoa easinopr. lie eff-
f ct occurring eight hours aft r the oral administration of 200 :.g of
hydrocor&son x tat©.
G1 ,:in t al, (1957) studied the ff ct of corticosteroids on
th production of liver glycog n 011 tw nty-four hour fasted,adrona-
loctOtaized rats. Jhey found that following th. injection of 1 mg.
of hydrocortisoneeither subcutaneously or intravenously, the MaiCftflMI
effect could be d tected about ight hours later, at a tin. when there
was an insignifioont amount of hormone in the blood. The hypcr-
glycaeoic effect of corticosteroids follows a similar tine course.
Thus West, (1953) reported that 3 of oral .-jethylprednisolono
produc d its p ak ff ct ight hours later, and with the sa.o dos of
oral pr inisolon , naximm ff ct occurr d b tv en four and eight
hours afterwards. Walton et al, (1910) described the ff ct of
various dos s of nethylpr dnisolon on blood glucose in four nor.nal
subjects. Irrespective of the dose used the onset of the ffect
occurred between two and four hours; the first glucose estimation
being performed two hour3 after the drug had been givn. fhey
found how ver, that the pea.; measurable ..ffect was affected by the
amount of steroid given, being greater and on the whol coning later
vith increasing dosage. In general, the peak effect occurred be¬
tween. si: and ten hours, and the duration was between si te n and
twenty-two hours.
Corticosteroids have now been used in bronchial asthma for
over twenty years. Carry r and his associates ver . th.. first
to use intramuscular cortisone in thre. patients vith asthma in
1950 and intravenous hydrocortisone was first us d in this condition
by Burrage and Irwin, (1955)> having been us.d in an oral farm the
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previous y ar by Schwartz. Prednisolone and prednisone were
osriginally introduced by Herzog and his coll agues in 1955*
Th ir therapeutic value in branchial asthma was demonstrated by
Baraoh et al, in the sane year. Very little however is known
with any certainty of their possible mod s a.., site of action in
bronchial asthma.
Goth, (1966) put forward the hypothesis that the anti-allergic
affect of corticosteroids is simply another manifestation of their
non-sp cific suiti-inflammatory action. However, as point ,-d oat
by Aviado and Carrillo, (197^) direct proof of this hypothesis i3
lacking. It has bo n suggested that the anti-allergic action
is achieved by increasing the stability of various membranes, such
as thos of ndoth lial and smooth muscle cells and of lysosoac3,
as well as possibly reducing enzyme activity, such as that of histi-
dine decarboxylase (Brocklehurst, 1968). Both prednisolone and
hydrocortisone have been reported as stabilizing lysosoa s thus re¬
tarding the release of inflammatory enzyme s both in vitro and .the
living cell, (Weismann, 1971)*
It has b en suggested that corticosteroids inhibit the forma¬
tion of antibodies (Bjorn bo et al, 1951; Gabrielsen and Good, 1967)*
In the passively immunized rabbit cortisone docs not influence the
l'vel of circulating antibodies, however, suppression of formation
of new antibo ies has be n reported in the actively imrmmtz- d rab¬
bit, (Gvrnuth t al, 1951).
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The effects of corticosteroids on th metabolism of th lympho¬
cyte have be.n studied in .detail. The synthesis of nucleic acid
and protein is depressed and glucose utilisation is decreased.
Th.. thymus loses intracellular potassium and gai it sodium. 'These
changes .ire probably secondary to a oar© fund, ja-tal action of cor¬
ticosteroids of which very little is known at present. Despite
the changes in lymphoid tissues (Hecider oadJohnson, 1949? Dart1stebsn
and Dougherty, 1954, Clamant, 1972), the corticosteroids do not signi¬
ficantly suppress anti-body synthesis in nan, although they do so in
animals, (Larson and Jonlinsoa, 1991)* Huffman and hllis, (1969)
immunized asthmatic children with diphth .ria and tetanus toxoid and
typhoid/paratyphoid audiafluonsa vaccines. Assays wer performed
for sp cific anti-body responses, Th y show.d tla.t corticosteroids
did not interfer- with the synthesis of circulating anti-body.
Inhibition of the formation or storage of histamine has also
been r ported, (Carrillo and Aviado, 1968). Cortisone strongly
inhibits th rate of histaain binding in th rat skin (hchayor et
al, 1954) and the formation of histaain in lung tissu , (Gefland, 1951
Beall, 1965)• hoaix and Brand, (1957) found marked falls in blood
histamine levels in asthxnatio patients who w re giv 11 therapeutic
doses of prednisolone. However, the method then mploy d for
estimating histamine levels was rather inaccurat.. More rec>ntly
Konoshita, (1963) lias report d that high blood histamine lev Is -
countered in status asthsaticus decreased to nor al lev Is in 4 out
of 6 patients, who were given corticosteroids. P pys, (1971)
uggested that corticosteroids would block *inducible histamine*
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produc d by histidin decarboxylase. Pho restoration of hista¬
mine to tissues which have been deple-t d of it is thor by delayed.
Corticoatoroids could also sensitise tlie A r captors in th-
airways, thus lower the rec-ptor-thr .snold to the action of catecho¬
lamines. Phe adrenal glucocorticoids seen to act vdth catechola¬
mines as a functional unit. It has been cstablisixed that in the
abs.ac. of these steroids the rcccptoaxthreahold for catecholamines
may be elevated, at timesto the point of complete unrcspoa3iven as
(haney and uoldst.in), 1257)*
Suggestions for other poasibl mechanises have includ I
dir ct rola-unt action on smooth muscl . Lefcoo, (1936) report J
that hydrocortisone added to an isolated organ bath produced relax¬
ation of guinea-pig tracheal muscl . Ginelli t al, (1964)
show d that cortisone di.riniahed the response to acetylcholine,
and hence inhibition of acetylcholine indue, d bronciiocoi4»triction
could be y t aaothor way in which corticosteroids night act.
Avion® ami Oarrillo, (1270) basing their studies on sensitised
and non-s nsitiaed aniiaals, concluded that the two most important
a onanisms app ar to b th< inhibition of format ion or storag of
histaaiiio and a .direct action of corticost eroids on bronchial smooth
muscle. Phcy shov;od that in rats the action of corticosteroids
consists not only of relaxation but also of a r duction in the re¬
activity of the airways to cigarette saokt (Aviado and Carrillo,
1969)* However, they failed to r produce similar local effect®
in doge (Carrillo and Aviado, 1970) * 1Mb emphasizes that cor¬
ticosteroids probably have different modes of action in various
speoies, underlines the need for groat care when extrapolating
front the animal experiment to the human situation*
Studies have recently be n carried out on the effect of cor¬
ticosteroids an two leucocyte membrane enzymes, 1 ucocyte adenyl
cyclase and adenosine triphosphatase, of normal and asthiaatic chil-
dr a, (Coffey et al, 1972). It was found that adenosine tripho¬
sphatase activity was increased in asthmatic patiants and that this in¬
crease was rtversod when corticosteroids wore administered. Hydro-
cartison- was found to stimulate adenyl cyclase and inhibit both
adonosin triphosphatase and phosphodiesterase. Coffey t al,
sugg-at four possible mechanisms for the action of corticost roids
in asthma; direct simulation of adenyl cyclase, restoration of re¬
sponsiveness of adanylcyelaso to catecholamines which was found to
be decreased in asthmatic patients, inhibition of adenosine triphos¬
phatase activity and inhibition of phosphodiesterase.
Hot only is the site and mode of action of corticosteroids in
bronchial asthma unknown, but there is also uncertainty as to the
exact site of airway obstruction in patients with bronchial asthma
(Haoklem, 1971)• Hogg at al, (1968, 1970) have shown at post¬
mortem examination that the major site of obstruction in lungs with
bronchitis and emphysema, as well as in those with bronchiolitis,
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pulmonary complications of fibrocystic disease, and bronchiectasis,
was in bronchioles 2 ram in diameter and less. No mention is
made of asthmatic lungs in thir studies. Campbell, Martin and
Riley, (1957)» based their work on a mathematical analysis of the
factors tending to open and close thr airways during a forced ex¬
piration. They measured the intrathoracic pressure at which maxi¬
mum expiratory flow occurs by means of an oesophageal balloon and con¬
cluded that critical narrowing first occurs in the large airways in
asthma. fir re has rec ntly Ven som- confirmation of Campbell's
findings by Gayrnrd (1968). Crofton and Douglas, (1969) remark
that bronchoscopy do s not sugg st any crude variation in broncho-
constriction among the larg bronchi in the asthmatic patients they
have studied.
Although it has yet to be proved possible to determine th
precise location of the narrowing that occurs during a spontan ous
or provok'd attack of asthma, some indication can be obtained from
the changes that take place in mechanical function. A number
of work rs hav shown that in asymptomatic patients, the distribu¬
tion of ventilation r mains uneven despit the fact that tests such
as the measurement of Raw and PflV^ ar normal (McFadden and Lyons,
1969; Woolcock et al, 1969? Levine < t al, 1970)• They assumed
that this was due to r gional differences in time constants of small
lung units and indicated residual abnormality in th small airways.
Noolcock et al, (1969) regard the small airways in adult lungs as a
"silent zone", in that obstruction within them causes little abnor-
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raality in tests which are specifically designed to detect it until
the dsgree of obstruction is quite advanced. It is now accepted
that changes in Raw reflect predominantly changes in larg airways
(Greeil, 1964)» whereas the F3V^ is determined mainly by the elastic
recoil of the lung and the resistance of the airways upstream from
the equal pressure point, (Macklem and Mead, 1967)*
McFadden and Lyons, (1969) measured the resistance of airways
during forced expirations upstream and downstream from equal pres¬
sure points, (Mead et al, 1967)©Offlbihiig the equal pr ssure point
cone pt with measurements of isovolume pressure-flow curves, in
asthmatics during recovery from acut attacks. Downstream re¬
sistance was measur 4 at the point that flow limitation was reached.
Fhey found that both upstr am and downstream resistances were in-
cr as'd, indicating that both large and small aim-jays are involved.
However, their data showed that the principle area of obstruction
appeared to b in the upstream pathways; i.e. from alveoli to tin
equal pressure points. Periph- ral airway obstruction may cause
equal pr ssure points to b displaced upstr am (Macklem et al, 1965)»
with th result that downstream r sistance is incr asd b cause the
downstream segment is lengthen d and not b oause there is intrinsic
abnormalities in the segment, (Maoklem, 1971). Cadr et al, (1971)
studying lung .mechanics during provocation of asthma with metacholine
showed that both the larger as well as the smaller airways were in¬
volved, but the response of th' larger airways was fast- r and of a
shorter duration than the rfspons of th smaller airways. The
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charact .ristic finding of plugging of the smaller airways "by viscid
plugs of mucus in lungs of patients dying in status asthnaticus
(Spencer, 1957; Dunnill, 1971)» indicates that in the nor prolong d
and s vere type of asthma it must also he assumed that many hronc. i«»
ol s ar ohstruct d.
There is .th rofor probably nor than one site of airway
obstruction. Thus there is evilence that in remission conoid r-
abl obstruction nay he ores at in p ripheral din-rays, (PcPadd n and
Lyon? 19-19; Uoolcock t al, 1959; Levin, t nl, 197^), vhereas, luring
an acute attack there is bronohographic viience that central airways
are narrow 1 (Dulfano and He'.: tson, 1951; Host in t al, 1947).
The r lativ contribution that the larg r and the smaller airways
nak , ith r singly or in combination, to the obstruction of the flow
of air in the various stages of asthma r mains to b d temin d.
Although, the present study throws very littl light on the nod-' of
action of corticosteroids in asthma, th results indict that ob¬
struction was pres nt both in the larger airways as sho'n by a marked
r duct ion in SCfaw and ~!.P,F.R., which an thought to r"fleet vainly
upper airway chang-s, as w 11 as in th peripheral airways as shown
by bhe changes in P.h.F.R,, a test, :ost determin d by th small r
airways. Th improve : nt is obvious fro : th -a i urn flow volume
p piatte' agnict o rc nta/v of cp~oiiv (vm /^~l).
H«-' ver, the changes of flow rat at the actual vital capacity ar
larger than this repres ntation v— sts. IThen the earn ma iraua
piratory flow volun curv s ar plott d against an absolut volume
seal , which shows the decrease in TLC and RV aft r treatment (Pig.
24, 75 and 26, )the 4 gr e of improvement that has occurred is
168.
even greater. Such a representation is also more accurate
physiologically. As no volume displacement body plethysmo-
graph was available absolute lung volumes were obtained from sep¬
arate measurements of helium dilution methods as suggested by (Bou-
huys et al, 19^9)• As can be s en from figur s 24 - 26,
parts of the lung which contributed little or nothing to flow be¬
fore treatm nt made significant contributions after th prednisolone
have been given.
Although the Vtg of the asthmatics studied was signficantly
greater than the F.R.C. measured by closed circuit helium dilution,
the differ nc betwe n the two measurements was not very big.
There have ben a number of studies in which lung volumes in asth¬
matic patients have been measured by both methods, (Meisn r and
Hugh Jones, 1968; Horzog et al, 1968; Corbeel, 1968; Woolcock t
al, 1971)• fhes- have in general shown marked differences be¬
tween the two methods ,m* patients on which these measurements
were carri- d out had hroever acute asthma or asthma of a much more
sev re degree than that of the patients presented in this study.
Woolcock et al, (1971) have sugg sted that the differ-noes obtained
betwe n plethysmography measurements and those obtained by helium
dilution, probably d'pend on the develops- nt of non-communicating
regions in asthiaa. In th pr-sent investigation, great car- was
taken to ensure that dilution of the helium was complete, by asking
the patients to perform thre relax-d vital capacity manoeuvres be¬
fore the final helium reading was taken. Studies comparing
plethysmography with prolonged gas dilution methods of measuring
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lung volumes hav shown good agreement in patients with chronic
airway obstruction (Tierney and Nadel, 1962} Ross et al, 1961).
Thus in Tierney and Model's work the mean diff rences between Vtg
and F.R,G. in a number of emphysematous pati nts was 990 ml when
the op n circuit dilution method for measuring F.R.C. was per¬
formed over s-veil minut s, hut fell to 130 nil when this was prolon-
g d to betwe' n twelve and eighteen minut s. This bears out
Bedell's (1956) original suggestion that gas dilution methods, un¬
less prolonged do not accurately measure the lung volun in son
patients with chronic airway obstruction.
Throughout the group of patients studied in the present in¬
vestigation the changes produced by the administration of cortico¬
steroids on body pi thysraographic measurements and flow volume
curves were consistent in ti ling and degre with thos produced in
the FGV-j and P.3.F.R. Although ?. l.F.R. is an effort dependent
manoeuvr , pres nt results demonstrate that it is as sensitiv an
index of chang as the more complicated measur raents, provided the
full co-op-ration of the pati nt in producing a maximal effort is
nsured on aoh occasion.
Th- administration of prednisolone r suited in a consistent
and significant improvers nt in PaO^, (A-a)D0o and venous admixture
off ct. Th re was no significant correlation between PaC^ and
airway obstruction as raeasur d by the F3V^, P.G.F.R. or SGaw.
A similar lack of correlation has been found by Rees, Millar and
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"Donald (1953) in their study of patients in status asthmticus and
by Shibel and iSosor (1970) in pati nte with chronic airway obatruc¬
tion. Alveolar ventilation show d no significant change,
fha ohang s in V_/VT ratio wer small or a gligible in all i>-
patients studied. In s. study of chronic asthmatic patients
treated -ith isopronalin© and a inophyllino, f i and Head, (1957)
report d a sidlar lack of chang in ratio, spite a narked
difference in (A-a)D0o. Thy claimed that in these particular
circu istanoos, (A-a)DQ„ is a mora s nsitive indf of change in v n~
tilation-perfusion distribution.
Two >f the patients, (Hi . -an J«C.) attained nor.ml ?a0?
values despite spirom trie and pi thymographic vid nc of persis¬
ting airway obstruction, Similar findings have been reported by
¥ ,1a.bhji(l9n6) and tn. ocu an" aocul ecu (1973) in so of the asth¬
matic patients they studi d. Ful ihan and his co-wor>: rs (19^7)
studying chroaio bronohitic patients who had been tr at d with beta-
» thasan© found significant improvement in PaOg and v - nous adm. -
ture cff« ct with no change in fciV^ and alveolar v ntil -iixi.
Such an i sproveaent in PaO^ is probably dus to a more uniform dis¬
tribution of ventilation in r lotion to perfusion.
It is to be hoped that this work is not merely an int root¬
ing physiological e rcisc but that it ray also have so:.to important
clinical connotations and p rhaps contribut in a snail way to the
managerr at of a lis as which Thomas illis (1677) described as
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Individual body plethysmographic values obtained from twenty-si
normal subjects*
Raw Gaw Vtg. SGaw
(cmHgO/l/sec) (l/see/craHgO) (l) (l/sec/cniHgO/lVTC)
Females
Hon-smokers
1. 1.25 0.80 3.30 O.242
2. 0*96 1.04 4.20 0.247
3* 1*41 0.71 2.93 0.242
4. 1.20 0.83 3-22 0.257
5. 1.03 0.97 3.73 0.260
6. 1.20 0.83 2.95 0.281
7. 1.15 0.87 3.15 0.276
8. 0.87 1.12 3.45 0.333
iles
>Ton-smokers
9. 0.97 1.03 4.98 0.206
10. 0.97 1.03 4.73 0.218
11. 1.14 0.88 3.97 0.222
12. 0.98 1.02 3.78 0.270
13. 1.02 0.98 3.16 0.310
14. 0.92 1.09 4« 66 0.234
15. 1.09 0.92 3.72 0.247
16. 1.12 0.89 4.60 0.193
17. 1.21 0.83 3.84 0.21
18. 1.30 0.77 3.80 0.202
19. 1.25 0.30 4-45 0.180




Raw Gaw Vtg. SGaw
(cmELO/l/sec) (fl/seo/coHpO) (1) (l/sec/cmE^O/Vtg)
Males
ITon-saokers
21. 0.85 1.17 4.51 0.260
Hales
Smokers
22. 1.44 O.69 3.50 O.198
23. 1.38 O.72 3.99 0.180
24. 1.60 0.63 3.50 0.180
25. 1.21 0.83 3.40 0.243
26. 1.1)4 0.65 4.05 0.160
Appendix.
Table (il)
Individual values obtained from 10 normal subjects on five different
days. Analysis of variance in Table III in text.
SUBJECT Vtg. Raw Gaw SGaw
(1) (cmlijO/l/sec) l/sec/craH^O l/sec/cm
HgO/l/vtg
1. E.M.K.F. 4.10 1.00 1.00 0.240
4-30 0.92 1.09 0.254
4-23 0.95 1.05 0.248
4-35 0.91 1.09 0.250
4-18 0.93 1.07 0.255
2. P.G. 3.30 1.24 0.81 0.240
3-50 1.19 0.84 0.240
3-43 1.18 0.84 0.245
3.37 1.27 O.78 0.231
3.28 1.24 0.80 0.243
3. L.C. 2.85 1.52 0.66 0.230
3.00 1.30 0.77 0.258
2.91 1.28 O.78 0.268
3.15 1.23 0.81 0.257
2.97 1.25 0.80 0.269
Appendix
cont. Table II
SUBJECT Vtg* Raw Gaw SGaw
(1) (caF^O/l/sec) l/sec/cmHo0 l/sec/cm/
H20/l/vtg
4. M.G. 3.40 1.20 0.84 0.240
3.20 1.30 O.77O 0.240
3.40 1.22 0.82 0.241
3.62 1.19 0.84 0.232
3.35 1.24 0.80 0.238
5-P.M. 3-97 1.14 0.88 0.222
3.88 1.09 0.92 0.238
3.86 1.10 0.90 0.233
4.00 1.12 0.89 0.223
3.79 1.09 0.91 0.240
6. G.D. 4-63 1.02 O.98 0.210
4.83 0.91 1.10 0.228
4.68 0.88 1.14 0.244
4.68 0.92 1.09 0.234
4.50 0.88 1.14 0.252
7• J•R«S« 3.22 1.00 0 1.00 0.310
3.19 0.93 1.08 0.338
Appendix
con-fc. Table (II)
SUBJECT Vtg. Raw Caw Sgaw
(1) (craH^O/l/sec) l/sec/cuiH^O l/sec/cm/
H20/l/vtg




3.21 1.04 0.96 0.300
8. R.C.B. 4.40 0.84 1.19 0.270
4-38 0.79 1.27 0.290
4-68 0.85 1.18 0.252
4.55 0.83 1.20 0.266
4.55 0.97 1.03 0.226
9. A.T.P. 3.69 1.10 0.91 0.247
3.78 1.02 O.98 0.260
3.60 1.13 0.89 0.248
3.83 1.06 0.94 0.246
3.71 1.16 0.87 0.234
10.D.B. 3.80 1.03 O.97 0.254
3.71 0.97 1.03 0.278
3.70 1.04 O.96 0.260
3.77 0.94 1.06 0.288
3.93 0.94 1.06 0.270
Appendix.
Experiment 2.
English Translation of cxp rinient by R. Monzies (Tentamen Physio-
logicum Inaugurale de Respiratione; Edinburgh, 1790)*
A strong and healthy man, 5ft. 8ins. tall, measuring 3ft.
3ins. round the thorax, was securely placed in th barrel ABCB
(Figure 4), which was fill ,d with water at a t mperaturc of 9B°F. up
to that part of the man's neck v/hich vas moat convenient for m insur¬
ing the rise and fall of water. This was found to be 1.25 ins.
His arterial pulsation, both b fore and after immersion was at the
rat' of 64 or 65 per minute, his respiration 14 or 14 per minute,
as had be n frequently not d b fore. Phis remained constant for
the two hours or raor during 'which he was in th barrel. All this
time he did not suffer any discomfort in breathing in and out or in
any other r sp-ct. Indeed, throughout the xp riment, the rise/
fall of th water was found to remain constant, viz. 1.25 ins.
When the man breathed in deeply he inhaled as much air as caus d the
water to flow over the edge of the cylinder. As the area of the
cylind r was 55-41 e*. ins. and that of the man's n ck 18; 55*41 -
18 x 1.25 = 45.76 c. ins. gives the volume of air normally breathed
in by the man. This .yp- riraent was repeated thr'e times, with
practically the same result. I considered it ncessary to carry
out the xp riraent to test his respiration by m ans of th~ bag in










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Individual results obtained in seoond stage of study.
Pred. Spirornetric measurements from Cotes, J. Lung Function,
Blackwell Scientific Publications, 1968.
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